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ABSTRACT 
Bovine adenovirus (BAdV)-3 is a non-enveloped, icosahedral virus with a double-stranded 
DNA genome, and is being developed as a vector for vaccination of animals and humans 
(Rasmussen et al., 1999; Zakhartchouk et al., 1999).  Expression of viral genes is divided into 
early, intermediate, and late phases.  The late genes of BAdV-3 are grouped into seven families 
(L1 to L7) based on usage of common polyadenylation site(s).  The L1 region of BAdV-3 
encodes the 52K protein, a non-structural protein conserved among members of the family 
Adenoviridae.  In human adenovirus (HAdV) -5, the 52K protein is involved in packaging of the 
viral DNA into the capsid.  The N-terminal half of the protein has been proposed to mediate 
serotype specificity of DNA packaging.  The objective of this study was to characterize the 52K 
protein of BAdV-3. 
DNA sequence analysis revealed that the BAdV-3 52K open reading frame encodes a protein 
of 370 amino acids rather than 331 amino acids as previously reported (Reddy et al., 1998). 
Western blotting with anti-52K serum detected the expression of a 40kDa protein at 24 to 72 hrs 
post-infection.  BAdV-3 52K localized predominantly to the nucleus in BAdV-3 infected cells 
and in transfected cells in the absence of other viral proteins.  Analysis of mutant 52K proteins 
revealed that residues 102-110 were necessary but not sufficient for nuclear import.  This 
suggests that residues upstream or downstream of the identified 52K nuclear localization signal 
(NLS) are required, or that the function of the NLS is dependent on its conformation within 52K. 
The nuclear import of 52K is significantly, but not completely, dependent on soluble factors, 
ATP, and temperature.  A peptide competing for binding to importin β and a peptide encoding 
the NLS of Ycbp80 were also able to inhibit nuclear import of 52K.  However, a dominant 
negative mutant of Ran was unable to block 52K nuclear import. These results suggest that 52K 
uses a classical importin α/importin β pathway for nuclear import. In support of this, a specific 
interaction between 52K and importin α3 was detected.  In addition, 52K was able to accumulate 
in the nucleus in the absence of soluble factors and ATP when the nuclear membrane was 
permeabilized with detergent.  This suggests that, in addition to nuclear import by the importin 
α/importin β pathway, 52K is able to accumulate in the nucleus by binding to nuclear 
components. 
A yeast two-hybrid system identified interactions between BAdV-3 52K and pV, pVI, pVII, 
and IVa2.  However, only the interaction with pVII could be confirmed by GST pulldown.  52K 
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and pVII also interact during BAdV-3 infection.  An interaction between 52K and pVII has 
previously been shown in HAdV-5 infected cells (Zhang and Arcos, 2005). 
Mass spectrometry analysis of proteins co-precipitating with BAdV-3 52K identified a 
cellular protein, NFκB-binding protein (NFBP), which interacted with 52K.  The interaction 
between NFBP and 52K was confirmed in vitro and in vivo.  NFBP has been shown to be 
essential for ribosomal RNA (rRNA) processing.  While NFBP is normally localized in the 
nucleolus, co-expression with 52K results in the redistribution of NFBP from the nucleolus to 
other parts of the nucleus. While this suggested that redistribution of NFBP by 52K could inhibit 
rRNA processing during BAdV-3 infection, we were unable to detect a difference in rRNA 
processing in cells expressing truncated or full-length 52K in the absence of other viral proteins.  
Since NFBP is a multi-functional protein, future experiments should focus on other possible 
biological functions of the interaction of NFBP with BAdV-3 52K. 
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1.0 LITERATURE REVIEW 
 
1.1 Adenoviruses 
Adenoviruses were first isolated in 1953 by two groups attempting to identify the causative 
agents of acute respiratory infections (Rowe et al., 1953; Hilleman and Werner, 1954). They were 
termed adenoviruses based on their initial isolation from adenoid tissues (Enders et al., 1956), 
and were later associated with acute respiratory infections and a cause of the common cold in the 
general population. 
All adenoviruses have a double-stranded DNA genome, ranging from 26 to 45 kilobases in 
size (Davison et al., 2003), which is contained in an icosahedral capsid (Berk, 2007). They can 
replicate in respiratory and gut epithelium, as well as the eye, but tissue tropism varies between 
serotypes. Although adenoviruses are present in a wide range of species, their replication is 
generally limited to their host species. However, the occasional presence of neutralizing 
antibodies to adenoviruses of other species suggests the possibility of asymptomatic infections in 
species other than the natural host (Shenk, 2001). 
 
1.1.1 Adenovirus taxonomy 
Adenoviruses comprise the family Adenoviridae. Numerous serotypes infecting a wide range 
of species have since been identified (Berk, 2007) and are divided into five genera: 
Mastadenovirus, which exclusively infect mammalian species; Aviadenovirus, whose members 
are limited to avian hosts; Atadenovirus, which can be found in mammalian, avian, and reptile 
hosts but have a common phylogenetic ancestor; Siadenovirus, which are phylogenetically 
closest to Aviadenovirus but which have been isolated from a wide range of species; and 
Ichtadenovirus, found in fish (Benko et al., 2002; Davison et al., 2003). 
The majority of identified adenoviruses belong to the Mastadenovirus genus and its members 
have been the most extensively characterized.  Members of the Mastadenovirus genus are limited 
to mammalian species and include all identified human adenoviruses.  Their genome size ranges 
from 30,536 bases for canine adenovirus type 1 to 36,519 bases for simian adenovirus type 25 
(Davison et al., 2003).  Several proteins present in the E1, E3, and E4 regions of the genome, as 
well as the capsid protein pV, are unique to members of the Mastadenovirus genus (Davison et 
al., 2003). 
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The members of the Aviadenovirus genus infect birds with varying degrees of pathogenicity.  
They have the largest genomes in the Adenoviridae family at up to 45 kilobases for fowl 
adenovirus type 8 (Ojkic and Nagy, 2000). Genomes of members of the Aviadenovirus genus 
lack homology to the corresponding E1, E3, and E4 regions of Mastadenoviruses (Chiocca et al., 
1996; Ojkic and Nagy, 2000), but at least two proteins from chicken embryo lethal orphan virus 
are able to bind to the cellular retinoblastoma protein and activate E2F-dependent transcription, 
complementing the function of the Mastadenovirus E1A protein (Lehrmann and Cotten, 1999). 
Members of the Atadenovirus genus have been identified from a wide range of host species, 
including cattle, birds, sheep, and snakes, but none from humans (Benko and Harrach, 1998; 
Both, 2004).  There is evidence that members of the Atadenovirus genus originated in reptilian 
species (Wellehan et al., 2004). Several features distinguish members of the Atadenovirus genus 
from the other adenovirus genera.  Their genomes have a high A/T content (Benko and Harrach, 
1998) and they lack homologs of the E1A protein, the E3 region, and the structural proteins V 
and IX (Xu et al., 2000; Davison et al., 2003; Both, 2004). Members of the Atadenovirus genus 
also encode two unique capsid proteins and several novel open reading frames not found in other 
adenoviruses. (Both, 2002; Both, 2004; Gorman et al., 2005).  
Analysis of members of the Siadenovirus genus shows that their closest phylogenetic 
relationship is to those from Aviadenovirus genus (Davison et al., 2000).  Three viruses are 
recognized members of this genus: turkey adenovirus type 3 (also known as turkey hemorrhagic 
enteritis virus), frog adenovirus type 1, and raptor adenovirus type 1 (Pitcovski et al., 1998; 
Davison et al., 2000; Kovács and Benko, 2009).  However, several other putative members of the 
Siadenovirus genus have been recently identified in a number of bird species as well as from a 
tortoise (Katoh et al., 2009; Rivera et al., 2009; Wellehan et al., 2009; Kovács et al., 2010).  The 
genomes of frog adenovirus type 1 and turkey adenovirus type 3 are 26,163 and 26,263 bases in 
length, respectively (Pitcovski et al., 1998; Davison et al., 2000).  This is significantly shorter 
than most other adenoviruses. Homologs of proteins encoded by the E1, E3, and E4 regions of 
members of the Mastadenovirus genus appear to be absent in members of the Siadenovirus genus 
(Davison et al., 2003).  However, members of the Siadenovirus genus have a protein related to 
bacterial sialidases (Davison et al., 2000).  
A single member of the genus Ichtadenovirus has been isolated to date.  Partial sequence 
analysis of white sturgeon adenovirus type 1 has demonstrated that it represents a genus distinct 
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from the other previously identified genera but shares characteristics of the non-Mastadenovirus 
genera (Benko et al., 2002; Kovács et al., 2003). 
 
1.1.2 Human adenovirus 
Human adenovirus (HAdV) was first isolated in the 1950s and identified as the causative 
agent of acute respiratory disease (Rowe et al., 1953; Hilleman and Werner, 1954). Adenoviruses 
are responsible for a small percentage of acute respiratory morbidity in the general population, an 
estimated 5-10% of respiratory illness in children, and mild and self-limiting infection in most 
immunocompetent adults (Berk, 2007).  Adenoviruses can also cause epidemic conjunctivitis and 
gastroenteritis in children (Mautner et al., 1995; O'Brien et al., 2009). In immunocompromised 
patients, such as individuals with acquired immunodeficiency syndrome and patients who have 
received organ or bone marrow transplants, adenoviruses can cause serious and often fatal 
disease (La Rosa et al., 2001; Kojaoghlanian et al., 2003; Leen and Rooney, 2005).  Although a 
number of HAdVs are found to be oncogenic in hamsters (Trentin et al., 1962), no HAdV has 
been shown to cause cancer in humans (McLaughlin-Drubin and Munger, 2008). 
To date, 51-54 serotypes of HAdVs have been identified (Berk, 2007; Jones et al., 2007; 
Ishiko et al., 2008; Ishiko and Aoki, 2009; Walsh et al., 2009).  Of these, HAdV serotypes 2 and 
5 have been the most extensively studied. The identified serotypes are distinguished by their 
resistance to neutralization by antibodies against other adenovirus serotypes (Berk, 2007). Based 
on their ability to agglutinate erythrocytes, oncogenicity in animals, and genetic homology, 
HAdVs are divided into six species, A to F (Berk, 2007). HAdV-52 is proposed to be the only 
member of a new species, G (Jones et al., 2007). 
 
1.1.2.1 Virus structure and genome organization 
Adenoviruses are non-enveloped, consisting of a protein shell encapsidating a DNA-
containing core, and have a diameter of approximately 75-90 nanometers (Niiyama et al., 1975; 
Berk, 2007).  The viral capsids are icosahedral, with fiber proteins projecting outward from the 
icosahedron’s vertices.  The capsid consists primarily of the hexon protein, of which there are 
720 copies per virion. These are grouped in trimers known as hexon capsomers (Vellinga et al., 
2005). These hexon capsomers subsequently assemble into groups of nine (GONs), which make 
up the faces of the icosahedron. At each of the 12 vertices is a penton capsomer, made up of 5 
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copies of the penton protein. These penton capsomers serve as the base for the fiber protein, 
which form trimers (Russell, 2009). In addition to these three major capsid proteins, several 
minor capsid proteins, namely IIIa, VI, VIII, and IX, are also present. An estimated 60 copies of 
protein IIIa are present in mature virions. It appears to be positioned on the inside of the capsid, 
between the penton base and its surrounding hexon capsomers (San Martín et al., 2008). A 
portion of IIIa may also be exposed on the outside of the viral capsid (Vellinga et al., 2005; San 
Martín et al., 2008). An earlier study suggested that IIIa is, in fact, located entirely on the outside 
of the capsid (Fabry et al., 2005). Mutations in IIIa prevent the formation of mature viral capsids, 
suggesting that it has an important role in assembly, and there is also evidence that it interacts 
with the core protein VII (Vellinga et al., 2005). Protein VI is located on the interior of the capsid 
beneath the penton base and interacts with the core protein V (Vellinga et al., 2005). Protein VIII 
appears to be present in the interior of the viral capsid (Fabry et al., 2005; Vellinga et al., 2005).  
Protein IX is located on the outside of the capsid, and acts to stabilize the groupings of hexons 
(Vellinga et al., 2005; Fabry et al., 2009). Protein IX is not required for virus replication, but 
contributes to the thermostability of the capsid, presumably through its interactions with the 
hexons (Vellinga et al., 2005). 
The virus core consists of the highly compacted double-stranded DNA genome and the viral 
core proteins.  Proteins V, VII, and µ are basic, arginine-rich proteins that bind to the viral DNA.  
Protein VII is the predominant core protein, with over 800 copies per virion (Berk, 2007). The 
viral DNA is condensed around nucleosome-like cores formed by protein VII (Vayda and Flint, 
1987). Protein V binds to protein VI and provides a link between the viral core and the capsid 
(Everitt et al., 1975; Berk, 2007). Also present in the core are the terminal protein, which is 
covalently attached to the 5’ ends of the viral DNA (Rekosh et al., 1977) and the viral protease, 
which is involved in virus maturation as well as entry and uncoating (Greber, 1998). 
 
1.1.2.2 Virus entry and release 
The early steps of adenovirus infection have been primarily determined from studies of 
HAdV. The first cellular receptor identified for adenovirus was the coxsackie and adenovirus 
receptor (CAR) for HAdV-2 and -5 (Bergelson et al., 1997). CAR is a member of the 
immunoglobulin superfamily and is involved in adhesion between epithelial cells (Arnberg, 
2009). Its distribution in human tissues is not completely characterized, but CAR mRNA has 
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been found in the heart, brain, pancreas, intestine, lung, liver, and kidneys (Zhang and Bergelson, 
2005).  In vitro, CAR acts as a receptor for species A, C, E, and F HAdVs, and some members of 
species D (Arnberg et al., 2000; Russell, 2009). There is some evidence that CAR may not be the 
primary receptor in vivo (Arnberg, 2009). Adenovirus tropism does not always correlate with 
expression and distribution of CAR, and ablating the ability to bind CAR does not change 
adenovirus distribution (Alemany and Curiel, 2001). Species B HAdVs are able to use CD80, 
CD86, or CD46 (except serotypes 3 and 7) as a receptor (Marttila et al., 2005; Short et al., 2006).  
Some species D adenoviruses have been shown to use sialic acid as a receptor (Arnberg et al., 
2000).  HAdV-40 and -41, which belong to species F, express both a long fiber and a short fiber 
(Favier et al., 2002). The long fiber binds to CAR, but the receptor for the short fiber has not 
been identified (Roelvink et al., 1998). A number of other host cell proteins or compounds, such 
as coagulation factors, heparan sulfate proteoglycans, and lactoferrin, have been found to bind 
adenovirus or promote transduction in vitro and could have roles as functional adenovirus 
receptors (Arnberg, 2009). 
After the fiber binds to its host cell receptor, efficient internalization requires a second 
interaction between the arginine-glycine-aspartic acid (RGD) motif of the penton base and αvβ3 
and αvβ5 integrins on the cell surface (Bai et al., 1993; Wickham et al., 1993). All sequenced 
HAdVs have this RGD motif with the exception of HAdV-40 and -41, which have a 
gastrointestinal tropism and show delayed internalization (Albinsson and Kidd, 1999; Zhang and 
Bergelson, 2005). The fiber protein is released from the viral capsid at the cell surface, a step that 
is dependent on the penton-integrin interaction (Greber et al., 1993; Nakano et al., 2000).  
The binding of the αv integrins by penton results in the activation of phosphoinositide-3-OH 
kinase (PI3K), which in turn activates Rho family guanosine triphosphatases and stimulates 
reorganization of the actin cytoskeleton to promote virus internalization (Li et al., 1998a; Li et al., 
1998b). The virus is primarily internalized by receptor-mediated endocytosis in clathrin-coated 
vesicles (Varga et al., 1991; Wang et al., 1998). After endocytosis, the pH of the vesicle becomes 
more acidic, creating an early endosome (Gastaldelli et al., 2008). The acidic pH of the 
endosomal compartment induces the virus capsid to begin dismantling, starting with the 
dissociation of IIIa, penton, and VIII (Greber et al., 1993; Wiethoff et al., 2005). These 
conformational changes in the viral capsid expose an amphipathic helix in protein VI (well-
conserved among human and non-human adenoviruses) that disrupts the endosomal membrane 
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and allows the virus to escape into the cytosol (Wiethoff et al., 2005). There, protein IX 
dissociates from the remains of the viral capsid, but at least some hexon capsomers remain 
associated with the viral DNA and core proteins (Greber et al., 1993). 
After escaping the early endosome, the partially disassembled capsid is translocated to the 
nucleus along microtubules (Leopold et al., 2000). Hexons still associated with the viral DNA 
can bind directly to the microtubule motor protein dynein, which allows minus-end directed 
movement of the viral capsid along the microtubules towards the nucleus (Bremner et al., 2009). 
Depolarization of microtubules or blocking minus-end transport using anti-dynein antibodies 
inhibits nuclear localization of adenovirus capsids (Leopold et al., 2000; Bremner et al., 2009).  
The capsids localize to nuclear pore complexes (NPCs) after transport along the microtubules 
by binding to CAN/Nup214, a filament protein on the cytosolic face of the NPC (Trotman et al., 
2001). There, several protein-protein interactions promote further disassembly of the viral capsid, 
such as the binding of histone H1 to hexon. For HAdV-2, it is proposed that histone H1 is then 
bound by nuclear import factors importin β and importin 7, transporting the histone/hexon 
complex into the nucleus and making the viral DNA bound by core proteins V and VII accessible 
for nuclear import (Trotman et al., 2001). Since this interaction is not observed in HAdV-3 it may 
not be a conserved mechanism of viral entry. The molecular chaperone hsc70 and the nuclear 
export protein CRM1 may also be involved in capsid disassembly and nuclear import of the viral 
DNA (Saphire et al., 2000; Strunze et al., 2005). Another nuclear import receptor, transportin, 
can bind protein V and protein VII and is required for importing the viral DNA/protein V/protein 
VII complex into the nucleus (Hindley et al., 2007). 
Different species of HAdV exhibit patterns of intracellular trafficking that diverge from the 
“classical” pathway of species C HAdVs such as HAdV-2 (Leopold and Crystal, 2007). HAdV-
12, a member of species A, does not escape early endosomes in a subclone of HeLa cells and 
accumulates in late endosomes and lysosomes (Chardonnet and Dales, 1970). Species B HAdVs 
that do not use CAR as a receptor also traffic to late endosomes and lysosomes (Miyazawa et al., 
2001; Shayakhmetov et al., 2003). After escaping from the lysosomes, which are transported near 
the nucleus in many cell types, the viral DNA is translocated into the nucleus as with species C 
HAdVs (Miyazawa et al., 2001; Leopold and Crystal, 2007). 
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1.1.2.3 Early gene expression 
The core protein VII remains associated with the viral DNA after its entry into the nucleus and 
for several hours post-infection (Johnson et al., 2004; Chen et al., 2007). The binding of protein 
VII to the viral DNA represses viral transcription during the early stages of infection, possibly as 
a mechanism to control the level of expression of the early proteins, and is released 10-12 hrs 
post-infection. Its release is dependent on E1A and transcription of viral genes. 
The first region of the viral genome to be transcribed is the E1A region (Nevins et al., 1979). 
Two major mRNA transcripts are generated from E1A by differential splicing (Perricaudet et al., 
1979). In HAdV-2 and HAdV-5, the two major E1A proteins have 289 and 243 amino acid 
residues and are termed 289R and 243R, respectively. Five conserved regions (CRs) have been 
identified in E1A: the N-terminus, CR1, CR2, CR3, and CR4 (Avvakumov et al., 2004). In 
HAdV-5, the 243R protein shares common N- and C-termini with the 289R protein but lacks a 
46-amino acid region near the center of the protein (Perricaudet et al., 1979). This gap 
corresponds to CR3 (Avvakumov et al., 2004). E1A has two primary functions: to induce the host 
cell to enter S phase, creating a permissive environment for viral replication, and to stimulate 
expression of other early viral genes.  
E1A is a potent transactivator, able to stimulate transcription from a variety of promoters. It 
does not bind DNA directly, but instead associates with the DNA-binding domains of 
transcription factors bound to promoters (Liu and Green, 1994). This allows it to activate 
transcription from a number of viral and cellular promoters. The CR3 domain in the E1A 289R 
protein contains a zinc finger domain that binds to a subunit of the cellular mediator complex, 
recruiting RNA polymerase II and stimulating assembly of the preinitiation complex required to 
begin transcription (Wang and Berk, 2002).  
E1A is also involved in stimulating the host cell to enter S phase. The CR1 and CR2 domains 
of E1A can bind to the cellular retinoblastoma (RB) protein and displace the bound cellular 
transcription factor E2F (Berk, 2005). Normally, release of E2F is mediated by cyclin-dependent 
kinases (CDKs) that help regulate entry into the cell cycle; CDK- or E1A-mediated release of 
E2F activates transcription of cellular genes including genes essential for the cell to enter into S 
phase. E2F also activates transcription from the viral E2A promoter in cooperation with the viral 
E4orf6/7 protein (Obert et al., 1994). 
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The E1A and E1B proteins are necessary and sufficient to transform cells (White, 2001). E1A 
de-regulates cell cycle checkpoints by forcing the cell into S phase, and this induces apoptosis 
(White, 2001). E1A binding to cellular proteins such as the retinoblastoma (RB) protein and 
CREB-binding protein/p300 leads to stabilization of p53, which in turn stimulates apoptosis 
(Gallimore and Turnell, 2001). The pro-apoptotic effects of E1A are counteracted by the E1B 
proteins, which is why both E1A and E1B proteins are required for transformation (Gallimore 
and Turnell, 2001). 
The E1B region encodes two proteins, E1B-55K and E1B-19K, that are involved in preventing 
apoptosis induced by viral infection and the actions of the E1A proteins (Berk, 2005). E1B-55K 
can bind to p53 and contains a repressor domain that suppresses transcription of p53-activated 
genes. Since activation of p53 normally leads to transcription of proapoptotic genes, binding of 
E1B-55K to p53 prevents apoptosis induced by virus infection or by E1A transformation. E1B-
55K also interacts with the viral E4orf6 protein and cellular proteins to form a ubiquitin ligase 
complex that targets p53 for degradation as well as a complex that responds to cellular DNA 
damage. The E1B-55K/E4orf6 complex is also important for events late in viral infection 
(discussed in section 1.1.2.6). The E1B-19K protein antagonizes the apoptosis response induced 
by E1A (Berk, 2005). E1B-19K is homologous to the cellular protein BCL-2 and is able to bind 
the proapoptotic proteins BAK and BAX and prevent them from forming pores in mitochondria 
that releases proteins such as cytochrome c and triggers apoptosis (Berk, 2005). 
The proteins expressed by the E2 region are involved in viral DNA replication (Berk, 2007). 
The E2A region encodes the viral DNA-binding protein (DBP), while the E2B region encodes 
the viral DNA polymerase (Pol) and the pre-terminal protein (pTP) (Berk, 2007). 
The E3 region is under the control of an E1A-responsive promoter and encodes proteins 
mainly involved in suppressing the host immune responses to viral infection (Weeks and Jones, 
1985; Wold et al., 1995; Horwitz, 2004). The 19-kilodalton glycoprotein (gp19K) is localized in 
the endoplasmic reticulum and sequesters class I major histocompatibility complex molecules, 
preventing them from being transported to the cell surface and potentially activating an immune 
response against viral infection (Pääbo et al., 1987; Horwitz, 2004). The gp19K protein is also 
able to sequester ligands recognized by natural killer cells (McSharry et al., 2008). The 14.7K 
protein inhibits tumor necrosis factor (TNF)-mediated apoptosis by preventing endocytosis of the 
TNF receptor (Gooding et al., 1988; Schneider-Brachert et al., 2006). The 14.5K and 10.4K 
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proteins form a receptor internalization and degradation (RID) complex that downregulates 
surface expression of Fas and TNF receptors involved in apoptosis and stimulates their 
degradation (Shisler et al., 1997; Tollefson et al., 1998; Chin and Horwitz, 2006). RID also 
downregulates the epidermal growth factor receptor to stimulate cell metabolism (Tollefson et al., 
1991) and inhibits NFκB activation and cytokine production (Horwitz, 2004). The 6.7K protein 
cooperates with RID to downregulate the receptors for the TNF-related apoptosis-inducing ligand 
(Benedict et al., 2001). The 11.6K protein differs from the other E3 proteins in that it is expressed 
at high levels during late times of infection and promotes apoptosis and cell lysis, and will be 
discussed later. 
The E4 region encodes proteins that appear to have a wide variety of functions during virus 
infection (Weitzman and Ornelles, 2005). It produces transcripts for six proteins, named after 
their open reading frames (E4orf1, orf2, orf3, orf4, orf6, and orf6/7). E4orf1 and E4orf4 activate 
the mammalian target of rapamycin that is required for efficient entry into S-phase (O'Shea et al., 
2005). The E4orf3 and E4orf6 proteins have functional redundancy and inhibit the cellular DNA 
damage response to prevent the viral genome from forming concatomers. E4orf3 also disrupts 
ND10 domains in the nucleus. The E4orf6 protein is highly conserved among HAdVs and forms 
a complex with the E1B-55K protein that has several important functions during virus infection 
(previously discussed in this section, p.8). The E4orf6 protein can also inhibit p53 independently 
of E1B-55K. E4orf6/7, as previously mentioned, enhances binding of E2F to the viral E2 
promoter. 
Two virus-associated RNA molecules (VA RNA) that also function to counteract host 
defences are transcribed from HAdV genomes. These two VA RNAs, VAI and VAII, have stable 
secondary structures and are able to inhibit activation of RNA-dependent protein kinase (PKR) 
(Mathews and Shenk, 1991). In the absence of VAI, activated PKR phosphorylates eIF2α, 
preventing translation initiation (O'Malley et al., 1986). VAI is also processed into viral micro 
RNAs that interact with the cellular complex responsible for RNA silencing and can alter 
expression of host genes (Andersson et al., 2005; Aparicio et al., 2010).  
 
1.1.2.4 DNA replication 
DNA replication begins 5-8 hrs after infection of HeLa cells with HAdV-2 or HAdV-5 at a 
multiplicity of infection of 10 (Berk, 2007). Three viral proteins encoded by the E2 region are 
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required for DNA replication: Pol, pTP, and DBP. The inverted terminal repeats (ITRs) located at 
each end of the linear genome contain origins of DNA replication where a preinitiation complex 
(PIC) consisting of viral and cellular proteins forms. Within the ITR are the binding sites for pTP 
and Pol (Temperley and Hay, 1992). Pol and pTP interact to form a heterodimer that binds to the 
minimal origin of replication (Temperley and Hay, 1992). Downstream of the minimal origin of 
replication are binding sites for two cellular proteins, the transcription factors nuclear factor I 
(NFI, also known as CAAT transcription factor) and nuclear factor III (NFIII, also known as Oct-
1). NFI and NFIII interact with Pol and pTP, respectively, and stimulate DNA replication by 
recruiting the Pol/pTP heterodimer to its binding site on the viral DNA, and by stabilizing the 
protein-DNA interaction (Chen et al., 1990; Mul et al., 1990; Mul and van der Vliet, 1992; 
Armentero et al., 1994; Coenjaerts et al., 1994).  
After the formation of the PIC, DNA replication is initiated using a protein-priming 
mechanism (de Jong et al., 2003). Pol catalyzes the covalent linkage of a dCMP residue to pTP, 
followed by the addition of A and T residues to create a pTP-CAT intermediate using residues 4-
6 of the 3’-GTAGTA-5’ sequence at the terminus of the ITR as a template. The pTP-CAT 
intermediate then jumps back to residues 1-3 and begins elongation of the new DNA strand from 
the template (King and van der Vliet, 1994). This jumping back mechanism protects against 
errors and prevents shortening of the genome (King et al., 1997). 
Synthesis of the new viral DNA proceeds 5’ to 3’, displacing one parental strand and using the 
other parental strand as a template (Lechner and Kelly, 1977). New rounds of DNA replication 
can be initiated from the same ITR, creating multiple single-stranded branches from the double-
stranded molecule as more strands are displaced by new strand synthesis. This is known as type I 
DNA replication. When synthesis of the daughter strand is complete, the result is a daughter 
duplex and a parental single strand. Type II replication occurs when the ITRs of this single strand 
hybridize, forming a panhandle structure and restoring the double-stranded origin of replication 
that can be recognized by the PIC. Synthesis of a new daughter strand from the 3’ end of the 
parental strand displaces the 5’ ITR hybridized to the 3’ ITR, creating a single strand template for 
synthesis of the daughter strand.  
In addition to pTP and Pol, the viral DBP is required for DNA replication. DBP stimulates the 
initiation of DNA replication by enhancing binding of NFI and Pol to the origin of replication 
(Stuiver and van der Vliet, 1990; van Breukelen et al., 2003). DBP is also required to unwind the 
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parental double-stranded helix during elongation. DBP destablizes the double-stranded helix and 
binds to the single parental strand displaced by DNA replication, protecting it from degradation 
(Zijderveld and van der Vliet, 1994). 
In order for the full viral genome to be replicated, cellular topoisomerase I (also called NFII) 
is required. In the absence of topoisomerase I, initiation of DNA synthesis is not affected but 
replication halts approximately a quarter of the way through the genome (Nagata et al., 1983).  
Presumably, topoisomerase activity is required to relax torsional stress placed on the viral DNA 
by the replication forks (Schaack et al., 1990). 
 
1.1.2.5 Intermediate and late gene expression 
Two viral proteins, IVa2 and pIX, are classified as intermediate or delayed-early since their 
expression is dependent on viral DNA replication but their transcripts appear earlier than those of 
the other late proteins (Binger and Flint, 1984). Expression of IVa2 and pIX is suppressed during 
the early stages of infection by cellular transcriptional repressors. The repressor for IVa2 remains 
to be identified (Chen et al., 1994; Lin and Flint, 2000; Iftode and Flint, 2004), while the 
repressor for pIX is the cellular protein RBP-2N (Dou et al., 1994). As new copies of the viral 
genome are synthesized the availability of binding sites for these repressors increases. This is 
proposed to titrate out the repressors and relieve the inhibition of IVa2 and pIX transcription 
(Dou et al., 1994; Lin and Flint, 2000; Iftode and Flint, 2004). 
The late genes encode structural proteins that make up the viral capsid (hexon, penton, fiber, 
IIIa, V, VI, VII, VIII, IX, and µ) and non-structural proteins (52K, 100K, 33K, 22K, and the viral 
protease). Expression of the late genes is controlled by the major late promoter (MLP). At early 
times during infection, transcription occurs from the MLP at a low level, producing only 
transcripts from the L1 region (Shaw and Ziff, 1980). The presence of an additional sequence in 
the tripartite leader at the 5’ end that is not included at late times of infection appears to inhibit 
translation from these transcripts, which code for the L1 52/55-kilodalton protein (Akusjärvi and 
Persson, 1981). Transcription from the MLP involves several viral and cellular factors. The 
TATA box is bound by the transcription factor TFIID (Sawadogo and Roeder, 1985), which 
recruits other factors that make up the transcription complex, including RNA polymerase II 
(Deng and Roberts, 2007). The cellular transcription factors MAZ and Sp1 bind to sequences 
within the MLP (Parks and Shenk, 1997). Both factors interact with E1A, and the presence of 
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E1A increases transcription activation of the MLP by MAZ and Sp1 by several fold. An inverted 
CAAT box element is bound by CCAAT-binding factor (CBF) (Reach et al., 1991), while 
another element is bound by the upstream stimulatory factor (USF; also called major late 
transcription factor) (Sawadogo and Roeder, 1985). The functions of USF and CBF may be 
redundant, with both proteins being able to recruit TFIID (Reach et al., 1991). Binding of USF to 
the MLP is enhanced by DBP (Zijderveld et al., 1994). USF only binds to the MLP after viral 
DNA replication (Toth et al., 1992), and thus may be important for the timing of MLP activation 
during viral infection. 
Sequences downstream of the transcription initiation site on the MLP are also required for 
maximum activation during viral infection (Leong et al., 1990). These two downstream enhancer 
sequences are DE1 and DE2, which is subdivided into DE2a and DE2b (Ali et al., 2007). DE2b is 
bound by DEF-B, while DE1 and DE2a are bound by DEF-A. DEF-B is a homodimer of the viral 
protein IVa2 (Tribouley et al., 1994; Lutz and Kedinger, 1996). The identity of DEF-A remains 
unclear, but was initially believed to be a complex of IVa2 and another viral protein (Lutz and 
Kedinger, 1996). There is evidence that the L4 33K protein alone constitutes DEF-A (Ali et al., 
2007). In addition, the L4 22K protein, but not 33K, enhances binding of IVa2 to the MLP and is 
required for MLP activation (Ostapchuk et al., 2006; Morris and Leppard, 2009). The 33K and 
22K proteins share a common N-terminus and reactivity of any antibodies raised to this sequence 
complicates analysis of the complexes bound at the MLP. 
Transcription from the MLP produces a single RNA transcript, which is then differentially 
spliced to create mRNA transcripts for the late viral genes (Goldberg et al., 1978; Imperiale et al., 
1995). The late mRNA transcripts are grouped into five families in human adenovirus based on 
common polyadenylation sites (Miller et al., 1980) and all share a common 5’ tripartite leader 
(Chow et al., 1977). Splicing of viral mRNAs is temporally regulated, with some splice sites only 
being used at later times of infection (Imperiale et al., 1995). The E4orf3, E4orf6, and L4 33K 
proteins have all been identified as splicing factors during viral infection (Imperiale et al., 1995; 
Törmänen et al., 2006). 
During late times in infection, viral mRNA transcripts are preferentially exported from the 
nucleus and translated in the cytoplasm over host mRNA transcripts (Babich et al., 1983). Export 
of cellular mRNAs to the cytoplasm is inhibited by the E1B-55K and E4orf6 proteins (Babich et 
al., 1983; Blackford and Grand, 2009). E1B-55K and E4orf6 also inhibit phosphorylation of the 
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translation initiation factor eIF2α by PKR (Spurgeon and Ornelles, 2009). The 100K protein 
encoded by the L4 region is also involved in the inhibition of cellular translation and promoting 
translation from viral transcripts by inhibiting the phosphorylation of the eukaryotic initiation 
factor 4E (Cuesta et al., 2000; Cuesta et al., 2004).  
 
1.1.2.6 Virus assembly and release 
When the viral structural proteins have been translated, they are transported to the nucleus 
where virus assembly occurs. The initiation of capsid assembly may be triggered by the 
adenovirus protease cleaving a C-terminal peptide of pVI which contains the nuclear localization 
signal (NLS) and the nuclear export signal (NES) (Wodrich et al., 2003). There is evidence that 
pVI acts as a shuttle to transport hexon, which lacks an identified NLS and is cytoplasmic when 
expressed in the absence of other viral proteins or in a mutant that lacks functional pVI, to the 
nucleus (Kauffman and Ginsberg, 1976; Wodrich et al., 2003). Cleavage of the pVI NLS could 
stop its shuttling activity and the transport of hexons into the nucleus and initiate virus assembly 
instead. 
The hexon monomers trimerize to form capsomers (Horwitz, 1969), using the 100K protein as 
a scaffold (Hong et al., 2005). The penton base interacts with fiber trimers, then assembles with 
the hexon capsomers to form intact capsids (Horwitz et al., 1969). Deletion of the IVa2 protein 
prevents capsid assembly (Zhang and Imperiale, 2003); this suggests that IVa2 may act as a 
scaffold protein for capsid formation. It has also been proposed that the formation of empty 
capsids is reversible or that they are a dead end product, and that capsid assembly in fact occurs 
around the viral nucleoprotein core (Zhang and Imperiale, 2003). However, there are several lines 
of evidence to dispute this model. First, pulse-chase experiments demonstrated that the empty 
capsids are precursors of mature capsids containing viral DNA (Sundquist et al., 1973) and that 
pVII appears in mature capsids more rapidly than structural proteins such as hexon after a pulse 
(Horwitz et al., 1969), suggesting that pVII and its associated viral DNA are inserted into already 
formed capsids. Additionally, intermediate viral particles associated with a portion of the viral 
genome are precursors of virions containing the complete viral genome, and young virions 
containing the viral genome but not the core proteins pV and pVII were detected (D'Halluin et al., 
1978a); these intermediates would not be predicted to be precursors of virions with the complete 
genome if capsid assembly occurred around the viral nucleoprotein complex. Empty viral capsids 
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have also been shown to associate with viral DNA (Tibbetts and Giam, 1979) with an affinity 
which suggests that the viral DNA binds to the empty capsid and then is inserted. Thus, the 
current model is that the adenovirus genome is packaged into preformed capsids (Ostapchuk and 
Hearing, 2005), a mechanism used by several bacteriophages as well as herpesviruses (Rao and 
Feiss, 2008; Mettenleiter et al., 2009).  
Packaging of the adenovirus genome is dependent on sequences present at the left end of the 
genome. Deletions at the left terminus prevent encapsidation of the viral DNA (Gräble and 
Hearing, 1990). In HAdV-5, the packaging signal is located between the left ITR and the coding 
sequence for E1A, between base pairs 200 and 400. Seven AT-rich repeats that are involved in 
packaging have been identified (Gräble and Hearing, 1992). These repeats are functionally 
redundant, but they do not direct genome packaging with equal efficiency (Gräble and Hearing, 
1990; Schmid and Hearing, 1997).  Spacing between the repeats has been shown to be important 
(Gräble and Hearing, 1992). This could be due to some secondary structure of the DNA required 
for packaging, or the binding of proteins to different repeats that need to interact to direct 
packaging. Repeats AI, AII, AV, and AVI have been shown to be the most important (Erturk et 
al., 2003).  Replacing the wild-type packaging domain with a single A repeat permits virus 
packaging, but at a lower level than wild-type (Gräble and Hearing, 1990; Schmid and Hearing, 
1997). However, a dimer of repeats AI and AII, a dimer of repeats AV-AVII, or six copies of 
repeat AI are necessary and sufficient for packaging at levels comparable to wild-type (Schmid 
and Hearing, 1997; Ostapchuk and Hearing, 2005).  The bipartite motif 5’-TTTG-N8-CG-3’ is 
required for packaging domain function of the dominant motifs and is conserved between 
different HAdV serotypes (Schmid and Hearing, 1997).  
A complex of cellular and viral proteins forms on the packaging domain and is termed P-
complex. The cellular proteins octamer-1 (Oct-1) and chicken ovalbumin upstream promoter 
transcription factor (COUP-TF) bind to the packaging sequences but do not appear to be required 
for packaging of the viral DNA (Schmid and Hearing, 1998; Erturk et al., 2003).  The cellular 
CCAAT displacement protein (CDP) is a component of the P-complex and, unlike Oct-1 and 
COUP-TF, is present in virus particles (Erturk et al., 2003).  However, mutations in the 
packaging signal that disrupted CDP binding produced viable viruses, while a mutation that was 
still bound by CDP did not permit virus replication, suggesting that the role of CDP in packaging 
is not essential (Ostapchuk et al., 2005). 
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Several viral proteins have also been implicated in packaging.  The IVa2 protein is part of the 
P-complex and binds directly to the packaging signal; it is essential for the packaging of the viral 
DNA (Zhang and Imperiale, 2000; Zhang et al., 2001; Perez-Romero et al., 2005; Tyler et al., 
2007). Binding of IVa2 to the A repeats of the packaging signal correlates with their efficiency of 
directing DNA packaging (Ostapchuk et al., 2005). IVa2 binds to the packaging sequence as a 
homodimer and as a heterodimer with the viral 22K protein encoded by the L4 region (Perez-
Romero et al., 2005; Ewing et al., 2007).  IVa2 recognizes the CG base pairs in the packaging 
motif, while 22K is able to recognize the TTTG sequence, but only in the presence of IVa2 
(Ostapchuk et al., 2006; Ewing et al., 2007).  The binding of IVa2 to the packaging sequence is 
also enhanced by 22K.  Deletion of 22K prevents the production of infectious virus particles 
without blocking viral gene expression or DNA replication, suggesting that its function in 
binding to the packaging domain is essential (Ostapchuk et al., 2006).  The third viral protein 
shown to have an essential role in packaging of the viral DNA is the 52/55-kilodalton protein. 
While it is not required for capsid assembly, it is essential for encapsidation of the viral DNA and 
the production of mature virions (Gustin and Imperiale, 1998). 
It is unclear precisely how the viral DNA is inserted into the capsid.  The viral DNA could be 
inserted into the preformed capsids in a complex with pVII, which binds to the viral DNA prior 
to encapsidation (Weber and Philipson, 1984), or pVII could be stripped from the viral DNA by 
an unknown mechanism as it is translocated into the capsid (Zhang and Arcos, 2005). In 
bacteriophages with double-stranded DNA genomes, the DNA is inserted into empty, preformed 
icosahedral capsids with an opening created by a portal protein (Rao and Feiss, 2008).  
Translocation of the DNA is driven by a motor with ATPase activity. A similar mechanism is 
observed in herpesviruses (Mettenleiter et al., 2009). IVa2 is able to bind ATP, and mutation of 
the ATP binding sites renders the protein unable to complement a IVa2-deleted virus (Ostapchuk 
and Hearing, 2008), indicating that the ability of IVa2 to bind ATP is somehow essential to virus 
replication. While IVa2 did not demonstrate detectable ATPase activity in vitro, which could be 
due to a low binding affinity or a requirement for other proteins such as 22K or 52K, it raises the 
possibility that IVa2 acts as a motor similar to those found in bacteriophages and herpesvirus.  
Activity of the viral protease is required to generate infectious virus (Weber, 1976). The 
protease is partially activated inside immature virions by binding to viral DNA, and then fully 
activated by the C-terminal fragment of pVI (pVIc) cleaved by the protease (Gupta et al., 2004). 
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DNA binding increases the catalytic activity of the protease by threefold, while pVIc increases it 
by 350-fold and the presence of both cofactors stimulates a 6000-fold increase (Mangel et al., 
1997). Presumably, binding to the viral DNA increases the protease activity sufficiently for it to 
cleave pVI and generate mature protein VI and the pVIc fragment, which then binds the protease 
to activate it completely. This mechanism delays protease activation until after viral assembly has 
begun, when the capsid proteins and DNA are close together. Cleavage of more pVI yields more 
pVIc and activates more protease molecules, which then cleave a number of viral proteins 
including pIIIa, pVII, pVIII, and pTP. Protease activity may also be required to release 52K from 
the virus particle, since 52K can be detected in young virions when there is no active protease 
(Hasson et al., 1992).  
Escape of the virus from the host cell is facilitated by several mechanisms. Actin can act as a 
cofactor for the viral protease, which cleaves cytokeratin 18 (Brown and Mangel, 2004). 
Cleavage of cytokeratin 18 prevents it from polymerizing, disrupting the host cell cytoskeleton 
and facilitating cell lysis and virus release (Chen et al., 1993). The E3 11.6-kDa protein, also 
known as the adenovirus death protein (ADP) is expressed from the E3 promoter during early 
stages of infection and at a much higher level from the MLP during late stages (Tollefson et al., 
1992). ADP is necessary for efficient lysis of the host cell (Tollefson et al., 1996), and while its 
mechanism of action is not known it appears to increase apoptosis when overexpressed (Yun et 
al., 2005). Finally, excess production of fiber during viral infection appears to facilitate virus 
escape by binding to CAR, thereby disrupting tight junctions and allowing the virus easier access 
to the apical surface of the epithelium (Walters et al., 2002).  
 
1.1.3 The 52/55-kilodalton protein 
The HAdV-5 52/55-kilodalton protein (hereafter referred to as 52K) exists as differentially 
phosphorylated forms of a 48-kilodalton precursor (Lucher et al., 1986; Hasson et al., 1992). 52K 
is encoded by the L1 region, and in HAdV-2 can be detected at low levels at around 10 hrs post 
infection and at higher levels by 15 hrs post infection. As previously discussed (p.11; section 
1.1.2.5), the transcript from the L1 region corresponding to 52K is present at early times during 
infection due to a low level of transcription from the MLP that results in a truncated transcript 
that includes the coding region for 52K (Shaw and Ziff, 1980). However, the inclusion of an 
extra region in the spliced tripartite leader appears to inhibit translation (Akusjärvi and Persson, 
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1981), explaining why 52K is not detected until later in infection despite the early presence of its 
mRNA. 52K localizes to regions in the nucleus separate from DNA replication centers and is 
associated with assembling viruses (Hasson et al., 1992). One to two molecules of 52K associate 
with each assembling virion (Hasson et al., 1992). Analysis of a 52K temperature-sensitive 
mutant of HAdV-5 revealed that 52K was essential for the production of mature virus particles 
but did not greatly affect DNA replication or late protein synthesis (Hasson et al., 1989; Gustin 
and Imperiale, 1998), suggesting that it had a role in viral assembly. It was found to be associated 
with empty capsids, intermediate particles, or young virions, but not mature capsids (Hasson et 
al., 1992). Since empty capsids were able to form in its absence, it does not function as a 
scaffolding protein (Gustin and Imperiale, 1998). The capsids formed in the absence of 52K 
could be found associated with the left end of the genome, further suggesting that the role of 52K 
is in DNA encapsidation rather than capsid assembly as a scaffolding protein (Hasson et al., 
1989). 52K interacts with the IVa2 protein in vitro and in infected cells (Gustin et al., 1996). 
Chromatin immunoprecipitation and in vitro binding studies have demonstrated that 52K can 
bind the packaging signal, but since purified 52K alone or with purified IVa2 does not complex 
with the packaging signal this interaction may be indirect or dependent on another protein 
(Ostapchuk et al., 2005; Perez-Romero et al., 2005). 52K is associated with the packaging signal 
in a IVa2-deleted virus, further suggesting that its association with the packaging signal can not 
be solely dependent on its interaction with IVa2. The N-terminal 173 amino acids (out of 416) of 
52K are required for its interaction with IVa2 in HAdV-5, while the N-terminal 331 residues are 
required for it to complement a 52K-deleted virus (Perez-Romero et al., 2006). Interactions 
between 52K and the core protein pVII and between IVa2 and pVII have also been demonstrated 
(Zhang and Arcos, 2005).  
Despite its potential lack of specificity for the packaging sequence, encapsidation of viral 
DNA by 52K is serotype specific. Replication of viruses lacking 52K can only be rescued by 
expression of a 52K protein of the same serotype (Wohl and Hearing, 2008). The serotype 
specificity was shown to require the N-terminal 191 amino acids in HAdV-5. IVa2 binding to the 
packaging signal was believed to be serotype specific since expression of IVa2 from HAdV-5 
supported replication of a chimeric virus with the ITR and packaging signal of HAdV-5 but the 
remainder of the genome from HAdV-7 (and therefore, expressing IVa2 from HAdV-7) (Zhang 
et al., 2001). However, a IVa2-deleted HAdV-5 could be rescued by expression of IVa2 from 
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HAdV-17, suggesting that the interaction between IVa2 and the packaging sequence may not be 
serotype specific (Wohl and Hearing, 2008). Growth of a 22K deletion mutant was also 
complemented by the expression of 22K from another serotype (Wohl and Hearing, 2008). This 
suggests that it is 52K, and not IVa2 or 22K binding to the packaging sequence, that determines 
the serotype specificity of DNA packaging by some undetermined mechanism or interaction. 
 
1.1.4 Bovine adenovirus 
Bovine adenovirus (BAdV) was first isolated in the 1960s (Darbyshire et al., 1965) and eleven 
serotypes have since been identified (Lehmkuhl and Hobbs, 2008). Although BAdVs have been 
associated with respiratory disease or enteric disease in cattle (Lehmkuhl et al., 1975; Smyth et 
al., 1996), they have also been isolated from apparently healthy animals (Darbyshire et al., 1965). 
BAdVs can cause sub-clinical to severe symptoms in experimental infections of calves 
(Lehmkuhl et al., 1975). 
 
1.1.4.1 Classification 
Based on phylogenetic sequence analysis, the identified serotypes of bovine adenoviruses are 
grouped in either the Mastadenovirus genus (BAdV-1, -2, -3, -9, and -10) or the Atadenovirus 
genus (BAdV-4, -5, -6, -7, -8, and strain Rus) (Harrach, 2000; Lehmkuhl and Hobbs, 2008). The 
Mastadenovirus serotypes are more closely related to adenoviruses of other host species, 
particularly ovine adenoviruses, than they are to each other, and each is classified as their own 
species. The Atadenovirus serotypes are more closely related to each other, particularly BAdV-4, 
-5, and -8.  
 
1.1.4.2 Bovine adenovirus type 3 
The strain of BAdV-3 was isolated from the eye of an apparently healthy cow (Darbyshire et 
al., 1965). Experimental infections of cattle can produce sub-clinical infections with the 
production of neutralizing antibodies (Mittal et al., 1999) or mild respiratory disease (Lehmkuhl 
et al., 1975). 
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1.1.4.2.1 Genome structure and organization 
The genome of BAdV-3 has been completely sequenced and is 34,446 base pairs long (Reddy 
et al., 1998). The G/C content of the genome is 54%, similar to that of HAdVs (Chroboczek et 
al., 1992; Reddy et al., 1998). The BAdV-3 genome has predicted open reading frames encoding 
33 proteins (Reddy et al., 1998; Reddy et al., 1999a; Kulshreshtha, 2009). The ITRs of BAdV-3 
are 195 bases in length, longer than many other adenoviruses, and have an unusually high G/C 
content (Shinagawa et al., 1987; Reddy et al., 1998). The packaging signal is present at the left 
end of the genome as in other adenoviruses, but it is unique in that portions of the E1A open 
reading frame appear to be required for packaging (Xing et al., 2003; Xing and Tikoo, 2007). 
BAdV-3 mutants deleted from the end of the ITR to approximately 40 nucleotides upstream of 
the E1A region are still able to package viral DNA, although at reduced levels. Deletion of 
sequences within the E1A open reading frame are required to render the virus non-viable. BAdV-
3 also lacks TATA or CAAT boxes between the inverted terminal repeat and upstream of the 
E1A start codon. However, evidence suggests that the E1A promoter is actually located within 
the ITR (Xing and Tikoo, 2006). 
The transcription map of BAdV-3 is shown in figure 1.1. Nine mRNA transcripts are produced 
from the E1 region, all sharing 5’ and 3’ termini (Reddy et al., 1999a). The longest of these 
transcripts is unspliced, representing the primary transcript. Unlike in HAdV, where the 
transcription units for E1A and E1B have independent promoters and polyadenylation sites, 
BAdV-3 E1A and E1B are expressed from the same transcription unit. The six transcripts 
produced from the E1A region are translated into three proteins of 211, 115, and 100 amino acids 
that share a common N-terminus. The C-terminal 22 residues of 115R are not present in the other 
two E1A proteins. Three of the transcripts detected have the same open reading frame for the 
211R E1A protein but have alternate splicing downstream. Similarly, two transcripts with the 
same open reading frame for the 115R protein have different splicing downstream. The 100R 
protein is detected beginning at 12 hrs post infection and until 36 hrs post infection, while the 
115R and 211R proteins were observed starting at 24 hrs after infection. The critical residues in 
the CR3 region responsible for transactivation in HAdV E1A are conserved in BAdV-3 E1A. 
BAdV-3 E1A is able to transactivate HAdV-5 genes, showing that it has functional as well as
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Figure 1.1 Transcription map of BAdV-3.  Location and direction of transcripts 
are indicated by arrows.  Scale in nucleotides. (Adapted from Reddy et al., 1998). 
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sequence homology (Zheng et al., 1994). Two transcripts from the E1B region are produced and 
code for proteins of 420 (E1Blarge) and 157 amino acids (E1Bsmall) with overlapping reading 
frames (Reddy et al., 1999a). Deletion analysis suggests that while E1A and E1Blarge are essential 
for replication, E1Bsmall is dispensable in some cell types (Zhou et al., 2001b). 
The E2 region coding for proteins involved in DNA replication is located on the 
complementary strand (Reddy et al., 1998). E2A codes for the DNA binding protein, which is 
432 amino acids long. This is shorter than the DBPs of some HAdVs but longer than some other 
adenoviruses, and the DBP of BAdV-3 shares homologies ranging from 38 to 47% with the 
DBPs of other members of the Mastadenovirus genus. The C-terminus of DBP required for many 
of its functions is conserved, as are zinc binding sites essential for DBP function. DBP is detected 
6-12 hrs post-infection and immunohistochemical detection of DBP can be used to quantify 
BAdV-3 titers in infected cells (Zhou et al., 2001a). The E2B region codes for the viral DNA 
polymerase (Pol) and the preterminal protein (pTP). Pol and pTP share 59-62% and 58-60% 
sequence identity, respectively, with their homologs in other members of the Mastadenovirus 
genus (Reddy et al., 1998). The Pol protein of BAdV-3 is 1,023 amino acids long. The zinc finger 
motifs of Pol are conserved with that of Pol proteins from other members of the Mastadenovirus 
genus except for a single histidine residue in each motif that is not essential for DNA replication 
(Baxi et al., 1998). The pTP protein is 649 amino acids long in BAdV-3 (Baxi et al., 1998). It 
contains a YSRLVYR motif similar to a conserved YSRLRYT motif in the pTP of other 
adenoviruses and which has been shown to be essential for protein priming of DNA replication 
initiation. The serine 580 residue of HAdV pTP to which dCMP is covalently attached by DNA 
Pol to initiate DNA replication is also conserved in BAdV-3 pTP, but the flanking sequences are 
not. Two of the three recognition sites for cleavage of pTP by the adenovirus protease are 
conserved in BAdV-3 pTP, as is the nuclear localization signal. 
The E3 region is located between the coding sequences for pVIII and the fiber protein as it is 
in HAdV (Reddy et al., 1998; Idamakanti et al., 1999). It is 1.5 kilobases long, about half the size 
of the E3 region of HAdV-2 and -5 (Mittal et al., 1992). Like HAdV, the E3 region is not 
essential for BAdV-3 replication in cultured cells (Zakhartchouk et al., 1998). Five transcripts are 
generated from the E3 region that contain open reading frames for four proteins of 284, 121, 86, 
or 82 amino acids (Idamakanti et al., 1999). The 284R protein is glycosylated but is not 
homologous to the 19K glycoprotein of HAdV and may be unique to BAdV-3 (Idamakanti et al., 
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1999). The 121R protein shares some homology with the 14.7K protein of HAdV and has been 
shown to protect mouse cells from TNF-mediated cell lysis (Zakhartchouk et al., 2001).  
The E4 region is positioned near the right end of the genome as it is in HAdV (Reddy et al., 
1998). Seven 5’- and 3’-coterminal mRNA transcripts are produced from the complementary 
strand and encode five unique open reading frames (Baxi et al., 1999). Two of these, ORF3 and 
ORF5, encode proteins of 268 and 219 amino acids respectively and share homology with the 
E4orf6 protein of HAdV. ORF1, ORF2, and ORF4 encode proteins 143, 69, and 143 amino acids 
in length respectively and may be unique to BAdV-3 as they lack identified homologs in other 
adenoviruses. The E4 proteins are not required for BAdV-3 replication in cultured cells (Baxi et 
al., 2001). 
In HAdVs, sequences for the VA RNAs are located between the E2B region encoding pTP 
and the L1 region encoding 52K. In BAdV-3, VA RNAs have not yet been identified (Reddy et 
al., 1998). Since in BAdV-3 pTP and 52K are situated close together, if the VA RNA sequences 
are present in the same location in BAdV-3 as in HAdV they must overlap the open reading 
frames for pTP and/or 52K. It is also possible that VA RNAs are present in a different region of 
the BAdV-3 genome or that BAdV-3 does not encode VA RNAs.  
The intermediate proteins pIX and IVa2 have approximately the same positions in BAdV-3 as 
in HAdV (Reddy et al., 1998). The pIX transcription unit is located downstream of the coding 
regions for E1A and E1B, while the IVa2 transcription unit is on the complementary strand 
downstream of the E2B region encoding pTP and Pol (Baxi et al., 1998; Zheng et al., 1999). The 
pIX transcription unit is 3’ co-terminal with the E1A and E1B regions (Zheng et al., 1999). The 
BAdV-3 pIX protein is 125 amino acids long and has sequence identity with pIX proteins from 
other members of the Mastadenovirus genus ranging from 16 to 28%. Its expression is detected 
24 hrs after infection and, like HAdV, it is present in the viral capsid (Reddy et al., 1999b) An 
RGD motif fused to the C-terminus of pIX enhances the ability of BAdV-3 to infect integrin-
expressing cells and a fluorescent protein fused to the C-terminus of pIX can be detected on the 
surface of the capsid, indicating that the C-terminus of pIX is exposed on the surface of the viral 
capsid (Zakhartchouk et al., 2004).  The IVa2 protein of BAdV-3 is 376 amino acids long, shorter 
than that of other adenoviruses (Reddy et al., 1998). It shares 64-70% sequence identity with the 
IVa2 proteins from other members of the Mastadenovirus genus. The IVa2 transcript has a 
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polyadenylation signal unique from that of pTP and DNA Pol, while in HAdV all three are 3’ co-
terminal. 
The organization of the major late promoter (MLP) and late genes of BAdV-3 is similar to that 
seen in HAdV. The MLP is located at 16.2 map units, with the late genes positioned downstream 
in distinct transcription units continuing to the right terminus of the genome (Reddy et al., 1998). 
Like the MLP of HAdV, the MLP of BAdV-3 contains a TATA box, an inverted CAAT box, a 
binding site for USF, and an initiator element. The downstream enhancer elements DE1 and DE2 
are also conserved in BAdV-3. The tripartite leader of BAdV-3 is 205 nucleotides in length and 
has a similar organization to that of HAdV, which is 201 nucleotides long. The three parts of the 
leader are located near the MLP (40 nucleotides), within the DNA Pol gene on the non-coding 
strand (78 nucleotides), and in the pTP gene on the non-coding strand (87 nucleotides). 
A significant difference between the late regions of HAdV and BAdV-3 is that the late 
transcripts of BAdV-3 are divided into seven families (L1 to L7) based on common 3’ 
polyadenylation sites, while HAdV late genes are grouped into five families (L1 to L5) (Reddy et 
al., 1998). The L1 region of BAdV-3 encodes four proteins: 52K, IIIa, penton, and pVII. In 
HAdV, penton and pVII are in the L2 region. The BAdV-3 52K protein was predicted to be 331 
amino acids long (Reddy et al., 1998). The pIIIa protein is 568 amino acids long and shares 52-
57% sequence identity with the pIIIa proteins from other members of the Mastadenovirus genus 
(Reddy et al., 1998). A putative site for cleavage by the viral protease is located 19 residues from 
the C-terminus of pIIIa. The penton protein of BAdV-3 is 482 amino acids long and shares 63-
65% sequence identity with penton proteins from other members of the Mastadenovirus genus 
(Reddy et al., 1998). A significant difference in the BAdV-3 penton is that it lacks the conserved 
RGD motif required for αvβ3 and αvβ5 integrin binding. It also lacks a leucine-aspartic acid-
valine motif that could bind α4β1 integrins, although a methionine-aspartic acid-valine motif is 
present. The penton proteins of canine adenovirus (CAdV)-1 and -2 also lack an RGD motif 
(Reddy et al., 1998; Soudais et al., 2000). The penton of CAdV-1 has a deletion in the middle of 
the coding region where the RGD motif is localized and is very similar to that seen in the BAdV-
3 penton (Reddy et al., 1998). The region of the penton protein that interacts with the fiber 
protein is conserved in BAdV-3. The core protein pVII of BAdV-3 is 171 amino acids long and 
has 44-53% sequence identity with pVII proteins of other members of the Mastadenovirus genus 
(Reddy et al., 1998). Like pVII from other members of the Mastadenovirus genus, and consistent 
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with a DNA-binding function, BAdV-3 pVII is highly basic (43 basic residues out of 171). The 
consensus cleavage site for the adenovirus protease is MYGG↓A and is located 19 nucleotides 
from the N-terminus of the protein, In HAdV-2, cleavage occurs 24 nucleotides from the N-
terminus at the recognition site MSGG↓A (Webster et al., 1989). 
The L2 region of BAdV-3 codes for a single transcript encoding the core protein pV, whereas 
in HAdV L2 codes for penton, pVII, and pV (Reddy et al., 1998). The pV protein of BAdV-3 is 
410 amino acids long and shares 28-41% sequence identity with pV proteins of other members of 
the Mastadenovirus genus. Like pVII and the pV proteins of other adenoviruses, BAdV-3 pV has 
a high content of basic amino acids (77 out of 410 residues). A sequence similar to the nuclear 
localization signal found in pV of HAdVs is present in BAdV-3 pV. 
The L3 region of BAdV-3 also produces only one transcript which encodes the µ protein, also 
known as pX (Reddy et al., 1998). In HAdV, µ is located in the L2 region. The µ protein of 
BAdV-3 is 80 amino acids long and shares 53-64% sequence identity with the µ proteins of other 
members of the Mastadenovirus genus. Like the other viral DNA-binding proteins, BAdV-3 µ 
contains a high proportion of basic amino acids (18 out of 80 residues). In HAdV, µ is cleaved by 
the adenovirus protease after residues 31 and 50, leaving a highly basic peptide of 19 amino acids 
in length (Anderson et al., 1989). Cleavage sites on BAdV-3 µ are predicted after residues 30 and 
50 to generate a basic product of 20 amino acids (Reddy et al., 1998). The nuclear localization 
signal of µ also appears to be conserved in BAdV-3. 
The L4 region produces a transcript coding for pVI, which is located in the L3 region in 
HAdV (Reddy et al., 1998). The BAdV-3 pVI protein is 263 amino acids in length and shares 32-
39% sequence identity with the pVI proteins of other members of the Mastadenovirus genus. 
Consensus cleavage sites for the viral protease are located in the N-terminus after residue 33 and 
in the C-terminus after residue 252. In HAdV, pVI cleavage occurs after residues 33 and 239 
(Weber, 1995). The 11 amino acid C-terminal peptide predicted by protease cleavage in BAdV-3 
has high sequence identity with the C-terminal peptide of the same size produced by cleavage of 
HAdV pVI (7 out of 11 residues), indicating that it should function as a cofactor for activation of 
the viral protease. 
The coding sequences for hexon and the viral protease are located in the L5 region of BAdV-3 
(Reddy et al., 1998). In HAdV, hexon and the protease are expressed from the L3 region along 
with pVI. The hexon protein of BAdV-3 is 910 amino acids long and has a high degree of 
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sequence identity with the hexon proteins of other members of the Mastadenovirus genus (66-
71%). Three regions in the protein sequence of BAdV-3 hexon show significant differences from 
that of HAdV-2, but these regions correspond to loops exposed on the surface of the virion (Hu et 
al., 1984; Crawford-Miksza and Schnurr, 1996). Two of these loops contain the hypervariable 
regions that contribute to differences between adenovirus serotypes. The hexon protein of BAdV-
3 is therefore predicted to have the same general structure as that of HAdV (Reddy et al., 1998). 
The BAdV-3 protease is 204 amino acids long and shows 65% sequence identity with the 
proteases of other members of the Mastadenovirus genus (Reddy et al., 1998). The active site of 
the HAdV-2 protease is formed by residues His54, Glu71, and Cys122 (Ding et al., 1996). The 
histidine and cysteine residues are present in BAdV-3 protease, but there is an aspartic acid 
residue in place of the Glu71 of the HAdV-2 protease. The region involved in binding pVIc is 
fairly well conserved between BAdV-3 and HAdV-2, as are most of the residues implicated in 
the binding of the protease to DNA (Gupta et al., 2004). 
The L6 region of BAdV-3 encodes the 100K, 33K, 22K, and pVIII proteins, which in HAdV 
are located in the L4 region (Reddy et al., 1998; Kulshreshtha, 2009). The 100K protein of 
BAdV-3 is 850 amino acids long, the largest 100K protein yet identified in members of the 
Mastadenovirus genus, and has 50-52% sequence identity with the 100K protein of other 
members of the Mastadenovirus genus. In HAdV-5, the 33K and 22K proteins are generated by 
differential splicing (Ostapchuk et al., 2006). The open reading frame of 22K is present in the 
unspliced mRNA and contains splice acceptor and donor sites for an intron within the open 
reading frame; when this intron is spliced out, an alternate reading frame sharing the N-terminus 
of 22K is generated that codes for 33K. In BAdV-3 the 22K protein is 274 amino acids long and 
the 33K protein is 279 amino acids long (Reddy et al., 1998; Kulshreshtha, 2009), both 
significantly larger than the 22K and 33K proteins of HAdV. BAdV-3 mutants with a stop codon 
inserted at amino acid 97 of 33K/22K are deficient in assembly of virus capsids, suggesting that 
one or both proteins are essential for capsid assembly (Kulshreshtha et al., 2004). Insertion of a 
stop codon at the seventh residue decreases the production of mature virus particles but is not 
lethal, suggesting that the C-terminus of either 33K or 22K is important for virus assembly 
(Kulshreshtha et al., 2004). The 33K protein of BAdV-3 interacts with the viral 100K and pV 
proteins (Kulshreshtha and Tikoo, 2008) and is able to transactivate the MLP (Kulshreshtha, 
2009). 
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The minor capsid protein pVIII of BAdV-3 is 216 amino acids long (Reddy et al., 1998). It 
shares 51-56% sequence identity with pVIII proteins in other members of the Mastadenovirus 
genus and has two consensus sites for cleavage by the adenovirus protease. 
The fiber protein is encoded by the L7 region of BAdV-3 and the L5 region in HAdV (Reddy 
et al., 1998). The BAdV-3 fiber is 976 amino acids long and has relatively low sequence identity 
with the fiber proteins of other members of the Mastadenovirus genus (22-27%) but retains the 
conserved sequence known to interact with the penton base and the sequence conserved at the 
beginning of the fiber head domain. The fiber shaft of BAdV-3 is quite long and has an usual 
structure with several bends (Ruigrok et al., 1994). The knob of the BAdV-3 fiber can be 
replaced with the fiber knob from HAdV-5, altering the virus tropism (Wu and Tikoo, 2004). 
Like the fiber protein of HAdV-2, the fiber protein of BAdV-3 contains an NLS at its N-terminus 
(Wu et al., 2004). Mutant BAdV-3 with the fiber NLS removed shows significantly impaired 
growth (Wu et al., 2004). 
 
1.1.4.2.2 Replication cycle 
BAdV-3 appears to enter cells by CAR- and integrin-independent mechanisms (Bangari et al., 
2005). A recent report suggests that BAdV-3 is able to use sialic acid as a receptor for cell entry 
(Li et al., 2009). Removing sialic acid residues or blocking it with a lectin inhibits infection of 
Madin-Darby bovine kidney (MDBK) cells by BAdV-3, as does removal of carbohydrates or 
glycoproteins containing sialic acid. This suggests that the BAdV-3 receptor has protein and 
carbohydrate components and expresses sialic acid that is recognized by the virus. Proteins of 97 
and 34 kilodaltons have been described as potential candidates for a BAdV-3 receptor but have 
not yet been identified or characterized (Li et al., 2009). Several human adenovirus serotypes 
have also been shown to use sialic acid as a receptor (Arnberg et al., 2000). 
The replication cycle of BAdV-3 in MDBK cells appears to be slower than for HAdV. The 
early proteins such as E1A are not detected until 12 hours post-infection (Reddy et al., 1999a) 
and DNA replication also appears to occur later in BAdV-3 than in HAdV (Zhou et al., 2001b). 
In HAdV, the early phase of infection lasts 5 to 6 hours before the onset of DNA replication and 
the beginning of the late phase of infection (Berk, 2007). 
As previously discussed, the packaging signal of BAdV-3 is similar to that of HAdV in that it 
contains functionally redundant repeats located on the left end of the genome, but appears to 
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extend into the E1A open reading frame (Xing et al., 2003; Xing and Tikoo, 2007). The 
consensus packaging sequence determined from studies of HAdV-5 does not appear to be well 
conserved in non-human adenoviruses. CAdV-2 has at least four redundant but not functionally 
equivalent packaging domains and only one instance of the HAdV-5 consensus sequence which 
does not appear to be very efficient at directing packaging (Soudais et al., 2001). Instead, 
mutation of TTTG/A sequences caused decreases in the efficiency of packaging; whether this 
sequence is bound directly or may be involved in the formation of secondary structures in the 
DNA required for packaging is unknown. Porcine adenovirus type 3 (PAdV-3) has a packaging 
domain localized within nucleotides 212 and 531 (Xing and Tikoo, 2003). There are six 
identified packaging domains identified in PAdV-3 that appear to be functionally redundant, but 
it has only one consensus sequence in common with CAdV-2 and none with HAdV-5 (Xing and 
Tikoo, 2004). Instead, continuous A/T regions flanked by G/C-rich regions are observed, with the 
A/T region having greater importance than the G/C-rich sequences. The BAdV-3 packaging 
domain does not contain any consensus packaging sequences with HAdV-5, CAdV-2, or PAdV-
3, but does have a number of A/T-rich motifs. The viral or cellular components that may bind to 
the BAdV-3 packaging signal have not been characterized. 
BAdV-3 replication is blocked in human cells (Wu and Tikoo, 2004). Transduction of many 
human cell lines by BAdV-3 is poor, but a chimeric fiber with the knob of HAdV-5 increases 
transduction efficiency. Inside the cell, BAdV-3 is able to express early and late proteins but 
infectious virus is not produced, suggesting that there is a species-specific block of replication, 
possibly at a late stage of infection. BAdV-3 is able to efficiently transduce 293 cells, but capsid 
assembly does not occur (Patel and Tikoo, 2006). Unlike in HeLa, Hep-2, and A549 cells, 
production of late proteins was not detected in 293 cells, which express the E1 proteins of 
HAdV-5. BAdV-3 DNA replication is inhibited in 293 cells, but this defect can be compensated 
for by expression of the simian virus 40 (SV40) T antigen and allows for virus replication, 
although titres are slightly lower compared to MDBK cells and replication appears to be slower 
(Patel and Tikoo, 2006).  
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1.2 Nuclear transport in Eukaryotes 
In the cell, transcription of DNA into RNA and translation of RNA into protein are 
sequestered in the nuclear and cytoplasmic compartments, respectively. While water, ions, and 
other small molecules can exchange freely, the exchange of larger molecules is regulated. 
 
1.2.1 Nuclear pore complexes 
Access to the nucleus is controlled by nuclear pore complexes (NPCs) inserted in the nuclear 
envelope. In vertebrates, the NPC has a molecular weight of approximately 120 MDa and is 
composed of over 30 unique proteins called nucleoporins (Nups) (Lim et al., 2008). Proliferating 
human cells have 2,000-5,000 NPCs per nucleus.  
The structure for the NPC has been determined and is well conserved (Lim et al., 2008). It 
consists of a cylinder with eight-fold symmetry inserted where the outer and inner nuclear 
membranes are fused to form a pore in the membrane. Eight filaments extend outward into the 
cytoplasm, and a “nuclear basket” made up of eight filaments joined by a distal ring extends 
inward to the nucleus (figure 1.2). The NPC is approximately 150 nm long and has an outer 
diameter of 125 nm. The pore formed by the NPC has a diameter of 60-70 nm at the cytoplasmic 
and nuclear faces, but narrows to 45 nm in the middle. There are also small channels 8 nm in 
diameter around the periphery of the NPC that may be involved in the diffusion of ions and small 
molecules between the nucleus and the cytoplasm. Proteins with a molecular mass greater than 
approximately 40 kDa are unable to cross the NPC unaided and require cellular transport factors 
in order to traverse the pore. 
The nucleoporins that make up the NPC are present in at least eight copies per NPC and can 
be divided into three main classes (Tran and Wente, 2006; Lim et al., 2008). The first class 
consists of transmembrane proteins that contain α-helices and are involved in anchoring the NPC 
to the nuclear membranes. The second class consists of Nups which are proteins with β propeller 
folds, which are made up of β folds arranged around a central axis and are involved in protein-
protein interactions, and α solenoid folds, which contain a curved pattern of α-helices. These 
form the core of the NPC. The third class consists of FG Nups, so named because they contain 
multiple domains of phenylalanine-glycine repeats that are important in transporting proteins 
across the NPC. The FG Nups account for one-third of the nucleoporins and have coiled-coil, β 
propeller, and β sandwich domains which may allow them to interact with the β propeller/α 
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Figure 1.2 Schematic diagram of NPC structure. 
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solenoid proteins in the core. The FG repeats, particularly the ring of phenylalanine, interact with 
hydrophobic residues on transport receptors such as importin β. While the precise mechanism by 
which the transport receptor/cargo complexes use the FG repeats to traverse the NPC is unclear 
(Lim 2008), it is proposed that sequential binding by the receptor to FG repeats throughout the 
pore allow the complex to “step” its way through the pore and exit into the nucleus. Other models 
suggest that the FG repeats block entry to the NPC until they are bound by a transport receptor.  
 
1.2.2 Ran-dependent nuclear transport 
The majority of transport into and out of the nucleus is dependent on the cellular GTPase Ran. 
Directional transport of cargos bound by soluble transport receptors is maintained due to 
differing levels of RanGTP and RanGDP between the cytoplasm and the nucleus, and specific 
interactions of RanGTP or RanGDP with transport receptors. 
 
1.2.2.1 Importins 
Transport of proteins to the nucleus is mediated by specific transport receptors called 
karyopherins or importins that recognize nuclear localization signals (NLSs) of cargo proteins 
and translocate them across the NPC through interactions with FG nucleoporins. Most transport 
is mediated by karyopherins belonging to the importin β family, of which there are over 20 types 
in higher eukaryotes (Fried and Kutay, 2003). All importin β-related proteins contain a RanGTP 
binding domain and have a common structural organization. The best characterized members of 
this family are importin β and transportin. Some cargo proteins are bound by importin β or 
transportin directly for transport to the nucleus, but there are also adaptor proteins that bind to 
importin β and to a cargo protein to direct nuclear import. 
The importin α family of proteins act as adaptors for importin β-directed nuclear import. There 
are six variants of importin α in humans that differ in their expression patterns in various tissues 
and can be bound by cargo proteins with varying specificity (Köhler et al., 1999). The members 
of the importin α family share a common domain organization (Herold et al., 1998; Goldfarb et 
al., 2004). Importin α interacts with importin β through its importin β binding (IBB) domain, a 
basic region near the N-terminus of the protein (Görlich et al., 1996a). The IBB domain is 
essential and sufficient for transport of importin α to the nucleus. Near the end of the IBB domain 
is an autoinhibitory signal, followed by ten hydrophobic armadillo (ARM) repeats, arranged in 
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tandem, each consisting of three α-helices connected by loops (Fontes et al., 2000). The ARM 
repeats form a concave, twisted structure of α-helices with a long groove. Two NLS binding sites 
in this groove have been identified that interact with monopartite and bipartite NLSs. The binding 
site for the nuclear export protein CAS (cellular apoptosis susceptibility) is located on one of the 
ARM repeats near the C-terminus of importin α and overlaps with part of the NLS binding site 
(Herold et al., 1998). 
The autoinhibitory signal located on the flexible IBB domain can also bind to the NLS-binding 
groove (Kobe, 1999). In the absence of importin β sequestering the IBB domain, importin α has 
less affinity for NLS binding since the flexible IBB domain blocks the NLS binding pocket. 
Importin β contains 19 HEAT repeats (named after the proteins in which they were first 
identified: huntingtin, elongation factor 3, the A subunit of protein phosphatase A, and Tor1 
kinase), each consisting of two α-helices in a hairpin structure (Bayliss et al., 2000). The HEAT 
repeats are linked together by loops or other α-helices and are similar to the ARM repeats of 
importin α. The HEAT repeats are coiled into a crescent-like structure. Ran and IBB binding 
occurs on the concave side (Cingolani et al., 1999; Vetter et al., 1999), while interaction with 
FxFG motifs on nucleoporins is mediated by HEAT repeats on the convex surface of importin β 
(Bayliss et al., 2000). 
Other members of the importin β family, such as transportins 1, 2, SR1, and SR2, and 
importins 4, 5, and 7, have been identified that are involved in nuclear import of cellular proteins 
such as mRNA binding proteins, ribosomal proteins, and histones (Fried and Kutay, 2003). These 
transport receptors bind directly to their cargo and transport them into the nucleus similarly to 
importin β/importin α-mediated nuclear import. 
 
1.2.2.2 Nuclear localization signals 
Nuclear localization signals that direct import of proteins into the nucleus are diverse, but in 
general consist of a region of basic amino acids. There are two types of “classical” NLSs 
recognized by importin α that have been well characterized: the monopartite NLS of the SV40 T 
antigen (PKKKRKV) (Kalderon et al., 1984) and the bipartite NLS of nucleoplasmin 
(KRPAATKKAGQAKKKK) (Robbins et al., 1991). These types of basic NLSs can be identified 
in a number of proteins. The monopartite SV40 NLS can bind to two different sites in the NLS-
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binding pocket of importin α (Fontes et al., 2000). The same two sites are bound by the essential 
residues of the bipartite NLS of nucleoplasmin (Fontes et al., 2000). 
NLSs can also exist that use the importin α/importin β pathway but do not match the 
convential monopartite or bipartite NLSs, suggesting that a variety of protein sequences can drive 
nuclear import (Christophe et al., 2000). In support of this observation, generation of random 
peptides yields a surprisingly high number of functional nuclear localization signals, over half of 
which do not appear to have a classical basic NLS. Some proteins lack a classical NLS in their 
primary sequence but can display an NLS motif when properly folded, such as the cellular 
retinoic acid binding protein-II (Sessler and Noy, 2005). The Vpx protein of simian 
immunodeficiency virus has an α-helix whose integrity is essential for nuclear localization 
(Rajendra Kumar et al., 2003). The influenza A virus nucleoprotein contains both a bipartite NLS 
and an NLS that is non-conventional, and it is the non-convential NLS that appears to be 
dominant (Wang et al., 1997; Wu and Pante, 2009). The non-conventional NLS is essential for 
nuclear localization of the nucleoprotein, and its selective exposure regulates the intracellular 
localization of nucleoprotein during virus infection (Wu and Pante, 2009).  
Proteins such as the human immunodeficiency virus (HIV)-1 Tat and Rev proteins (Truant and 
Cullen, 1999) and the Rex protein of human T-cell leukemia virus type 1 (Palmeri and Malim, 
1999) have been identified that contain arginine-rich NLSs that can bind directly to importin β. 
Nuclear import of these proteins can be blocked by an IBB domain peptide (Palmeri and Malim, 
1999; Truant and Cullen, 1999), suggesting that these arginine-rich NLSs bind to importin β in 
the same manner as the IBB domain of importin α. 
The ribosomal protein rpL23a contains a beta-like import receptor binding (BIB) domain that 
can bind to receptors of the importin β family and act as a nuclear localization signal (Jäkel and 
Görlich, 1998). Binding of the BIB domain to importin β is distinct from importin α binding, as 
well as independent of M9 NLS binding to transportin. Similarly, the Stat1 protein uses importin 
α/importin β for nuclear import, but it binds importin α on its C-terminus in a region distinct from 
SV40 NLS binding (Sekimoto et al., 1997). The nucleoprotein of influenza virus A is also able to 
bind to importin α at a site distinct from that used by the SV40 NLS through its non-conventional 
NLS (Wang et al., 1997; Melen et al., 2003).  
The heterologous nuclear ribonucleoprotein A1 contains a nuclear localization signal that has 
been termed an M9 NLS (Pollard et al., 1996). Transport of M9 NLSs is mediated by transportin, 
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a member of the importin β family. The M9 NLS is approximately 40 amino acids long and has 
an overall positive charge (Siomi and Dreyfuss, 1995; Cook et al., 2007). Transportin is primarily 
involved in the nuclear import of mRNA-binding proteins and ribosomal proteins (Fried and 
Kutay, 2003). Serine/arginine-rich proteins involved in splicing of pre-mRNA contain 
phosphorylated RS domains (arginine/serine repeats) that are recognized and transported to the 
nucleus by transportin-SR2 (Lai et al., 2001). 
 
1.2.2.3 Nuclear import cycle 
Directional import of NLS-containing proteins from the cytoplasm into the nucleus is 
maintained by the levels of RanGTP in the nucleus and RanGDP in the cytoplasm, and the 
affinity of import receptors and export receptors for RanGTP or RanGDP (Fried and Kutay, 
2003). A schematic of Ran-dependent nuclear import is shown in figure 1.3. 
In the cytoplasm, the cargo protein NLS is bound by importin α/importin β. The importin 
β/importin α/cargo complex is transported across the NPC into the nucleus by importin β 
interactions with FG Nups. Once inside the nucleus, RanGTP binds to importin β and causes it to 
release importin α and its bound cargo (Görlich et al., 1996c). When the IBB domain of importin 
α is no longer interacting with importin β, it folds back into the NLS-binding pocket of importin 
α, releasing the cargo protein into the nucleus (Kobe, 1999). The RanGTP/importin β complex is 
exported to the cytoplasm, while importin α is bound by the export factor CAS (Kutay et al., 
1997). The interaction of CAS with importin α requires RanGTP and is mutually exclusive with 
NLS binding to importin α (Herold et al., 1998; Fried and Kutay, 2003). This exclusivity prevents 
cargo proteins from being exported back out of the nucleus. The RanGTP/CAS/importin α 
complex is exported to the cytoplasm along with RanGTP/importin β (Kutay et al., 1997; Fried 
and Kutay, 2003). There, Ran hydrolyzes GTP and RanGDP releases bound importin β and CAS, 
which in turn releases importin α. The transport receptors are now able to bind a new cargo and 
begin the cycle again. 
Maintaining high levels of Ran-GDP in the cytoplasm and Ran-GTP in the nucleus is critical 
for this directional transport (Fried and Kutay, 2003). Ran hydrolysis of GTP is normally very 
slow, with a half life of several hours. In the cytoplasm, the Ran-specific GTPase activating 
protein (RanGAP) increases the rate of hydrolysis by a factor of 105, maintaining low levels of 
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Figure 1.3 Ran-dependent nuclear import by importin α/importin β. 
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cytoplasmic RanGTP (Klebe et al., 1995). RanGAP is localized on the cytoplasmic side of the 
NPC. A means of returning exported Ran to the nucleus is also required to maintain nuclear 
levels of RanGTP. Cytoplasmic RanGDP is transported to the nucleus by nuclear transport factor 
2 (NTF2), where the Ran-specific guanine nucleotide exchange factor (RanGEF) stimulates the 
exchange of GDP for GTP by a factor of 105 and triggers dissociation of NTF2 and RanGDP 
(Klebe et al., 1995; Fried and Kutay, 2003). RanGEF can bind to chromatin (Nemergut et al., 
2001) or to nucleoporins on the nuclear face of the NPC (Fontoura et al., 2000), restricting its 
localization to the nucleus so that cytoplasmic RanGEF does not result in an increase of 
cytoplasmic RanGTP. 
 
1.2.3 Ran-independent nuclear transport 
Alternative transport pathways to the nucleus that are independent of Ran have been 
described, but are poorly characterized and lack a consensus (Stochaj and Rother, 1999). In 
general, transport receptors (such as importin β, transportin 1, CRM1, and exportin-t) can enter 
the nucleus without the need for other soluble factors such as Ran (Kose et al., 1997; Kutay et al., 
1998; Nakielny and Dreyfuss, 1998; Zhang et al., 2003). Numerous proteins not involved in 
nuclear transport have also been shown to be capable of entering the nucleus without the use of 
importin α/importin β and Ran.  
Some proteins appear to direct nuclear import by binding directly to nucleoporins, localizing 
to the nucleus without a requirement for additional soluble factors such as Ran or importin β. The 
import of heterogenous ribonucleoprotein K is independent of soluble factors and may shuttle in 
and out of the nucleus by binding directly to nucleoporins (Michael et al., 1997). The Tax protein 
of human T cell lymphotropic virus type 1 can bind directly to p62, a nucleoporin also shown to 
interact with importin β, and is imported into the nucleus independently of soluble factors (Tsuji 
et al., 2007). The nuclear import of IκBα, involved in the regulation of the NFκB family of 
transcription factors, and the Vpr protein of HIV-1 may also be mediated by direct binding to 
nucleoporins (Jenkins et al., 1998; Sachdev et al., 2000). 
Nuclear import of the SV40 NLS can be mediated by the cellular protein calmodulin in a 
calcium-dependent, GTP-independent manner (Sweitzer and Hanover, 1996). The release of 
calcium into the cytoplasm triggered by cell signaling events may induce calmodulin-dependent 
nuclear import of proteins such as the SOX family transcription factors and thus may represent a 
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method of inducible nuclear import in the cell (Hanover et al., 2009). An importin β-like protein 
may also be involved in calmodulin-mediated import, but it is independent of Ran.  
Accumulation of proteins in the nucleus can also be assisted by (or dependent on) binding to 
nuclear components. The respiratory syncytial virus matrix protein and the integrase protein of 
HIV-1 can be imported into the nucleus by Ran-dependent pathways, but can also accumulate in 
the nucleus at lower levels in the absence of soluble factors by binding to nuclear components 
(Ghildyal et al., 2005; Hearps and Jans, 2006). The HIV-1 Tat protein is also able to accumulate 
in the nucleus by binding to nuclear components, but unlike the integrase protein its import is not 
increased by the presence of soluble factors (Efthymiadis et al., 1998). 
 
1.2.4 Nuclear transport of adenovirus proteins 
The mechanisms of nuclear transport of some adenovirus proteins have been described for 
events during cell entry, which has been previously discussed (section 1.1.2.3), and for nuclear 
transport of viral proteins synthesized during infection. In general, the nuclear localization signals 
of some viral proteins have been identified but the import pathways used during viral infection 
are often uncharacterized.  
The viral capsid is able to bind to CAN/Nup214 on the NPC, and histone H1 binds to hexon 
(Trotman et al., 2001). A proposed model suggests that an importin β/importin 7 heterodimer 
directs nuclear import of the histone H1/hexon complex into the nucleus, disassembling the viral 
capsid and exposing the viral DNA core. The core proteins V and VII bound to the viral DNA are 
recognized by transportin, which directs import of the viral DNA into the nucleus (Hindley et al., 
2007). The M9 NLS, also recognized by transportin, is able to block nuclear accumulation of the 
viral DNA, while the SV40 NLS that uses the importin α/importin β pathway is not. 
Viral proteins synthesized in the cytoplasm that exert their effects in the nucleus or proteins 
that are required for virus assembly must be transported back to the nucleus after translation. The 
E1A protein contains a short NLS at its C-terminus (KRPRP) and is transported to the nucleus by 
importin α/importin β (Lyons et al., 1987; Kohler et al., 2001). While several isoforms of 
importin α can support the import of E1A, it has the strongest preference for importin α3 (Kohler 
et al., 2001). The E1B-55K/E4orf6 complex shuttles between the nucleus, and each protein 
appears to contain an NLS as well as a nuclear export signal (NES) (Dobbelstein et al., 1997; 
Grand et al., 1999; Querido et al., 2001). E4orf6 also has an arginine-rich α-helix that acts as a 
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nuclear retention signal by masking the NES in the absence of E1B-55K (Querido et al., 2001). 
The E4orf6/7 protein has an arginine-rich NLS and relocalizes the E2F-4 transcription factor to 
the nucleus during infection (Schaley et al., 2005). 
The hexon protein that makes up the majority of the viral capsid does not have an identified 
NLS and is cytoplasmic when expressed in the absence of other viral proteins (Wodrich et al., 
2003). The pVI protein contains both an NLS and an NES in its C-terminus, which allows it to 
shuttle between the nucleus and the cytoplasm and helps to direct the hexon protein to the 
nucleus (Wodrich et al., 2003). A virus mutant with a temperature-sensitive mutation in pVI is 
defective for capsid assembly and does not transport hexon to the nucleus (Kauffman and 
Ginsberg, 1976). The NLS/NES of pVI is removed by the viral protease late in infection, 
retaining VI in the nucleus for capsid assembly (Wodrich et al., 2003).  
Protein VII contains three NLS domains and can bind in vitro to importin α, importin β, 
importin 7, and transportin (Wodrich et al., 2006). The mature form of VII found in virus capsids 
appears to have a preference for transportin, while the premature pVII produced during viral 
infection primarily uses the importin α/importin β pathway for nuclear import (Hindley et al., 
2007). 
The 100K protein contains a nuclear localization signal in a glycine-arginine-rich domain that 
is located near its C-terminus and a nuclear export signal in the middle of the protein. The 100K 
protein is localized in both the cytoplasm and the nucleus during virus infection (Cuesta et al., 
2004; Koyuncu and Dobner, 2009). There is some evidence that the 100K protein plays a role in 
the nuclear localization of hexon (Hong et al., 2005). 
The NLS of the fiber protein is located in its N-terminus (Hong and Engler, 1991). The 
sequence 1MKRARPSEDTF11 was shown to be sufficient for nuclear targeting of fiber in HAdV-
2, while the deletion of the underlined KRAR sequence abolished nuclear localization. The 
sequence 1MTKRVRL7 from HAdV-7 fiber was able to complement the deletion of the essential 
KRAR sequence. In BAdV-3, the fiber protein NLS is located slightly further away from the N-
terminus, with residues 16KAKR19 being essential for nuclear import (Wu et al., 2004). Residues 
12-22, however, were not sufficient for nuclear localization of fiber. 
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1.3 Ribosomal RNA processing 
Eukaryotic ribosomes are made up of a small 40S subunit and a large 60S subunit. In humans, 
the 40S subunit contains an 18S ribosomal RNA (rRNA) 1,870 nucleotides in length and 30 to 50 
ribosomal proteins (Nazar, 2004). The 60S subunit consists of three rRNA molecules: 5S (121 
nucleotides), 5.8S (156 nucleotides) and 28S rRNA (5,070 nucleotides). The 60S subunit also 
contains 40-50 ribosomal proteins (Nazar, 2004). The synthesis of rRNA and ribosome assembly 
is closely associated with the nucleolus. 
 
1.3.1 Ribosomal RNA processing in eukaryotes 
The 5.8S, 18S, and 28S rRNAs are derived from a single pre-rRNA transcribed by RNA 
polymerase I (Nazar, 2004). The 5S rRNA gene is transcribed separately by RNA polymerase III, 
while genes encoding ribosomal-associated proteins are transcribed by RNA polymerase II 
(Cavanaugh et al., 2004). In mammals, there are 150-200 copies of rRNA genes (rDNA) present 
on different chromosomes, arranged in tandem and separated by untranscribed spacers 
(Cavanaugh et al., 2004). Transcription of rDNA accounts for 40-60% of all transcription in the 
cell. In mammals, the rDNA promoter has a core promoter element, an upstream promoter 
element and has two identified transactivators. Selectivity factor 1 (SL1) is required for rDNA 
transcription and is analogous to the TFIID protein for RNA polymerase II in that it acts to 
recruit the preinitiation complex and the TATA-binding protein to the promoter. Upstream 
binding factor (UBF) enhances rDNA transcription but is not essential. Transcription of rDNA 
can be regulated in a number of ways (Cavanaugh et al., 2004; Lempiäinen and Shore, 2009). 
Cell cycle-dependent kinases can modify SL1 and UBF activity by phosphorylation. The 
mammalian target of rapamycin kinase that is responsive to nutrient availability can also affect 
factors involved in rDNA transcription. The UBF protein can also be sequestered by the RB 
protein, inhibiting rDNA transcription.  
The pre-rRNA transcript is processed by covalent modification and cleaved into mature rRNA 
species (Nazar, 2004) (figure 1.4). In HeLa cells, the 45S pre-rRNA transcript has several 
transcribed spacers surrounding the rRNA sequences (Hadjiolova et al., 1993). A 5’ external 
transcribed spacer (ETS) is located upstream of the 18S rRNA sequence. Two internal 
transcribed spacers (ITS) lie between the 18S and 5.8S rRNA sequences (ITS1), and between the 
5.8S and 28S rRNA sequences (ITS2). A 3’ETS lies downstream of the 28S rRNA sequence.  
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Figure 1.4 Ribosomal RNA processing in HeLa cells. The processing of pre-ribosomal 
45S rRNA to 18S, 5.8S, and 28S rRNA in HeLa cells. Cleavages are indicated A-G.  
Processing can occur by one of two pathways depending on the order of cleavages C and 
D. (Adapted from Hadjiolova et al., 1993.). 
Pathway B 
Pathway A 
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The first cleavage steps remove part of the 5’ETS and the entire 3’ETS. Two pathways of 
processing can then occur, dependent on the order of the next two cleavage events. In the first 
pathway, the next cleavage step removes the remainder of the 5’ETS, followed by cleavage at the 
end of ITS1. The 21S product of this cleavage contains the 18S rRNA sequence and ITS1; 
cleavage of ITS1 generates 18S rRNA. The 32S product contains the 5.8S and 28S rRNA 
sequences separated by ITS2. Cleavage at the end of ITS2 generates 28S rRNA and a 12S 
product containing the 5.8S rRNA sequence and ITS2, which is then cleaved to generate 5.8S 
rRNA. In the second pathway, cleavage at the end of ITS1 occurs prior to the removal of the 
5’ETS, generating a 30S product containing the 5’ETS, the 18S rRNA sequence, and ITS1, and 
the same 32S product composed of 5.8S, ITS2, and 28S generated in the first pathway after 
cleavage at ITS1. The 32S product is processed in the same manner as in the first pathway. 
Removal of the 5’ETS from the 30S subunit generates the 21S product containing 18S and ITS1; 
ITS1 is then removed to produce 18S rRNA as in the first pathway. 
During or shortly after the pre-rRNA precursor is transcribed, covalent modifications such as 
methylation and pseudouridine synthesis take place within the 18S, 5.8S, and 28S regions (Gerbi 
and Borovjagin, 2004). Small nucleolar RNA molecules (snoRNAs) complementary to the 
modification sites bind and recruit small nucleolar ribonucleoprotein (snoRNP) complexes that 
modify the pre-rRNA molecule. The U3 snoRNA that makes up part of the U3 snoRNP base 
pairs to complementary sequences within the 5’ETS with the assistance of nucleolin. Binding of 
U3 snoRNA to the ETS and other sites within the rRNA is required for several of the first 
cleavage steps in rRNA processing, while binding of U8 snoRNA to other sequences is required 
for other processing steps, particularly the generation of 28S rRNA. In addition to binding of 
snoRNAs and snoRNPs, the pre-rRNA associates with ribosomal and non-ribosomal proteins to 
form a pre-ribosomal particle (90S in yeast, 80S in mammals) (Cavanaugh et al., 2004; Gerbi and 
Borovjagin, 2004; Henras et al., 2008). The 80S/90S pre-ribosome is processed into the 40S and 
60S subunits, then transported to the cytoplasm where the final processing steps occur and 
additional ribosomal proteins are added to generate mature, functional ribosomes (Henras et al., 
2008).  
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1.3.2 Inhibition of ribosomal RNA processing during adenovirus infection 
In cells infected with HAdV-2, it was observed that production of new ribosomes decreased 
during infection to 20% of the level seen in uninfected cells (Raskas et al., 1970). In HAdV-12-
infected cells, there is a decrease in the amount of new 28S, 18S, and 5.8S rRNAs in the 
cytoplasm and a new rRNA species not observed in uninfected cells appears (Ledinko, 1972; 
Lawler et al., 1989). The amount of 28S and 18S rRNA produced in HAdV-5 infected cells 
shows a dramatic decrease as the infection progresses (Castiglia and Flint, 1983). The amount of 
28S rRNA produced at 12 hrs post infection was only 10% of the level in uninfected cells and 
less than 1% at 24 hrs. The production of 18S rRNA showed a less severe inhibition, falling to 
approximately 40% of control cell levels at 12 hrs post infection and less than 10% at 24 hrs. It 
was also demonstrated that while synthesis of ribosomal proteins is suppressed in adenovirus-
infected cells, they are not downregulated more than other cellular proteins. This appears to be 
due to the generalized inhibition of host cell translation during infection. If the decreased levels 
of 28S and 18S were due to the virus interfering with host cell translation and inhibiting proteins 
required for their production, it would be expected that their inhibition would lag behind that of 
host cell proteins. The inhibition of 28S and 18S rRNA production reached 50% at an average of 
9.7 and 15 hrs post infection, respectively, while inhibition of host cell protein synthesis was 50% 
at an average of 12.3 hrs. The levels of other pre-rRNA species decreased during infection, but 
the 45S pre-rRNA did not, suggesting that the decrease in mature rRNA species is due to 
inhibition of pre-rRNA processing rather than rRNA synthesis by RNA polymerase I. It is 
possible that the virus also interferes with transport of the rRNA to the cytoplasm, since the 
levels of 28S rRNA decreased much more rapidly in the cytoplasm than in the nucleus. 
In HAdV-2-infected cells, the UBF protein involved in activation of rDNA transcription is 
recruited to centers of viral DNA replication, but this does not appear to affect the localization of 
RNA polymerase I, the rate of pre-rRNA synthesis, or, in contradiction with results of Castiglia 
and Flint (1983), rRNA processing (Lawrence et al., 2006). Several viral proteins including IVa2, 
pV, pVII, and µ have been shown to localize to the nucleolus (Lutz et al., 1996; Matthews, 2001; 
Lee et al., 2003; Lee et al., 2004b). Redistribution of nucleolar proteins such as nucleolin and 
B23 by pV has been shown (Matthews, 2001). Other nucleolar proteins are also relocalized 
during adenovirus infection (Lam et al., 2010). However, inhibition of rRNA processing has not 
yet been linked to a viral protein. 
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1.3.3 Inhibition of ribosomal RNA processing by viruses 
Several other viruses have been shown to inhibit rRNA metabolism during infection, either by 
interfering with rRNA synthesis, rRNA processing, or both. The mechanisms by which these 
viruses interfere with rRNA synthesis and processing are often not well characterized, 
particularly with respect to inhibition of rRNA processing. Interactions with nucleolar proteins 
and disruption of nucleoli by many viruses could be important due to the close relationship of 
rRNA processing with nucleolar proteins and structures (Hiscox, 2002). 
 
1.3.3.1 Poliovirus 
Poliovirus is a member of the Picornaviridae family and has a single-stranded, positive-sense 
RNA genome (Banerjee et al., 2005). Poliovirus infection disrupts normal rRNA processing, 
since the levels of several minor rRNA species are increased in infected cells (Weinberg et al., 
1967). The viral protease is also able to cleave SL1 and decrease the levels of UBF, inhibiting 
transcription from the rDNA promoter and downregulating pre-rRNA production (Banerjee et al., 
2005). 
 
1.3.3.2 Vesicular stomatitis virus 
Vesicular stomatitis virus (VSV) is a member of the Rhabdoviridae family and has a single-
stranded, negative-sense RNA genome (Lyles and Rupprecht, 2007). VSV is able to inhibit both 
synthesis and processing of rRNA (Zan et al., 1990; Ahmed and Lyles, 1998). The VSV matrix 
protein can inhibit RNA polymerase I-dependent transcription of 45S pre-rRNA. The processing 
of the 45S precursor is also inhibited by a distinct but unidentified viral protein. 
 
1.3.3.3 Poxviruses 
Members of the Poxviridae family are large, enveloped viruses that contain a double-stranded 
DNA genome and replicate entirely in the cytoplasm of infected cells (Moss, 2007). Members of 
the Poxviridae family such as vaccinia virus and Shope fibroma virus have been shown to inhibit 
the production of mature rRNA during infection (Salzman et al., 1964; Ewton and Hodes, 1967). 
The mechanisms by which this occurs have not been well characterized, but inhibition appears to 
occur by downregulating RNA synthesis as well as inhibition of either transport of rRNA to the 
cytoplasm or rRNA processing. 
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1.3.3.4 Herpes simplex virus 
Members of the family Herpesviridae such as herpes simplex virus (HSV) are enveloped 
viruses with a double-stranded DNA genome (Pellett and Roizman, 2007). During HSV 
infection, synthesis of 45S pre-rRNA and processing of the precursor into 28S and 18S rRNA 
decrease (Wagner and Roizman, 1969). As the levels of 28S and 18S decline, heavier species 
accumulate, indicating a defect in processing. The production of 45S rRNA drops to 30% of the 
level observed in uninfected cells, while the levels of 28S and 18S rRNA are 10% or less of the 
amount from control cells. HSV also alters the intracellular distribution of rRNA, recruiting it to 
virus-induced regions in the nucleus where viral DNA replication, transcription, and assembly 
occur (Besse and Puvion-Dutilleul, 1996). 
 
1.3.3.5 Human immunodeficiency virus 
HIV-1 belongs to the family Retroviridae , a family of enveloped viruses with single-stranded, 
positive-sense RNA genome that is reverse transcribed into double-stranded DNA that can 
integrate into host cell chromosomal DNA (Goff, 2007). The HIV-1 Tat protein inhibits the 
processing of rRNA (Ponti et al., 2008). Probes specific for the 5’ETS and two sites in ITS1 
detected increased levels of various rRNA precursors in Drosophila flies expressing the Tat 
protein, indicating a defect of rRNA processing. Tat interacts with fibrillarin and U3 snoRNA 
and can bind to the region of rRNA between the 5’ETS and 18S where an early cleavage step 
occurs. Since both fibrillarin and U3 snoRNA are involved in early steps of processing pre-
rRNA, it is likely that their interaction with Tat somehow disrupts these processing steps. 
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2.0 HYPOTHESIS AND OBJECTIVES 
 
2.1 Hypothesis 
Non-human adenoviruses such as bovine adenovirus (BAdV)-3 are being studied for use as 
expression vectors for vaccine delivery and gene therapy (Reddy et al., 1999b). A number of 
differences between human adenoviruses (HAdVs) and BAdV-3 have been observed. Differences 
in cell entry (Bangari et al., 2005), transcriptional organization of the genome (Reddy et al., 
1998), and the packaging signal located at the left end of the genome (Xing and Tikoo, 2003; 
Xing and Tikoo, 2007) have been observed in BAdV-3 compared to HAdVs. In addition, several 
proteins unique to BAdV-3 are present in the E3 and E4 regions (Reddy et al., 1998; Idamakanti 
et al., 1999) and the virus-associated RNAs present in HAdVs appear to be absent in BAdV-3 
(Reddy et al., 1998). Because of these differences between HAdVs and BAdV-3, it is important 
to characterize the structure and function of BAdV-3 proteins. 
Interactions between viral proteins and between viral and cellular proteins are important for 
adenovirus replication. For example, interactions between structural proteins are critical for the 
formation of the adenoviral capsid (Vellinga et al., 2005), while interactions between early viral 
proteins and cellular proteins such as the retinoblastoma protein and p53 are essential for the 
virus to push the cell into S phase and prevent apoptosis induced by virus replication (Berk, 
2005). 
All sequenced adenoviruses contain a non-structural protein termed 52K (Davison et al., 
2003). In HAdV, 52K has been shown to be essential for encapsidation of the viral genome 
(Hasson et al., 1989; Gustin and Imperiale, 1998) and interacts with the viral pVII and IVa2 
proteins (Gustin et al., 1996; Zhang and Arcos, 2005). We propose to study the 52K protein of 
BAdV-3 and hypothesize that the BAdV-3 52K protein interacts with additional viral and cellular 
proteins during BAdV-3 infection of bovine cells. 
 
2.2 Objectives 
The overall objective of this work is to characterize the 52K protein of BAdV-3, as a step 
towards developing BAdV-3 as an expression vector. 
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The specific objectives of this work are: 
 
(i) To raise specific antibodies against the BAdV-3 52K protein and characterize its open 
reading frame, its expression during BAdV-3 infection, and its intracellular 
localization; 
(ii) To identify viral and cellular proteins interacting with BAdV-3 52K; 
(iii) To identify if possible the biological functions of detected interactions. 
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3.0 CHARACTERIZATION OF 52K PROTEIN OF BAdV-3 
 
3.1 Introduction 
Adenoviruses are non-enveloped, icosahedral viruses containing a double-stranded DNA 
genome. The virus enters the cells by endocytosis, escapes the pre-lysosomal compartment, and 
travels to the nuclear envelope where it releases the viral DNA into the nucleus. Expression of 
viral genes is divided into early, intermediate, and late phase of viral infection. The early and 
intermediate genes are transcribed after the viral DNA enters the nucleus and prior to the onset of 
DNA replication. In contrast, the late genes are transcribed after the onset of viral DNA 
replication and are grouped into different families based on usage of polyadenylation signals.  
Bovine adenovirus (BAdV)-3, a member of the Mastadenovirus genus, is being developed as a 
vector for vaccination of animals and humans (Rasmussen et al., 1999; Zakhartchouk et al., 
1999). Earlier, determination of the genome sequence and transcriptional map (Reddy et al., 
1998) suggested that the BAdV-3 genome is also organized into early, intermediate, and late 
regions. The late genes are all expressed from the major late promoter (MLP) and are grouped 
into seven families (L1 to L7) based on usage of polyadenylation sites. Although the genome 
organization appears to be similar to human adenovirus (HAdV)-5, recent studies have identified 
distinct features of BAdV-3 (Reddy et al., 1998; Idamakanti et al., 1999; Xing and Tikoo, 2003; 
Bangari et al., 2005; Xing and Tikoo, 2006; Xing and Tikoo, 2007). 
The L1 region of HAdV-5 encodes a nonstructural protein named 52/55K (Lucher et al., 
1986), which is expressed as two differentially phosphorylated forms of a 48-kDa precursor 
(Lucher et al., 1986; Hasson et al., 1992). The 52K protein is involved in packaging of 
adenovirus DNA (Hasson et al., 1989; Gustin and Imperiale, 1998). The N-terminal half of the 
52K protein mediates serotype specificity for packaging of the viral genome into the capsid 
(Wohl and Hearing, 2008). Although the 52K protein is predominantly localized in the nucleus of 
infected cells (Lucher et al., 1986; Hasson et al., 1992), the molecular mechanism involved in 
nuclear localization is not known. 
Protein entry into the nucleus is regulated by the nuclear pore complexes (NPCs), which are 
embedded in the nuclear membrane and form a channel through which regulated transport in and 
out of the nucleus can occur (Lim et al., 2008). Proteins larger than ~40 kDa cross the NPC (Lim 
et al., 2008) only after interaction of a nuclear localization signal (NLS) with one or more soluble 
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transport receptors (Kalderon et al., 1984; Robbins et al., 1991). Classical NLSs contain one or 
two clusters of basic amino acids, however a growing number of non-classical NLSs that do not 
fit this consensus have been identified (Christophe et al., 2000).  
The majority of protein trafficking into and out of the nucleus is dependent on the cellular 
GTPase Ran and soluble transport receptors such as importin α and importin β (Fried and Kutay, 
2003). However, some proteins can bind to importin β without importin α (Palmeri and Malim, 
1999; Truant and Cullen, 1999) or to receptors such as transportin (Pollard et al., 1996) for 
nuclear import. While these mechanisms are still Ran-dependent, Ran-independent nuclear 
import mechanisms such as calcium-dependent calmodulin-mediated (Hanover et al., 2009) or 
nucleoporin-mediated (Michael et al., 1997; Tsuji et al., 2007) have also been reported.  
Homologs of 52K have been identified in other members of the Mastadenovirus genus 
including BAdV-3 (Reddy et al., 1998; Davison et al., 2003). The L1 region of the late 
transcription unit of BAdV-3 encodes the 52K protein (Reddy et al., 1998), which is collinear 
with 52K of HAdV-5. Since BAdV-3 52K shows 56.8% to 61.6% sequence identity to 52K 
proteins of other Mastadenoviruses (Reddy et al., 1998), we sought to characterize this protein. 
Here, we report its characterization and identification of pathway(s) mediating nuclear 
localization of the BAdV-3 52K protein.  
 
3.2 Materials and Methods 
 
3.2.1 Cell lines and viruses 
Madin Darby bovine kidney (MDBK) cells were propagated in minimal essential medium 
(MEM; Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum (FBS; SeraCare 
Life Sciences, Inc.). COS7 cells (Gluzman, 1981) were propagated in Dulbecco’s modified 
Eagle’s medium (DMEM; Invitrogen) supplemented with 10% FBS. Wild-type BAdV-3 (WBR-1 
strain) was propagated in MDBK cells in MEM supplemented with 2% FBS and purified by 
cesium chloride density-gradient centrifugation (Reddy et al., 1999a). The virus titer was 
determined by plaque assay (Mittal et al., 1995) to be 5 x 108 plaque-forming units (pfu)/mL. 
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3.2.2 Sequence analysis 
Sequence alignment of BAdV-3 52K with the sequences of 52K proteins of other 
Mastadenoviruses was performed with Clone Manager (Sci Ed Software) using a BLOSUM 62 
scoring matrix.  
 
3.2.3 GST fusion protein 
A 312-bp HincII/EagI fragment of 52K corresponding to amino acids 29 to 133 (nucleotides 
10072 to 10384 of the BAdV-3 genome, Genbank AF03014) was cloned into SmaI-EagI-
digested plasmid pGEX-5x-2 (GE Healthcare) downstream and in frame with glutathione-S-
transferase (GST) to create plasmid pGEX-52K(N). The translation frame of the fusion protein 
was verified by DNA sequencing. The plasmid pGEX-52K(N) DNA was transformed into E. coli 
BL21 cells. An aliquot of an overnight culture was added to 12 mL 2xTY broth [16g/L tryptone, 
10 g/L yeast extract, 5 g/L sodium chloride] containing 100 µg/mL ampicillin and grown at 37˚C 
with shaking to an OD600 of approximately 0.6. Fusion protein expression was induced by the 
addition of 0.1mM isopropyl-β-D-thiogalactopyranoside (IPTG). After incubation of 2-3 hrs, the 
cells were harvested by centrifugation (6,000xg for 15 min), resuspended in 0.1 M phosphate 
buffered saline (PBS), and lysed by the addition of lysozyme (0.1 mg/mL) for 5 minutes at room 
temperature followed by ten freeze/thaw cycles. The lysate was cleared by centrifugation 
(10,000xg for 10 min) and GST-52K(N) fusion protein was purified using glutathione sepharose 
columns (GE Healthcare) as per manufacturer’s instructions. The purity of the eluted protein was 
confirmed by sodium dodecyl sulphate (SDS) - polyacrylamide gel electrophoresis (PAGE). The 
proteins were separated by 10% SDS-PAGE and the gel was stained for 15 minutes with 
Coomassie Blue. Finally, the gel was destained with destaining solution [10% acetic acid, 40% 
methanol] to visualize protein bands. 
 
3.2.4 Immunization 
 Antibodies against the GST-52K(N) protein were raised by subcutaneous immunization of 
rabbits with 500 µg of purified GST-52K(N) emulsified in Freund’s complete adjuvant (Sigma-
Aldrich). Three boosts of 300 µg GST-52K(N) emulsified in Freund’s incomplete adjuvant 
(Sigma-Aldrich) were given at 21, 42, and 63 days post immunization. Finally, serum was 
collected at day 74 of primary immunization, aliquoted, and stored at –20˚C. 
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3.2.5 Western blotting 
MDBK cells were grown in 6-well plates to 80-90% confluency and infected with wild-type 
BAdV-3 at a multiplicity of infection (MOI) of 4 plaque forming units (pfu)/cell. At indicated 
times post infection, infected cells were harvested by centrifugation at 3,000 rpm (950xg) for 5 
minutes and lysed by addition of RIPA buffer [0.15 M NaCl, 50 mM Tris-HCl (pH 8.0), 1% NP-
40, 1% deoxycholate, 0.1% SDS] containing 1 µg/mL each aprotinin, leupeptin, and pepstatin A. 
Proteins from lysates of infected cells were separated by 10% SDS-PAGE and transferred to a 
nitrocellulose membrane (Bio-Rad). The membrane was blocked with 1% bovine serum albumin 
(BSA) in TBST [Tris-buffered saline (pH 8.0), 0.05% tween 20] overnight at 4˚C and probed 
with anti-52K serum diluted 1:100 in TBST containing 0.1% BSA for 1 hour at room 
temperature. After three TBST washes, the membranes were probed with alkaline phosphatase 
(AP)-conjugated goat anti-rabbit IgG (Jackson Immunoresearch) diluted 1:10,000 in TBST 
containing 0.1% BSA for 1 hr at room temperature. The membranes were washed three times in 
TBST and developed using a colorimetric kit. 
 
3.2.6 Immunofluorescence microscopy 
MDBK cells seeded in 2-well glass slides were infected with wild-type BAdV-3 at an MOI of 
4. COS7 cells seeded on 4-well glass slides were transfected with 1µg of plasmid DNA as 
indicated in the text and figures using ExGen transfection reagent (Fermentas) as per the 
manufacturer’s instructions. Twenty-four hrs post infection or post transfection, the cells were 
fixed in 100% methanol for 20 minutes at -20˚C. After three washes in PBS, cells were blocked 
with 2% goat serum in PBS for 30 minutes, then probed with anti-52K serum (diluted 1:50) and a 
mouse anti-nucleolin monoclonal antibody (Stressgen; diluted to 1 µg/mL) in PBS containing 1% 
goat serum for 1 hr at room temperature. After three washes in PBS, Cy2-conjugated goat anti-
rabbit IgG (Jackson Immunoresearch; diluted 1:400) and Cy3-conjugated goat anti-mouse IgG 
(Jackson Immunoresearch; diluted 1:800) in PBS containing 1% goat serum were added for 1 hr 
at room temperature. Cells were washed three times in PBS and stained with 2 µg/mL 4’,6-
diamino-2-phenylindole (DAPI), then mounted in Citifluor mounting reagent (Citifluor, Ltd., 
Leicester, U.K.) and visualized on an Axiovert UV microscope using Zeiss AxioVision software. 
Cells transfected with plasmids expressing enhanced yellow fluorescent protein (EYFP) fusion 
proteins were fixed 24 hrs post transfection with 3.7% paraformaldehyde in PBS for 15 min, 
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washed three times in PBS and stained with 2 µg/mL DAPI. Finally, the cells were analyzed 
using Axiovert UV Microscope and Zeiss AxioVision software. 
 
3.2.7 Plasmid construction 
(a) Construction of pcDNA.52K. A 1,124-bp fragment containing the 52K open reading frame 
was amplified by PCR using primers CP1 and CP2 (table 3.1), and plasmid pTG5435 (containing 
the full-length BAdV-3 genome) (Rasmussen et al., 1999) DNA as a template. The PCR product 
was digested with EcoRI-BamHI and ligated to EcoRI–BamHI digested pcDNA3.1(-) 
(Invitrogen) creating plasmid pcDNA.52K (figure 3.1). 
(b) Construction of pEY.52K. The 1,124-bp PCR fragment containing 52K described in section 
3.2.7 (a) was blunt-end ligated to EcoRV-digested plasmid Litmus28i (New England Biolabs). A 
clone with 52K inserted in the same orientation as the Litmus28i LacZ ORF was selected and 
named L28i.52K. A 1.1 kb SnaBI-SalI fragment was isolated from plasmid L28i.52K and ligated 
to AfeI-XhoI-digested plasmid pEYFPN1 (Clontech), creating plasmid pEY.52K (figure 3.1). 
(c) Construction of 52K deletion mutants. Sequential deletions in the 52K ORF were created as 
previously described (Lee et al., 2004a). A schematic of the overlap PCR strategy is shown in 
figure 3.2. All deletions were confirmed by restriction enzyme analysis and sequencing. 
(i) Construction of pEY.52K∆1. A 984-bp fragment amplified by PCR using primers ∆1F and 
CP2 (table 3.1), and plasmid pcDNA.52K DNA as a template was ligated to SrfI-digested 
plasmid PCR-Script Amp (Stratagene). A clone with the mutant 52K ORF inserted in the same 
orientation as the plasmid PCR-Script Amp T7 promoter was selected and named pScript-∆1. A 
1kb EcoRV-SalI fragment was isolated from plasmid pScript-∆1 and ligated to AfeI-XhoI 
digested plasmid pEYFPN1 creating plasmid pEY.52K∆1 (figure 3.1). 
(ii) Construction of pEY.52K∆2. A 141-bp fragment was amplified by PCR using primers CP1 
and ∆2R (table 3.1), and plasmid pcDNA.52K DNA as a template. Similarly, a 851-bp fragment 
was amplified by PCR using primers ∆2F and CP2 (table 3.1), and plasmid pcDNA.52K DNA as 
a template. The two PCR fragments were mixed, annealed, and amplified by PCR using primers 
CP1 and CP2. This 974-bp PCR product was ligated to SrfI-digested plasmid PCR-Script Amp. A 
clone with the mutant 52K ORF inserted in the same orientation as the PCR-Script Amp T7 
promoter was selected and named pScript-∆2. A 990-bp EcoRV-SalI fragment was isolated from
Table 3.1 Primers used for PCR. 
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Primer name Sequence 
CP1 5’-GAATTCATGCATCCCGCTTTACGGCAAATG-3’ 
CP2 5’-GGATCCACTCATTCGTCGACTTCAT-3’ 
∆1F 5’-AGAATTCATGCTGTACGCGCACCCGGACAC-3’ 
 
∆2F 
∆2R 
         5’-TGCGGCGAGAAGGCCGGTCGG-3’ 
3’-CCACAGCTCACGCCGCTCTTCCGGCCA-5’ 
 
∆3F          5’-GGGAGCCGAGTGCGGGCTTACGAGCAAAC-3’ 
∆3R 3’-CTTGGGCTTCCCTCGGCTCACGCCCGA-5’ 
 
∆4F           5’-GCCCACATGGGCAGCAAGACCCTTACG-3’ 
∆4R 3’-GAGTCGGTTTCGGGTGTACCCGTCGTTC-5’ 
 
∆5F           5’-GCATACGCGCAGTCCATTGTGGTGCAAGAG-3’ 
∆5R 3’-GAAACGCCTCCGTATGCGCGTCAGGTAA-5’ 
 
∆6F              5’-GAGGGACGATTTGTGCCGCTTGACAAGGAG-3’ 
∆6R 3’-GTATCGTCTCGGGCTCCCTGCTAAACACGGC-5’ 
 
∆7F           5’-GCCCGCAAGGCGGAGCTGCTGTTCAACC-3’ 
∆7R 3’-GTTTGTAATACGGGCGTTCACTGTGCACA-5’ 
 
∆8R 5’-TCTCCCGACGCCTGCCTATGC-3’ 
 
∆3.1F             5’-GAGGAACCCGCCGGAATGCCCCGAAAGCG-3’ 
∆3.1R 3’-CTGGCGTCGCCCCTCCTTGGGCGGCCTTAC-5’ 
 
∆3.2F             5’-TTGCGCGCCGAAGGGGACTTTGAGGTGGAT-3’ 
∆3.2R 3’-CGGCCAGCTGTCAACGCGCGGCTTCCCCTG-5’ 
 
∆3.3F              5’-GGCATCAGCCGGGCGTACGAGCAAACGGTG-3’ 
∆3.3R 3’-CCTACTCGCGTGACCGTAGTCGGCCCGCATG-5’ 
 
CP3 5’-ATTCGTCGACTTCATCGTCC-3’ 
NLSmF 5’-TGCCCGAAGAGGAGGTGCTGACCGAAGGGGACTTTGAGG-3’ 
NLSmR 3’-CAGCCGTCAACGCGCGGCCGTACGGGCTTCTCCTCCACG-5’ 
CP4 5’-ATGGCTAGCGGCATGCCCCGAAAGCGGGTGCTGACCAAAGGAGAAGA 
ACTCTTCACTGGAGTTGTCCCAATTC-3’ 
CP5 5’-AGCACGTGTCTTGTAGTTGCCGTCATC-3’ 
Overlapping regions to create deletions are shown in bold. Restriction enzyme sites 
are underlined. Start and stop codons for the 52K open reading frame are indicated in 
bold italics.  
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Figure 3.1. Schematic representation of 52K constructs and mutants. Amino acids 
deleted by PCR mutagenesis are indicated. Plasmid names are indicated on the left; 
proteins expressed from these plasmids are indicated on the right. 
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Figure 3.2 Schematic of deletion mutagenesis by overlap PCR. A. Amplification of 
upstream and downstream sequences. Forward and reverse primers are designed 
complementary to sequences flanking the region to be deleted (in black) and contain a 
sequence complementary to the other primer in the pair (filled arrows). Two separate PCR 
reactions amplify the regions upstream and downstream of the area to be deleted, using 
forward and reverse primers complementary to the ends of the gene (open arrows). B. 
Overlap PCR. The products of the two PCR reactions are mixed and amplified using the 
non-chimeric primers. C. PCR product. The product of the final PCR reaction contains the 
desired deletion. (Adapted from Lee et al., 2004a)  
A. 
B. 
C. 
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plasmid pScript-∆2 and ligated to AfeI-XhoI digested plasmid pEYFPN1 creating plasmid 
pEY.52K∆2 (figure 3.1). 
(iii) Construction of pEY.52K∆3. A 279-bp fragment was amplified by PCR using primers 
CP1 and ∆3R (table 3.1), and plasmid pcDNA.52K DNA as a template. Similarly, a 728-bp 
fragment was amplified by PCR using primers ∆3F and CP2 (table 3.1), and plasmid 
pcDNA.52K DNA as a template. The two PCR fragments were mixed, annealed, and amplified 
by PCR using primers CP1 and CP2. This 989-bp PCR product was ligated to SrfI-digested 
plasmid PCR-Script Amp. A clone with the mutant 52K ORF inserted in the same orientation as 
the PCR-Script Amp T7 promoter was selected and named pScript-∆3. A 1,005-bp EcoRV-SalI 
fragment was isolated from plasmid pScript-∆3 and ligated to AfeI-XhoI digested plasmid 
pEYFPN1 creating plasmid pEY.52K∆3 (figure 3.1). 
(iv) Construction of pEY.52K∆4. A 399-bp fragment was amplified by PCR using primers CP1 
and ∆4R (table 3.1), and plasmid pcDNA.52K DNA as a template. Similarly, a 581-bp fragment 
was amplified by PCR using primers ∆4F and CP2 (table 3.1), and plasmid pcDNA.52K DNA as 
a template. The two PCR fragments were mixed, annealed, and amplified by PCR using primers 
CP1 and CP2. This 962-bp PCR product was ligated to SrfI-digested plasmid PCR-Script Amp. A 
clone with the mutant 52K ORF inserted in the same orientation as the PCR-Script Amp T7 
promoter was selected and named pScript-∆4. A 978-bp EcoRV-SalI fragment was isolated from 
plasmid pScript-∆4 and ligated to AfeI-XhoI digested plasmid pEYFPN1 creating plasmid 
pEY.52K∆4 (figure 3.1). 
(v) Construction of pEY.52K∆5. A 552-bp fragment was amplified by PCR using primers CP1 
and ∆5R (table 3.1), and plasmid pcDNA.52K DNA as a template. Similarly, a 449-bp fragment 
was amplified by PCR using primers ∆5F and CP2 (table 3.1), and plasmid pcDNA.52K DNA as 
a template. The two PCR fragments were mixed, annealed, and amplified by PCR using primers 
CP1 and CP2. This 983-bp PCR product was ligated to SrfI digested plasmid PCR-Script Amp. A 
clone with the mutant 52K ORF inserted in the same orientation as the PCR-Script Amp T7 
promoter was selected and named pScript-∆5. A 999-bp EcoRV-SalI fragment was isolated from 
plasmid pScript-∆5 and ligated to AfeI-XhoI digested plasmid pEYFPN1 creating plasmid 
pEY.52K∆5 (figure 3.1). 
(vi) Construction of pEY.52K∆6. A 666-bp fragment was amplified by PCR using primers CP1 
and ∆6R (table 3.1), and plasmid pcDNA.52K DNA as a template. Similarly, a 335-bp fragment 
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was amplified by PCR using primers ∆6F and CP2 (table 3.1), and plasmid pcDNA.52K DNA as 
a template. The two PCR fragments were mixed, annealed, and amplified by PCR using primers 
CP1 and CP2. This 983-bp PCR product was ligated to SrfI-digested plasmid PCR-Script Amp. A 
clone with the mutant 52K ORF inserted in the same orientation as the PCR-Script Amp T7 
promoter was selected and named pScript-∆6. A 999-bp EcoRV-SalI fragment was isolated from 
plasmid pScript-∆6 and ligated to AfeI-XhoI digested plasmid pEYFPN1 creating plasmid 
pEY.52K∆6 (figure 3.1). 
(vii) Construction of pEY.52K∆7. A 792-bp fragment was amplified by PCR using primers 
CP1 and ∆7R (table 3.1), and plasmid pcDNA.52K DNA as a template. Similarly, a 185-bp 
fragment was amplified by PCR using primers ∆7F and CP2 (table 3.1), and plasmid 
pcDNA.52K DNA as a template. The two PCR fragments were mixed, annealed, and amplified 
by PCR using primers CP1 and CP2. This 959-bp PCR product was ligated to SrfI-digested 
plasmid PCR-Script Amp. A clone with the mutant 52K ORF inserted in the same orientation as 
the PCR-Script Amp T7 promoter was selected and named pScript-∆7. A 975-bp EcoRV-SalI 
fragment was isolated from plasmid pScript-∆7 and ligated to AfeI-XhoI digested plasmid 
pEYFPN1 creating plasmid pEY.52K∆7 (figure 3.1). 
(viii) Construction of pEY.52K∆8. A 940-bp fragment amplified by PCR using primers CP1 
and ∆8R (table 3.1), and plasmid pcDNA.52K DNA as a template was ligated to SrfI-digested 
plasmid PCR-Script Amp. A clone with the mutant 52K ORF inserted in the same orientation as 
the PCR-Script Amp T7 promoter was selected and named pScript-∆8. A 1,002-bp EcoRV-SacI 
fragment isolated from plasmid pScript∆8 was ligated to AfeI-SacI digested plasmid pEYFPN1 
creating plasmid pEY.52K∆8 (figure 3.1). 
(ix) Construction of pEY.52K∆3.1. A 267-bp fragment was amplified by PCR using primers 
CP1 and ∆3.1R (table 3.1), and plasmid pcDNA.52K DNA as a template. Similarly, a 830-bp 
fragment was amplified by PCR using primers ∆3.1F and CP2 (table 3.1), plasmid pcDNA.52K 
DNA as a template. The two PCR fragments were mixed, annealed, and amplified by PCR using 
primers CP1 and CP2. This 1,043-bp PCR product was ligated to SrfI-digested plasmid PCR-
Script Amp. A clone with the mutant 52K ORF inserted in the same orientation as the PCR-
Script Amp T7 promoter was selected and named pScript-∆3.1. A 1,059-bp EcoRV-SalI 
fragment was isolated from plasmid pScript-∆3.1 and ligated to AfeI-XhoI digested plasmid 
pEYFPN1 creating plasmid pEY.52K∆3.1 (figure 3.3). 
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52K 102-110 GFPβGal 
pNLS-GFPβGal  
Figure 3.3. Schematic representation of 52K mutants and NLS-GFPβGal fusion.  
Amino acids deleted by PCR mutagenesis are indicated. Plasmid names are indicated 
on the left; proteins expressed from these plasmids are indicated on the right. The 
mutations introduced by PCR in pEY.52KNLSm are indicated. The sequence of the 
putative 52K NLS (amino acids 102-110) fused to GFPβGal is indicated. 
52K∆3.1 
52K∆3.2 
52K∆3.3 
52KNLSm 
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(x) Construction of pEY.52K∆3.2. A 315-bp fragment was amplified by PCR using primers 
CP1 and ∆3.2R (table 3.1), and plasmid pcDNA.52K DNA as a template. Similarly, a 800-bp 
fragment was amplified by PCR using primers ∆3.2R and CP3 (table 3.1), and plasmid 
pcDNA.52K DNA as a template. The two PCR fragments were mixed, annealed, and amplified 
by PCR using primers CP1 and CP3. This 1,087-bp PCR product was ligated to EcoRV-digested 
plasmid Litmus28i. A clone with the mutant 52K ORF inserted in the same orientation as the 
Litmus28i LacZ ORF was selected and named L28i∆3.2. A 1,112-bp XhoI-BamHI fragment was 
isolated from plasmid L28i∆3.2 and ligated to XhoI-BamHI digested plasmid pEYFPC1 
(Clontech) creating plasmid pEY.52K∆3.2 (figure 3.3). 
(xi) Construction of pEY.52K∆3.3. A 381-bp fragment was amplified by PCR using primers 
CP1 and ∆3.3R (table 3.1), and plasmid pcDNA.52K DNA as a template. Similarly, a 725-bp 
fragment was amplified by PCR using primers ∆3.3F and CP2 (table 3.1), and plasmid 
pcDNA.52K DNA as a template. The two PCR fragments were mixed, annealed, and amplified 
by PCR using primers CP1 and CP2. This 1,088-bp PCR product was ligated to SrfI digested 
plasmid PCR-Script Amp. A clone with the mutant 52K ORF inserted in the same orientation as 
the PCR-Script Amp T7 promoter was selected and named pScript-∆3.3. A 1,104-bp EcoRV- 
SalI fragment isolated from plasmid pScript-∆3.3 was ligated to AfeI-XhoI digested plasmid 
pEYFPN1 creating plasmid pEY.52K∆3.3 (figure 3.3). 
(d) Construction of pEY.52KNLSm.A 318-bp fragment was amplified by PCR using primers CP1 
and NLSmR (table 3.1), and plasmid pcDNA.52K DNA as a template. Similarly, a 814-bp 
fragment was amplified by PCR using primers NLSmF and CP2 (table 3.1), and plasmid 
pcDNA.52K DNA as a template. The two PCR fragments were mixed, annealed, and amplified 
by PCR using primers CP1 and CP2. This 1,124-base pair PCR product was ligated to EcoRV-
digested Litmus28i. A clone with the mutant 52K inserted in the opposite orientation of the 
Litmus28i LacZ ORF was selected and named L28i.NLSm. A 1,149 XbaI-SalI fragment was 
isolated from plasmid L28i.NLSm and ligated to NheI-XhoI digested plasmid pEYFPN1 creating 
plasmid pEY.52KNLSm (figure 3.3). 
(e) Construction of pNLS-GFPβGal. The putative NLS of 52K was fused to the N-terminus of a 
green fluorescent protein-beta galactosidase (GFPβGal) fusion protein in the plasmid pGFP/βGal 
(Wu et al., 2004). Briefly, a 360-bp fragment was amplified by PCR using primers CP4 and CP5 
(table 3.1), and plasmid pGFP/βGal DNA as a template. The PCR product was digested with 
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NheI-PmlI and ligated to NheI–PmlI digested plasmid pGFP/βGal creating plasmid pNLS-
GFPβGal (figure 3.3).  
(f) Construction of pGEX-52K. A 1.1 kb EcoRI-SalI fragment was isolated from plasmid 
pcDNA.52K and ligated to EcoRI–XhoI digested plasmid pGEX-5x1 (GE Healthcare) creating 
plasmid pGEX-52K (figure 3.1). 
 
3.2.8 Proteins and peptides for nuclear import assays 
Plasmids encoding a fusion protein of glutathione-S-transferase, the nuclear localization signal 
of the simian virus 40 (SV40) T antigen, and green fluorescent protein (GST-NLS-GFP) and a 
dominant negative mutant of Ran fused to GST (GST-RanQ69L) were provided by Y. Yoneda 
(Yokoya et al., 1999; Tachibana et al., 2000). The plasmids were transformed into E. coli BL21 
cells and expressed and purified as previously described (Imamoto et al., 1995). The transformed 
BL21 cells were grown overnight in Luria-Burtani (LB) broth with 100 µg/mL ampicillin (LB-
AMP) at 37˚C with shaking. An aliquot of the overnight cultures was added to 500 mL of LB-
AMP and grown at 37˚C to an OD550 of 1.2. Protein expression was induced by the addition of 1 
mM IPTG and incubation for 14 hours at room temperature with shaking. The plasmid pGEX-
52K was transformed into E. coli BL21 cells for expression. The BL21 cells were grown 
overnight in LB-AMP at 37˚C with shaking. An aliquot of the overnight culture was added to 500 
mL of LB-AMP and grown to an OD600 of 0.5-0.6. Protein expression was induced by the 
addition of 0.1 mM IPTG and the culture was incubated for 3 hours at 37˚C. 
The cells were harvested by centrifugation at 6,000xg for 15 min and resuspended in 25 mL of 
GST purification buffer [50 mM Tris-HCl (pH 8.3), 1 mM ethylenediamine-tetraacetic acid 
(EDTA), 2 mM dithiothreitol (DTT), 500 mM NaCl, 1 µg/mL each leupeptin and aprotinin] and 
lysed by two freeze-thaw cycles followed by sonication (4 x 30 seconds). After centrifugation of 
the lysate (20,000xg for 30 min), the supernatant was collected, mixed with 200 µL washed 
glutathione-sepharose beads (GE Healthcare), and incubated overnight at 4˚C on a nutator. Beads 
were washed four times in GST purification buffer before purified proteins were eluted by two 15 
minute incubations with GST elution buffer [50 mM Tris-HCl (pH 8.3), 1 mM EDTA, 2 mM 
DTT, 100 mM NaCl, 10 mM reduced glutathione]. The eluted protein was dialyzed against three 
changes of dialysis buffer [20 mM HEPES (pH 7.3), 100 mM potassium acetate, 2 mM DTT, 1 
µg/mL each aprotinin and leupeptin] for 6-8 hours.  
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To confirm expression and purity of the bacterially expressed proteins, eluted protein was 
analyzed by SDS-PAGE and Western blot. Eluted proteins were separated by 10% SDS-PAGE. 
The gel was stained with Coomassie blue for 15 minutes then incubated with several changes of 
destaining solution to visualize total protein. In addition, proteins were analyzed by Western blot 
using goat anti-GST antibody (GE Healthcare) and AP-conjugated rabbit anti-goat IgG (Jackson 
Immunoresearch).  
The nuclear import inhibitory peptides corresponding to amino acids 1-30 (MFNRKRRGDF 
DEDENYRDFRPRMPKRQRIP) of the protein Ycbp80 (Görlich et al., 1996b) or amino acids 
10-51 (RMRKFKNKGKDTAELRRRRVEVSVELRKAKKDEQILKRRNVC) of importin α 
(Görlich et al., 1996a) were synthesized using a Pioneer Peptide Synthesis system (Perkin 
Elmer). 
 
3.2.9 In vitro nuclear import assays 
In vitro nuclear import assays were carried out based on the protocol of Adam et al. (1990). 
MDBK cells (70-80% confluent) seeded onto glass coverslips were washed in ice-cold transport 
buffer (TB) [20 mM HEPES (pH 7.3), 110 mM potassium acetate, 5 mM sodium acetate, 2 mM 
magnesium acetate, 1 mM ethylene bis-(β-aminoethylether)-N,N,N’,N-tetra-acetic acid (EGTA), 
2 mM DTT, and 1 µg/mL each of aprotinin and leupeptin] for 5 min on ice before permeabilizing 
with 40 µg/mL digitonin (Calbiochem) in TB for 5 min on ice. Cells were washed three times for 
5 min each in TB on ice to remove soluble cytoplasmic factors. Coverslips were inverted on 20 
µL complete transport solution [ATP-regenerating system (1 mM adenosine triphosphate (ATP), 
5 mM creatine phosphate, 20 units/mL creatine phosphokinase), 20 µM cargo protein (GST-52K 
or GST-NLS-GFP), 50% rabbit reticulocyte lysate (Promega) in TB] and incubated at 30˚C in a 
humidified chamber for 20 min to allow nuclear import to occur. In some cells, wheat germ 
agglutinin (WGA) was added at 0.4 mg/mL in TB for 10 min prior to incubation with complete 
transport solution. The dominant negative mutant RanQ69L was pre-loaded with 2 mM 
guanosine triphosphate (GTP) for 1 hour at 4˚C and added to complete transport solution at a 
concentration of 25 µM. Inhibitory peptides were added to complete transport solution at a 
concentration of 1 mM (50-fold molar excess). After incubation with the complete transport 
solution, cells were fixed in 3.7% paraformaldehyde in PBS for 15 min at room temperature and 
washed three times in PBS. Cells incubated with complete transport solution containing GST-
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NLS-GFP were counterstained with 2 µg/mL DAPI for 5 min, washed in PBS, then mounted on 
slides in Citifluor mounting reagent and visualized on an Axiovert UV microscope using Zeiss 
AxioVision software. Cells incubated with complete transport solution containing GST-52K were 
permeabilized using 0.5% Triton-X-100 in PBS for 5 min, then stained with anti-52K serum and 
Cy2-conjugated goat anti-rabbit IgG as described in section 3.2.6.  
 
3.2.10 Purification of nuclear import receptors 
Plasmids encoding GST fusions of importin α1, importin α3, importin α5, importin α7, or 
importin β were a gift from M. Köhler and have been previously described (Depping et al., 2008). 
The plasmid pGEX-5x1 encoding GST was purchased from GE Healthcare. The plasmids were 
individually transformed into E. coli M15 (pRep4) cells (plasmids encoding GST fused to 
importin α1, α3, α5, or α7) or BL21 cells (plasmids encoding GST alone or GST fused to 
importin β) for expression. An aliquot of an overnight culture was added to 50 mL LB-AMP and 
grown at 37˚C to an OD600 of approximately 0.3. Protein expression was induced by the addition 
of IPTG at a concentration of 0.6 mM and incubated for 3.5 hrs at 37˚C. Cells were harvested by 
centrifugation (6,000xg for 15 minutes) and resuspended in 5 mL GST purification buffer. Cells 
were lysed by two freeze-thaw cycles and sonication (4 x 30 sec) and the lysate was cleared by 
centrifugation (20,000xg for 30 min). The supernatant was added to 50 µL washed glutathione-
sepharose beads and allowed to bind overnight at 4˚C on a nutator. Beads were washed four 
times in GST purification buffer and eluted by two 15 min incubations with GST elution buffer. 
Protein expression and purity was confirmed by SDS-PAGE and Western blotting as described in 
section 3.2.8. 
 
3.2.11 In vitro binding assay 
GST or GST fusions of importin α1, importin α3, importin α5, importin α7, or importin β 
(16µg per binding reaction) were individually bound to 25 µL of washed glutathione sepharose 
beads in IP buffer [20 mM HEPES (pH 7.5), 100 mM potassium acetate, 0.5 mM EGTA, 5 mM 
magnesium acetate, 250 mM sucrose] for 6 hrs at 4˚C on a nutator. Radiolabeled 52K was 
synthesized by in vitro transcription and translation of plasmid pcDNA.52K in the presence of 
[35S]-methionine (Perkin Elmer) using a TNT T7 Coupled Reticulocyte Lysate System 
(Promega). Fifteen µL of the radiolabeled translation mixture was added to GST or individual 
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GST-importin fusion proteins on glutathione sepharose beads and incubated overnight at 4˚C on 
a nutator. Beads were washed four times in IP buffer. The bead bound proteins were separated by 
10% SDS-PAGE. The gel was fixed in destain solution containing 5% glycerol for 30 min and 
dried onto filter paper. The gel was exposed to a phosphor screen (Kodak) overnight and 
visualized on a Bio-Rad Molecular Imager FX using Quantity One software (Bio-Rad). 
 
3.3 Results 
 
3.3.1 Identification of 52K open reading frame 
Earlier, it was reported that the BAdV-3 52K ORF was predicted to span nucleotides 9988 to 
10983 and encode a protein of 331 amino acids (Reddy et al., 1998) (Genbank accession no. 
AF030154). However, resequencing of the region of the BAdV-3 genome containing the 52K 
ORF revealed an error in the published sequence with a missing base at position 10918 compared 
to the published sequence of 52K. The published sequence 10915CGTTCG10921 should actually 
read 10915CGTCG10920. Removal of the additional base causes a shift in the 52K ORF (figure 3.4). 
The new open reading frame ends at 11098ATGAGT11103 (underlined bases, numbering based on 
the uncorrected Genbank sequence), overlaps with the start codon of the open reading frame for 
IIIa (italicized), and encodes a protein 370 amino acids long. This error in the published sequence 
explains why Reddy et al. (1998) noted that the predicted BAdV-3 52K protein had a large C-
terminal deletion compared to the 52K proteins of other adenoviruses. 
The revised BAdV-3 52K protein is similar in length to the 52K proteins of other 
Mastadenoviruses (table 3.2). Sequence alignment shows that it also shares a high degree of 
sequence identity (50% to 60%) with the 52K proteins of other Mastadenoviruses (table 3.2).  
 
3.3.2 52K-specific antibodies 
To test the antibodies raised against a GST fusion protein expressing a fragment of the N-
terminus of 52K (amino acids 29-133), proteins from BAdV-3 infected cell lysate and uninfected 
MDBK cell lysate were separated by SDS-PAGE, transferred to a nitrocellulose membrane, and 
probed in Western blot with the anti-52K serum. As shown in figure 3.5, the anti-52K serum 
recognized a protein with a molecular weight of 40 kDa in the BAdV-3 infected lysate (lane 2).
62 
 
 
10911 CAGGCGTTCGGGAGATGAGC 10930...10991 TCGACGAATGAGTG 11004 
10911 CAGGCGT-CGGGAGATGAGC 10929...10990 TCGACGAATGAGTG 11003 
 
       ArgArgSerGlyAspGlu 
       ArgArg ArgGluMetSer              ValAspGluStop 
Figure 3.4 Identification of 52K open reading frame. The sequencing error that was 
found in the published 52K sequence shifts its open reading frame. The GenBank 
sequence (AF030145) and its predicted protein translation are listed on the top lines; the 
actual sequences of the DNA and protein translation are listed underneath. The new stop 
codon for 52K is underlined; start codon for IIIa protein is indicated in bold. Base 
numbering is based on the GenBank sequence. 
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 Length % Sequence identity 
BAdV-3 370 -- 
HAdV-2 415 55% 
HAdV-5 415 56% 
HAdV-12 373 59% 
HAdV-11 388 58% 
HAdV-17 374 60% 
HAdV-4 390 58% 
HAdV-40 380 59% 
CAdV-1 389 50% 
CAdV-2 388 50% 
PAdV-3 345 50% 
PAdV-5 354 58% 
BAdV-1 348 55% 
Percent sequence identity indicates identical residues based on sequence 
alignment with BAdV-3 52K. HAdV, human adenovirus; CAdV, canine 
adenovirus; PAdV, porcine adenovirus. 
Table 3.2 Sequence identity of BAdV-3 52K protein with other 52K 
proteins. 
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Mock BAdV-3 
Figure 3.5 Testing 52K antibodies. Mock infected or BAdV-3 infected 
MDBK cells were harvested 48 hours after infection and lysates were 
examined by Western Blot using anti-52K serum. The anti-52K serum 
recognizes a virus-specific protein that corresponds to the predicted size of 
52K. Molecular weight standards are indicated in kDa. 
1 2 
– 52K 
65 
 No such protein could be detected in uninfected cells (lane 1). The protein could be detected 
between 24-72 hrs post-infection but not at 12 hrs post-infection (figure 3.6). 
 
3.3.3 Subcellular localization of 52K protein 
To determine the localization of the BAdV-3 52K protein, MDBK cells were infected with 
BAdV-3 and analyzed by indirect imunofluorescence using rabbit anti-52K serum and Cy2 
labeled goat anti-rabbit IgG. As seen in figure 3.7, BAdV-3 52K predominantly localized in the 
nucleus of infected cells. Moreover, dual-label imunofluorescence using Cy2 labeled 52K-
specific serum and Cy3 labeled nucleolin-specific serum suggested that 52K does not localize to 
the nucleolus of infected cells.  
Since 52K was shown to localize in the nucleus during BAdV-3 infection, we wished to 
determine if this localization was dependent on any other viral protein. To this end, we cloned the 
52K gene into the eukaryotic expression vector pcDNA and transfected COS7 cells. Like BAdV-
3 infected cells, dual immunoflorescence staining suggested that 52K localized in the nucleus, 
but not in the nucleolus of transfected cells (figure 3.8). The accumulation of 52K in the nucleus 
in transfected cells indicates that the nuclear localization of 52K is not dependent on any other 
viral protein. 
As the small size of 52K (~40 kDa) could potentially allow it to cross the nuclear pore 
complex by passive diffusion without the assistance of soluble transport receptors (Lim et al., 
2008), we constructed a plasmid expressing 52K fused in frame to the N-terminus of EYFP 
(pEY.52K). The expected size of this protein (~70 kDa) should prevent diffusion into the 
nucleus, and therefore any nuclear accumulation should be due to active transport by soluble 
receptors such as importin α/importin β. As seen in figure 3.9, while EYFP expressed alone is 
dispersed throughout the cell (panel C), the 52K-EYFP fusion protein localizes in the nucleus of 
transfected cells (panel F). The results suggest that 52K contains an NLS that mediates its active 
transport into the nucleus. 
 
3.3.4 Identification of the 52K nuclear localization signal 
To identify the location of the 52K NLS, a series of internal deletions covering the entire 52K 
ORF were generated (figure 3.1). These deletions were cloned into pEYFPN1 to be expressed as 
52K-EYFP fusion proteins. These deletions were confirmed by restriction enzyme analysis and 
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Figure 3.6 Expression of 52K during BAdV-3 infection in bovine cells. 
MDBK cells were infected with BAdV-3 and harvested at various times 
post infection. Expression of 52K is detected 24 hours post infection and 
continues out to 72 hours post infection. Mock-infected MDBK cells were 
used as a control. Molecular weight standards are indicated in kDa. 
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Figure 3.7 Intracellular localization of 52K during BAdV-3 infection. MDBK cells 
were infected with BAdV-3 and fixed 24 hours post-infection. The intracellular 
localization of 52K was determined by immunostaining with anti-52K antisera and Cy2-
conjugated goat anti-rabbit IgG (panel A) as described in Materials & Methods. Nuclei 
were stained with DAPI (panel B) and nucleoli were visualized by immunostaining with an 
anti-nucleolin antibody and Cy3-conjugated goat anti-mouse IgG (panel C). A merge of 
the images is shown in panel D. 
A B 
C D 
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Figure 3.8 Intracellular localization of 52K in transfected cells. COS7 cells were 
transfected with pcDNA.52K to observe the intracellular distribution of 52K in the absence 
of other viral proteins. 52K was visualized using 52K antisera and Cy2 conjugated goat 
anti-rabbit IgG (panel A). Nuclei were stained with DAPI (panel B) and nucleoli were 
stained with a mouse anti-nucleolin antibody and Cy3 conjugated goat anti-mouse IgG 
(panel C). A merge of the Cy2, DAPI, and Cy3 images (panel D) shows that 52K is 
localized in the nucleus but excluded from nucleoli. 
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pEYFPN1 
pEY.52K 
EYFP DAPI Merge 
D E F 
Figure 3.9 Intracellular localization of a 52K-EYFP fusion protein. COS7 cells were 
transfected with plasmid pEYFPN1 (panels A-C) or pEY.52K (panels D-F). EYFP was 
visualized directly (panels A, D) and nuclei were stained with DAPI (panels B, E). A 
merge of the EYFP and DAPI images shows that while EYFP is distributed throughout the 
cell (panel C), the 52K-EYFP fusion accumulates in the nucleus (panel F). 
A B C 
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sequencing of mutant plasmid DNA. COS7 cells were transfected with individual plasmid DNAs. 
At 24 hrs post transfection, the cells were stained with DAPI and analyzed by fluorescent 
microscopy. As seen in figure 3.10, all mutant 52K proteins except 52K∆3 localized 
predominantly in the nucleus of transfected cells. The punctate staining observed in 52K∆3 
appears to be an artifact of the fixation process since in unfixed cells, 52K∆3 can be observed 
diffused throughout the cytoplasm. These results suggested that the 52K NLS is localized 
between amino acids 90-134. 
To further identify the 52K NLS, we constructed mutant 52Ks containing three smaller 
deletions within amino acids 90-134 that targeted two predicted α-helices and a cluster of three 
basic amino acids (figure 3.3). Deletion of the predicted α-helices (52K∆3.1 and 52K∆3.3) did 
not alter the intracellular localization (figure 3.11). A nine amino acid deletion that included three 
basic residues (52K∆3.2), however, disrupted the nuclear localization (figure 3.11). This suggests 
that the essential residues for the 52K NLS are contained within the sequence 
102GMPRKRVLT110. Since basic residues are often critical to NLS function, we constructed a 
mutant 52K in which the basic arginine and lysine residues were mutated to glutamic acid 
(R105E, K106E, R107E; 52KNLSm) (figure 3.3). As seen in figure 3.12, mutation of the amino 
acids 105RKR107 to 105EEE107 prevented nuclear accumulation of the 52KNLSm protein. This 
demonstrates that amino acids 102-110 of 52K acts as an NLS and that the basic residues at 
positions 105, 106, and 107 are essential for its function. 
To determine if amino acids 102-110 are sufficient to direct nuclear import, the sequence 
102GMPRKRVLT110 was fused in frame to the N-terminus of a green fluorescent protein-beta 
galactosidase (GFPβGal) fusion protein (Wu et al., 2004) (figure 3.3). The GFPβGal protein does 
not contain an NLS and is localized in the cytoplasm of transfected cells (figure 3.13). The NLS-
GFPβGal fusion protein containing the putative 52K NLS also localizes in the cytoplasm (figure 
3.13). These results suggest that while the sequence 102GMPRKRVLT110 including 105RKR107 
residues is essential for nuclear import of 52K, it is not sufficient to direct nuclear import of a 
cytoplasmic protein. 
 
3.3.5 In vitro nuclear import of 52K 
To investigate the pathway by which 52K is imported into the nucleus, we used an in vitro 
nuclear import assay (Adam et al., 1990). Cells were seeded onto glass coverslips and treated 
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Figure 3.10 Intracellular localization of 52K-EYFP deletion constructs. 
Plasmids expressing 52K mutants fused to EYFP were transfected into COS7 cells 
and visualized directly under a fluorescent microscope. 
pEY.52K∆1 
pEY.52K∆2 
pEY.52K∆3 
pEY.52K∆4 
pEY.52K∆5 
pEY.52K∆6 
pEY.52K∆7 
pEY.52K∆8 
EYFP DAPI Merge 
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pEY.52K∆3.1 
pEY.52K∆3.2 
pEY.52K∆3.3 
EYFP DAPI Merge 
Figure 3.11 Identification of 52K NLS. Plasmids expressing deletion constructs were 
transfected into COS7 cells and visualized. The 52K∆3.1 and 52K∆3.3 proteins, which 
have deletions in predicted α-helices, were nuclear, while the 52K∆3.2 construct that lacks 
a cluster of basic residues was distributed throughout the cell.  
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EYFP DAPI Merge 
Figure 3.12 Mutation of the putative 52K NLS. COS7 cells were transfected with 
pEY.52KNLSm and visualized by fluorescent microscopy. The 52KNLSm protein does 
not accumulate in the nucleus. 
74 
 
Figure 3.13 Fusion of putative 52K NLS to GFPβGal. Expression of pGFPβGal and pNLS-
GFPβGal in transfected COS7 cells. GFPβGal was visualized directly and cells were 
counterstained with DAPI. The GFPβGal protein alone localizes in the cytoplasm. Fusion of 
the residues 102-110 of 52K is not sufficient to direct the nuclear import of the NLS-GFPβGal 
fusion protein. 
pGFPβGal 
pNLS-GFPβGal 
GFP DAPI Merge 
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with digitonin, which permeabilized the cell membrane but left the nuclear envelope intact. Cells 
were washed to remove soluble cytosolic factors, then incubated with a transport mixture 
containing the cargo protein of interest, an ATP-regenerating system, and a source of cytosolic 
factors. 
Since the nuclear import of the simian virus 40 (SV40) NLS has been well characterized, the 
in vitro nuclear import assay was established using a GST-NLS-GFP fusion protein (containing 
GST, the NLS of the SV40 T antigen, and green fluorescent protein) (figure 3.14 A). The nuclear 
import of GST-NLS-GFP was dependent on cytosolic factors, since omitting the rabbit 
reticulocyte lysate abolished nuclear import (figure 3.14 B). Moreover, absence of the ATP 
regenerating system (figure 3.14 C) or carrying out the import reaction at 4˚C (figure 3.14 G) also 
inhibited nuclear import of GST-NLS-GFP, showing that the import is temperature- and energy-
dependent. Addition of wheat germ agglutinin (WGA), which binds to the nuclear pores and 
blocks protein transport through the NPC, prevented fusion protein GST-NLS-GFP from entering 
the nucleus (figure 3.14 H). A dominant-negative mutant of Ran that is unable to hydrolyze GTP 
to GDP (RanQ69L) also blocked nuclear import of GST-NLS-GFP (figure 3.14 I). 
Next, we examined the nuclear import of the GST-52K fusion protein. Purified GST-52K 
accumulates in the nucleus in the in vitro assay (figure 3.14 D). Its nuclear import is significantly 
reduced but not completely inhibited in the absence of cytosolic factors (figure 3.14 E), 
suggesting that some nuclear accumulation of GST-52K can occur independently of soluble 
transport receptors. The absence of the ATP regenerating system slightly inhibited nuclear 
accumulation of GST-52K (figure 3.14 F), although it should be noted that there could be ATP 
present in the rabbit reticulocyte lysate used as a source of cytosolic factors. Performing the 
import reaction at 4˚C slightly inhibited nuclear accumulation of GST-52K (figure 3.14 J), 
whereas nuclear accumulation of GST-NLS-GFP is almost completely inhibited at 4˚C (figure 
3.14 G). The addition of wheat germ agglutinin appears to block the nuclear import of GST-52K 
(figure 3.14 K), indicating that 52K utilizes the nuclear pores to enter the nucleus. The presence 
of RanQ69L does not appear to have any inhibitory effect on GST-52K nuclear import (figure 
3.14 L).  
 Specific peptide inhibitors known to block nuclear import using the importin-α-importin-β 
import pathway were used to further characterize the nuclear import pathway of 52K. A 41-
amino acid peptide from the N-terminus of importin α that corresponds to its importin β binding 
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GST-NLS-GFP 
–RRL –ATP 
4˚C +WGA 
GST-NLS-GFP 
+RanQ69L 
GST-52K 
GST-52K 
Figure 3.14 In vitro nuclear import assays. MDBK cells were permeabilized with digitonin 
and incubated with complete transport mixture containing GST-NLS-GFP or GST-52K. Import 
reactions were carried out in the absence of cytoplasmic factors (-RRL), ATP and an ATP-
regenerating system (-ATP), at 4˚C, after incubation with wheat germ agglutinin (WGA), or in 
the presence of the dominant negative mutant RanQ69L. 
A B C 
D E F 
G H I 
J K L 
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(IBB) domain (Görlich et al., 1996a) competes for binding to importin β, and thus should inhibit 
importin α/importin β-mediated nuclear import. Addition of the IBB peptide to the in vitro 
nuclear import reaction significantly inhibited nuclear import of GST-NLS-GFP (figure 3.15 A) 
and GST-52K (figure 3.15 C). A peptide corresponding to the importin α-binding domain of the 
yeast cap binding protein 80 (Ycbp80) was used to compete for importin α binding (Görlich et 
al., 1996b). While the Ycbp80 peptide was able to completely inhibit nuclear import of GST-
NLS-GFP (figure 3.15 B), nuclear import of GST-52K was only partially inhibited in the 
presence of Ycbp80 (figure 3.15 D).  
Several proteins have been identified that are able to diffuse passively across the nuclear pore 
and accumulate in the nucleus by binding to nuclear components (Efthymiadis et al., 1998; 
Ghildyal et al., 2005; Hearps and Jans, 2006). To determine if 52K is capable of accumulating in 
the nucleus by binding to nuclear components, a nuclear import assay was performed without 
soluble factors or an ATP regenerating system in the presence or absence of 0.5% Triton-X-100 
to permeabilize the nuclear envelope. Under these conditions, with free diffusion between the 
nucleus and the cytoplasm, GST-52K should only be able to accumulate in the nucleus if it binds 
to nuclear components. In the absence of Triton-X-100, no nuclear accumulation of GST-52K 
was observed (figure 3.16 A). When Triton-X-100 was added to permeabilize the nuclear 
envelope, GST-52K is able to accumulate in the nucleus (figure 3.16 B). This suggests that GST-
52K was able to accumulate in the nucleus independently of soluble transport factors by binding 
to nuclear components. 
 
3.3.6 Interaction of 52K with transport receptors in vitro 
Since the nuclear import of 52K appears to be largely dependent on active transport mediated 
by importin α/importin β, we wished to determine if it was able to bind to transport receptors in 
vitro. GST fusions of importin α1, importin α3, importin α5, importin α7, and importin β were 
expressed in bacteria and purified for use in a binding assay. The GST-importin fusions were 
allowed to bind to in vitro translated radiolabeled 52K, then precipitated using glutathione 
sepharose beads, separated by SDS-PAGE, and visualized by autoradiography. GST alone was 
used as a negative control. As seen in figure 3.17, GST-importin α3 was able to bind radiolabeled 
52K (lane 4). No such binding was observed when GST fusions of importin α1, importin α5, 
importin α7 or importin β were used to pull down radiolabeled 52K (figure 3.17, lanes 3, 5, 6, 
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GST-NLS-GFP 
GST-52K 
Figure 3.15 Inhibition of nuclear import by specific peptides. Peptides corresponding 
to the importin β-binding domain of importin α (IBB Impα) or the nuclear localization 
signal of the yeast cap binding protein 80 (Ycbp80) were added to the nuclear import 
assay at 50-fold molar excess. The IBB Impα peptide blocks the import of both GST-
NLS-GFP (A) and GST-52K (C), while the Ycbp80 NLS completely blocks GST-NLS-
GFP (B) but only partially inhibits the nuclear import of GST-52K (D). 
A B 
C D 
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Figure 3.16 Nuclear accumulation of GST-52K in the presence of 
permeabilizing detergent. A nuclear import assay using GST-52K without 
soluble cytosolic factors or ATP was carried out in the absence (-TX100; panel 
A) or presence (+TX100; panel B) of 0.5% Triton-X-100 to permeabilize the 
nuclear envelope. 
A B 
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Figure 3.17 In vitro interaction of 52K with transport receptors.  GST fusions of 
importin α1, α3, α5, α7, and importin β along with GST alone were incubated with in 
vitro translated, [35S]-labeled 52K and pulled down with glutathione sepharose 
beads.  Samples were separated by 10% SDS-PAGE and visualized using a phosphor 
screen.  10% of the input [35S]-52K was run as a control (lane 2).  Molecular weight 
standards are indicated in kDa (lane 1). 
M 52K α1  α3  α5  α7 β1 GST  
97 – 
66 – 
46 – 
30 – 
1 2 3 4 5 6 7 8 
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and 7). This suggests that 52K is imported by the importin α/importin β pathway, with specificity 
for importin α3. 
 
3.4 Discussion  
Members of all adenovirus genera encode a positional homolog of 52K (Davison et al., 
2003), suggesting that this protein has an essential function in adenovirus replication. Mutant 
adenoviruses containing a deletion of the 52K gene form only capsids which are devoid of full 
length genomic DNA, suggesting 52K is involved in the packaging of the adenovirus genome 
(Gustin and Imperiale, 1998). However, the exact mechanism regarding the involvement of 52K 
in this process is not clear. Although the 52K proteins encoded by different adenoviruses 
including BAdV-3 share 50-60% sequence identity, the 52K protein has been suggested to 
determine the serotype specificity of adenovirus DNA packaging (Wohl and Hearing, 2008). The 
experiments presented in this study were designed to characterize the protein and determine the 
nuclear localization mechanism of 52K of BAdV-3. 
An earlier report suggested that mRNA of the BAdV-3 52K protein is predicted to encode a 
protein of 331 amino acids. However, a sequencing error discovered in the published BAdV-3 
sequence (Reddy et al., 1998) revealed that the 52K open reading frame actually encodes a 
protein of 370 amino acids. A protein of 40 kDa is detected in BAdV-3 infected cells which is 
consistent with the calculated mass (40.8 kDa) of the 52K protein. The 52K protein is localized 
predominantly in the nucleus of BAdV-3 infected cells.  
While water, ions, and small proteins (less than 40kDa) can diffuse freely between the nucleus 
and the cytoplasm through NPCs (Lim et al., 2008), the transport of larger molecules is primarily 
energy-dependent and regulated by the NPCs (Lim et al., 2008). Proteins to be transported into 
the nucleus may contain classical nuclear localization signals (NLSs), which consists of a single 
stretch of basic amino acids (e.g SV40 T antigen) or a bipartite NLS consisting of two clusters of 
basic amino acids (e.g. nucleoplasmin) separated by a linker of ten amino acids (Kalderon et al., 
1984; Robbins et al., 1991), or non-classical NLSs that do not fit these consensus sequences 
(Christophe et al., 2000). It is clear that active transport of proteins to the nucleus requires an 
NLS. The nuclear localization of 52K in the absence of other viral proteins suggested that the 
protein contains an NLS(s). 
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Analysis of mutant BAdV-3 52K proteins suggested that amino acids 102GMPRKRVLT110 
contain a potential NLS. Interestingly, mutation of three basic residues (105RKR107) to acidic 
residues (105EEE107) abolished nuclear import, indicating that these residues are essential for 
nuclear localization of 52K. However, residues 102GMPRKRVLT110 were not sufficient to direct 
nuclear import of a predominantly cytoplasmic fusion protein (GFPβGal). It is possible that 
residues upstream or downstream of this motif are required for efficient nuclear import of 
protein. Although deletion of the C-terminal 8 residues containing a cluster of basic amino acids 
abolishes the nuclear import of DNA helicase Q1 (Seki et al., 1997), upstream sequences are 
required for it to be bound by importin α3 (Miyamoto et al., 1997). It is also possible that the 
conformation of the NLS within 52K is important. It has been shown that protein context can 
modulate NLS specificity. For example, exchanging the NLSs of RCC1 and nucleoplasmin 
(which bind preferentially to importin α3 and several different importins, respectively) does not 
confer importin-binding specificity (Friedrich et al., 2006). 
An in vitro nuclear import assay showed that 52K nuclear import could be reconstituted. The 
absence of soluble cytoplasmic factors, an ATP regenerating system, and performing the nuclear 
import reaction at 4˚C inhibited the nuclear accumulation of GST-52K to varying degrees but did 
not block it completely. This suggests that some nuclear import of 52K can occur independently 
of soluble factors and energy. Several proteins such as β-catenin (Fagotto et al., 1998) and the 
Tax protein of human T cell lymphotropic virus type 1 (Tsuji et al., 2007) have been identified 
that are able to enter the nucleus by binding directly to nucleoporins and do not require soluble 
factors for nuclear import. Nuclear import of both β-catenin (Yokoya et al., 1999) and Tax (Tsuji 
et al., 2007) is energy-independent but inhibited when the import reaction is performed on ice. 
Since 52K, unlike β-catenin and Tax, is partially inhibited in the absence of cytosolic factors or 
ATP, this suggests that it is unlikely that 52K nuclear import is mediated by binding to 
nucleoporins. 
A dominant negative mutant of Ran was not able to block nuclear import of 52K, suggesting 
that 52K can be imported into the nucleus in a Ran-independent manner. However, addition of a 
peptide containing the IBB domain of importin α prevented nuclear accumulation of 52K. If 
GST-52K is capable of entering the nucleus in a Ran-independent manner, it should also be able 
to do so independently of importin α/importin β. It is possible that even though the RanQ69L 
mutant was pre-loaded with GTP that it somehow was insufficient to inhibit Ran-dependent 
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import of GST-52K. It is also possible that the IBB peptide successfully competed for binding to 
importin β but that 52K remained bound to importin α, preventing it from entering the nucleus 
independently of soluble factors as it did under other assay conditions.  
Addition of a peptide containing the nuclear localization signal of Ycbp80 was able to 
partially inhibit nuclear import of GST-52K, suggesting that the peptide was competing with 52K 
for binding to importin α. The Ycbp80 peptide corresponds to the domain required for binding to 
the yeast importin α homolog SRP1p, and may act as a nuclear localization signal (Görlich et al., 
1996b). Since different nuclear localization signals have varying affinities for transport receptors 
(Köhler et al., 1999), it is possible that the 52K NLS can bind to importin(s) with a higher affinity 
than the Ycbp80 peptide. This would explain why the Ycbp80 peptide was able to completely 
inhibit nuclear import of the GST-NLS-GFP protein but only partially block nuclear import of 
GST-52K. 
 Taken together, these results suggest that nuclear import of 52K is largely mediated by a 
classical importin α/importin β-dependent pathway, in spite of the inability of the RanQ69L 
mutant to inhibit nuclear import of GST-52K. An in vitro binding assay detected an interaction 
between 52K and importin α3.  
Permeabilization of the nuclear envelope with detergent permitted 52K to accumulate in the 
nucleus. This suggests that 52K is able to enter the nucleus independently of soluble factors or 
ATP by diffusing through the nuclear pore and binding to nuclear components. The size of 52K 
is close to the threshold for diffusion across the nuclear pore (Lim et al., 2008). It therefore 
appears that nuclear import of 52K can be mediated by recognition of its NLS by importin α3 and 
a classical importin α/importin β import pathway, but that 52K can also accumulate in the 
nucleus by passive diffusion and binding to nuclear components. This is similar to the nuclear 
import of the matrix protein of respiratory syncytial virus (Ghildyal et al., 2005) and the integrase 
protein of HIV-1 (Hearps and Jans, 2006), which both use importin α/importin β import pathways 
but are capable of accumulating in the nucleus independently of soluble factors. 
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4.0 INTERACTION OF BAdV-3 52K WITH VIRAL AND CELLULAR PROTEINS 
 
4.1 Introduction 
Adenoviruses are non-enveloped viruses containing a double-stranded DNA genome and are 
found in a wide range of mammalian and non-mammalian species.  
Protein-protein interactions are important for efficient replication of adenoviruses. Interactions 
among adenoviral proteins including structural proteins (hexon, penton, fiber, VI, IIIa, and IX) 
(Vellinga et al., 2005), viral DNA polymerase and the pre-terminal protein (Temperley and Hay, 
1992), E1B-55K and E4orf6 proteins (Blackford and Grand, 2009), L4-22K and IVa2 protein 
(Ostapchuk et al., 2006), IVa2 and pVIII (Singh et al., 2005), pVII, IVa2 and 52K proteins 
(Zhang and Arcos, 2005), and 33K with 100K and pV (Kulshreshtha and Tikoo, 2008) have been 
reported. Similarly, interactions between adenoviral proteins and cellular proteins including E1A 
and cellular transcription factors (Berk, 2005), E1B-55K and p53 protein (Berk, 2005), E1B-19K 
protein and BAX/BAK proteins (Berk, 2005), E1B-55K/E4orf6 proteins and host cell factors 
(Blackford and Grand, 2009), E3-19K glycoprotein and class I MHC molecules (Horwitz, 2004), 
100K protein and eIF4G (Cuesta et al., 2000), and 33K protein and bovine presenilin-1-
associated protein (PSAP) (Kulshreshtha, 2009) have been reported. 
The 52/55-kDa (“52K”) protein encoded by the L1 region of human adenovirus (HAdV)-5 has 
been shown to be essential for encapsidation of the viral DNA (Hasson et al., 1989; Gustin and 
Imperiale, 1998) and interacts with the viral IVa2 and pVII proteins during HAdV-5 infection 
(Gustin et al., 1996; Ostapchuk et al., 2005; Zhang and Arcos, 2005). The L1 region of the late 
transcription unit of bovine adenovirus (BAdV)-3 encodes the 52K protein (Reddy et al., 1998), 
which is collinear with 52K of HAdV-5. Although 52K proteins encoded by different 
adenoviruses including BAdV-3 share 50-60% sequence identity, the 52K protein has been 
suggested to determine the serotype specificity of adenovirus DNA packaging (Wohl and 
Hearing, 2008). This suggests that the adenovirus 52K protein may interact with specific 
viral/cellular proteins, thereby contributing to serotype specificity of DNA packaging. Here, we 
report the interaction of BAdV-3 52K with other viral/cellular proteins. 
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4.2 Materials and Methods 
 
4.2.1 Cell lines and virus 
Madin-Darby bovine kidney (MDBK) cells were propagated in minimal essential medium 
(MEM; Invitrogen) supplemented with 10% fetal bovine serum (FBS; SeraCare Life Sciences). 
COS7 cells were propagated in Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) 
supplemented with 10% FBS. Wild type BAdV-3 (WBR-1 strain) was grown in MDBK cells in 
MEM supplemented with 2% FBS (Reddy et al., 1999a). The virus was purified and titered as 
described in section 3.2.1. 
 
4.2.2 Plasmids 
(a) Yeast expression plasmids. Plasmids expressing BAdV-3 genes in the yeast expression 
plasmid pGADT7 (Clontech) have been previously described (Kulshreshtha and Tikoo, 2008). A 
1.1kb EcoRI-BamHI fragment was isolated from plasmid pcDNA.52K (section 3.2.7) and ligated 
to EcoRI-BamHI digested pGBKT7 (Clontech) to create the plasmid pGBK.52K. 
(b) Deletions in 52K ORF. Sequential deletions in the 52K ORF were created by PCR as 
previously described (section 3.2.7).  
(i) Construction of pc.52K∆1. The 984-bp PCR product (section 3.2.7 (c) (i)) was digested 
with EcoRI-BamHI and ligated to EcoRI-BamHI digested plasmid pcDNA 3.1(-) (Invitrogen) to 
create plasmid pc.52K∆1. 
(ii) Construction of pc.52K∆2. The 974-bp PCR product created by two-step overlap PCR 
(section 3.2.7 (c) (ii)) was digested with EcoRI-BamHI and ligated to EcoRI-BamHI digested 
plasmid pcDNA 3.1(-) (Invitrogen) to create plasmid pc.52K∆2. 
(iii) Construction of pc.52K∆3. The 989-bp PCR product created by two-step overlap PCR 
(section 3.2.7 (c) (iii)) was digested with EcoRI-BamHI and ligated to EcoRI-BamHI digested 
plasmid pcDNA 3.1(-) (Invitrogen) to create plasmid pc.52K∆3. 
(iv) Construction of pc.52K∆4. The 962-bp PCR product created by two-step overlap PCR 
(section 3.2.7 (c) (iv)) was digested with EcoRI-BamHI and ligated to EcoRI-BamHI digested 
plasmid pcDNA 3.1(-) (Invitrogen) to create plasmid pc.52K∆4. 
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(v) Construction of pc.52K∆5. The 983-bp PCR product created by two-step overlap PCR 
(section 3.2.7 (c) (v)) was digested with EcoRI-BamHI and ligated to EcoRI-BamHI digested 
plasmid pcDNA 3.1(-) (Invitrogen) to create plasmid pc.52K∆5. 
(vi) Construction of pc.52K∆6. The 983-bp PCR product created by two-step overlap PCR 
(section 3.2.7 (c) (vi)) was digested with EcoRI-BamHI and ligated to EcoRI-BamHI digested 
plasmid pcDNA 3.1(-) (Invitrogen) to create plasmid pc.52K∆6. 
(vii) Construction of pc.52K∆7. The 959-bp PCR product created by two-step overlap PCR 
(section 3.2.7 (c) (vii)) was digested with EcoRI-BamHI and ligated to EcoRI-BamHI digested 
plasmid pcDNA 3.1(-) (Invitrogen) to create plasmid pc.52K∆7. 
(viii) Construction of pc.52K∆8. A 940-bp fragment amplified by PCR using primers CP1 
(table 3.1) and ∆8Rs (5’-GGATCCTCACTCCCGACGCCTGCCTATGC-3’) and plasmid 
pcDNA.52K DNA as a template was digested with EcoRI-BamHI and ligated to EcoRI-BamHI 
digested plasmid pcDNA 3.1(-) (Invitrogen) to create plasmid pc.52K∆8. 
(c) Plasmids expressing NFBP. Plasmids expressing NFBP fused to a hemagglutinin (HA) 
epitope tag (pcDNA-NFBP-HA) or fused to enhanced yellow fluorescent protein (EYFP) 
(pEY.NFBP) were a gift from T. Sweet (Center for Neurovirology, Philadelphia, PA) and have 
been previously described (Sweet et al., 2005). 
 
4.2.3 Antibodies 
The production of anti-52K serum was previously described (section 3.2.4). To raise anti-pVII 
serum, two peptides corresponding to residues 24-47 and 89-117 (GenBank Accession 
#AAD09724) were synthesized on a Pioneer Peptide Synthesis system (Perkin Elmer). 
Immunization of a rabbit with the two peptides was carried out as described in section 3.2.4, 
using 500 µg of peptide for the initial immunization and 300µg for subsequent boosts.  
 
4.2.4 Yeast two-hybrid system 
A GAL4 Matchmaker yeast two-hybrid system (Clontech) was used to detect interactions 
between BAdV-3 52K and other viral proteins as previously described (Kulshreshtha and Tikoo, 
2008). Briefly, plasmid pGBK.52K was co-transformed into yeast strain AH109 with individual 
pGADT7 plasmids expressing different BAdV-3 proteins. The co-transformed AH109 were 
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plated on low (Leu–/Trp–), medium (Leu–/Trp–/His–), and high (Leu–/Trp–/His–/Ade–/X-α-gal) 
stringency selective dropout media to screen for protein-protein interactions. 
 
4.2.5 GST pulldown assay 
The plasmid pGEX-52K (section 3.2.7) expressing a GST-52K fusion protein or pGEX5x2 
(GE Healthcare) expressing GST alone were individually transformed into E. coli BL21 cells and 
expression was induced as previously described (section 3.2.8). Cells were harvested by 
centrifugation (6,000xg for 15 min) and resuspended in GST binding buffer [540 mM NaCl, 2.7 
mM KCl, 10.15 mM Na2HPO4, 1.75 mM KH2PO4, 10 mM MgCl2, 1% Triton X-100, 1 µg/mL 
each aprotinin and leupeptin]. Cells were lysed by sonication (4 x 30 sec) and lysate was cleared 
by centrifugation (12,000xg for 15 min). The supernatant was added to 200 µL washed 
glutathione-sepharose beads (GE Healthcare) and incubated overnight at 4˚C on a nutator. Beads 
were washed four times in GST binding buffer and the amount of protein bound to the beads was 
quantitated. BAdV-3 genes (IVa2, pV, and pVII) cloned in pGADT7 (section 4.2.2) were 
translated in vitro using a TNT T7 Coupled Reticulocyte Lysate System (Promega) in the 
presence of [35S]-methionine (Perkin Elmer), as per the manufacturer’s instructions. In vitro 
translated proteins (10 µL) were individually added to 100 µg of GST-52K or GST bound to 
glutathione-sepharose beads and incubated overnight in GST binding buffer at 4˚C on a nutator. 
Beads were washed four times in GST binding buffer and resuspended in 2X SDS sample buffer 
[100 mM Tris-HCl (pH 6.8), 4% SDS, 0.2% bromophenol blue, 10% glycerol] containing 2% β-
mercaptoethanol (βME). Samples were boiled for 5 min, vortexed to release protein from the 
sepharose beads, and briefly centrifuged. Samples were separated by 10% SDS-PAGE. The gel 
was fixed in destain solution [10% acetic acid, 40% methanol] containing 5% glycerol, dried onto 
filter paper, and exposed to a phosphor screen (Kodak). The phosphor screen was visualized on a 
Bio-Rad Molecular Imager FX using Quantity One software (Bio-Rad). 
 
4.2.6 Western blotting 
MDBK cells seeded in 6-well plates were infected with BAdV-3 at a multiplicity of infection 
(MOI) of 4 pfu/cell. Virus was allowed to adhere to the cells for 2 hrs in serum-free MEM, then 
FBS was added to a final concentration of 2%. At indicated times post infection, cells were 
harvested by centrifugation at 3,000 rpm (950 g) for 5 minutes and lysed by the addition of RIPA 
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buffer [0.15 M NaCl, 50 mM Tris-HCl (pH 8.0), 1% NP-40, 1% deoxycholate, 0.1% SDS] 
containing a protease inhibitor cocktail (Sigma-Aldrich), followed by sonication (4 x 30 sec). 
Cell lysates were cleared by centrifugation (10,000xg for 10 min), separated by 12% SDS-PAGE, 
and transferred to a polyvinylidene fluoride (PVDF) membrane. The membrane was blocked at 
4˚C overnight in 10% skim milk in TBST [Tris-buffered saline (pH 8.0) containing 0.05% tween 
20], and then probed with anti-pVII serum diluted 1:200 in TBST containing 1% skim milk for 1 
hr at room temperature. After three TBST washes, the membrane were probed with alkaline 
phosphatase-conjugated goat anti-rabbit IgG (Jackson Immunoresearch) diluted 1:10,000 in 
TBST containing 1% skim milk for 1 hr at room temperature. Finally, the membrane was washed 
three times in TBST and developed using a BCIP/NBT chromagenic substrate (Sigma-Aldrich). 
 
4.2.7 Co-immunoprecipitation of 52K and pVII 
MDBK cells seeded into 10 cm plates were infected with BAdV-3 at a multiplicity of 
infection (MOI) of 5 pfu/cell as described in section 4.2.6. At 24 hrs post-infection, cells were 
incubated in 1 mL of E1A lysis buffer [50 mM HEPES (pH 7.0), 250 mM NaCl, 0.1% Nonidet P-
40, 50 mM sodium fluoride, 1 µg/mL each aprotinin and leupeptin] for 30 min on ice. Lysates 
were transferred to a microcentrifuge tube and cleared by centrifugation at 10,000xg for 5 min. 
An aliquot of each lysate was used as an unimmunoprecipitated control. Samples were incubated 
with 30 µL of antibody (anti-52K serum, anti-pVII serum, or pre-immune serum as a control) for 
1 hr on ice. Protein A sepharose beads rehydrated in E1A lysis buffer (0.1 g/mL) were added (50 
µL/sample) and incubated for 4-6 hrs at 4˚C on a nutator. Beads were washed four times in E1A 
lysis buffer, then resuspended in 2X SDS sample buffer containing 2% βME and boiled for 5 
min. Samples were separated by 10% SDS-PAGE and transferred to a PVDF membrane. The 
membrane was blocked overnight in 10% skim milk in TBST, then probed with anti-52K or anti-
pVII serum diluted 1:200 in TBST with 1% skim milk for 1 hr. Membranes were washed three 
times for 1 hr each in TBST before probing with horseradish peroxidase conjugated goat anti-
rabbit IgG light chain specific serum (Jackson Immunoresearch) diluted 1:10,000 in TBST with 
1% skim milk for 1 hr at room temperature. Membranes were washed again in TBST (3 x 1 hr 
each) and developed with an ECL Advance kit (GE Healthcare) as per the manufacturer’s 
instructions. Membranes were exposed to x-ray film for 5 minutes and developed. 
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4.2.8 Mass spectrometry analysis of proteins co-precipitating with 52K 
MDBK cells were infected with BAdV-3 at a MOI of 5 pfu/cell as described in section 4.2.6. 
At 48 hrs post-infection, the cells were harvested by centrifugation at 3,000 rpm (1,950xg) for 10 
min, washed in phosphate-buffered saline (PBS) and resuspended in 4 mL of 
radioimmunoprecipitation buffer (RIPA) [50 mM Tris-Cl (pH 8.0), 150 mM NaCl, 0.1% sodium 
dodecyl sulfate (SDS), 1% nonidet P 40, 1% deoxycholic acid] containing 1 µg/mL each 
aprotinin, leupeptin, and pepstatin A. The resuspended cells were sonicated (4 x 30 seconds) and 
lysate was cleared by centrifugation at 10,000xg for 5 minutes. Anti-52K serum (30 µL) was 
added to 200 µL of cell lysate supernatant and 200 µL RIPA, and incubated for 6-8 hours at 4˚C 
on a nutator. Protein A sepharose beads were rehydrated in RIPA (0.1g/mL), washed, and 100µL 
was added to each binding reaction and incubated overnight at 4˚C on a nutator. Finally, the 
beads were washed four times with RIPA and mixed with an equal volume of 2X SDS sample 
buffer. Samples were boiled for 5 min and separated by 10% SDS-PAGE. Gels were stained with 
Coomassie blue for 15 min and washed in several changes of destain solution for 4-6 hrs. 
Sections of the gel were excised and sent for mass spectrometry identification of proteins. 
Mass spectrometry analysis of the gel fragments was performed at the National Research 
Council Plant Biotechnology Institute (Saskatoon, SK). Protein identification was performed 
using a workflow similar to that described by Sheoran et al. (2005). In brief, excised bands from 
the SDS-PAGE separation were subjected to an automated process of de-staining, reduction, and 
alkylation, followed by tryptic digestion, using a MassPrep II Proteomics Workstation 
(Micromass, UK). The resulting tryptic peptides were detected using on-line chromatography 
coupled to a Q-ToF Ultima Global mass spectrometer (Micromass, UK). The mass spectrometry 
data was processed and searched against the NCBInr database, hosted by NRC (Ottawa), using 
MASCOT Daemon (Matrix Science Ltd., London, UK) identifying proteins present in the gel 
band. 
 
4.2.9 Co-immunoprecipitation of in vitro translated proteins 
Proteins were translated using a TNT T7 Coupled Reticulocyte Lysate System (Promega). 
Plasmid pcDNA-NFBP-HA DNA (1 µg) was in vitro transcribed and translated in the absence of 
[35S]-methionine. Similarly, individual plasmid (pcDNA.52K, pc52K∆1 to pc52K∆8) DNA (1 
µg) was in vitro transcribed and translated in the presence of [35S]-methionine (Perkin-Elmer). 
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For each in vitro binding reaction, 45 µL of unlabeled NFBP-HA was mixed with 45 µL 
radiolabeled wild-type or mutant 52K protein in GST binding buffer and incubated at 4˚C for 4 
hrs on a nutator. The proteins were incubated with 10 µL of a mouse monoclonal anti-HA 
antibody (Sigma-Aldrich) or a mouse anti-c-myc antibody (Sigma-Aldrich) overnight at 4˚C on a 
nutator. GammaBind G Sepharose beads (GE Healthcare) were washed and added to binding 
reactions (50 µL per reaction) for 4 hrs at 4˚C on a nutator. Finally, the beads were washed three 
times in GST binding buffer and mixed with an equal volume of 2X SDS sample buffer 
containing 2% βME. Samples were boiled for 5 min and separated by 10% SDS-PAGE. Gels 
were fixed in destain solution containing 5% glycerol for 30 min and dried onto filter paper, then 
exposed to a phosphor screen (Kodak). The phosphor screen was visualized on a Bio-Rad 
Molecular Imager FX using Quantity One software (Bio-Rad).  
 
4.2.10 Immunofluorescence microscopy 
COS7 cells were seeded onto 4-well glass slides and transfected with 1 µg of indicated 
plasmid DNA using lipofectin (Invitrogen) in Opti-MEM (Invitrogen) per the manufacturer’s 
instructions. After 24 hrs, cells were fixed in 3.7% paraformaldehyde for 15 minutes at room 
temperature, washed three times in PBS, and permeabilized with 0.2% Triton X-100 for 5 
minutes. After three washes with PBS, the cells were blocked in 2% goat serum for 30 mins. The 
cells were incubated with rabbit anti-52K serum diluted 1:50 and/or a mouse anti-nucleolin 
monoclonal antibody (Stressgen) diluted to 1 µg/mL for 1 hr at room temperature. After three 
PBS washes, the cells were incubated with Cy2-conjugated goat anti-rabbit IgG (Jackson 
Immunoresearch) and/or Cy3-conjugated goat anti-mouse IgG diluted 1:800 for 1 hr at room 
temperature. After three PBS washes, cells were counterstained with 2 µg/mL DAPI for 5 min, 
mounted in Citifluor mounting reagent, and visualized on an Axiovert UV microscope using 
Zeiss AxioVision software. 
 
4.3 Results 
 
4.3.1 Yeast two-hybrid analysis of BAdV-3 proteins interacting with 52K 
To identify BAdV-3 proteins that interact with BAdV-3 52K, a yeast two-hybrid system was 
used as previously described (Kulshreshtha and Tikoo, 2008). Briefly, viral proteins were 
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expressed in a pGADT7 vector fused to the activation domain of the yeast GAL4 protein. The 
BAdV-3 52K protein was expressed in a pGBKT7 vector fused to the DNA-binding domain of 
the GAL4 protein. Interactions between 52K and any of the other viral proteins brings the GAL4 
activation domain in proximity to the GAL4 DNA binding domain and allows activation of yeast 
reporter genes that are used as selection markers. Yeast co-transformed with pGBK.52K and 
individual pGADT7 plasmids expressing BAdV-3 proteins were grown on low-, medium-, and 
high-stringency selective media to screen for interactions. As a control, pGBK.52K was also co-
transformed with pGADT7 but did not permit growth on selective media (data not shown), 
indicating that pGBK.52K alone cannot activate expression of the reporter genes. 
The results of the yeast two-hybrid screen are shown in figure 4.1. Yeast co-transformed with 
pGBK.52K and pGADT7-IVa2 were able to grow on medium-stringency media (figure 4.1, 
panel A) but not on high-stringency media (data not shown), suggesting that there could be a 
weak or transient interaction between 52K and IVa2. 52K has been shown to interact with IVa2 
in HAdV-5 (Gustin et al., 1996). However, co-transformation of yeast with pGBKT7 and 
pGADT7-IVa2 also permits growth on medium-stringency media (figure 4.1, panel C), so this 
could also be a false positive. Similarly, co-transformation of yeast with pGBK.52K and 
pGADT7-pVI permitted growth on medium-stringency media (figure 4.1, panel A) but not high-
stringency media (data not shown). However, co-transformation of pGADT7-pVI and pGBKT7 
also permitted growth on medium-stringency media (figure 4.1, panel C), suggesting that this is a 
false positive and not indicative of an interaction between 52K and pVI. 
Yeast co-transformed with pGBK.52K and pGADT7-V grew on medium-stringency (figure 
4.1, panel A) and high-stringency media (figure 4.1, panel B), but did not hydrolyze X-α-gal. 
This suggests that while these co-transformed yeast were able to activate the two reporter genes 
required for survival on the high-stringency dropout media, the MEL1 reporter gene was not 
activated despite being under the control of the same GAL4 promoter. Co-transformation of yeast 
with pGBKT7 and pGADT7-V did not permit growth on selective media (data not shown), 
indicating that pV alone is not activating the reporter genes. 
Co-transformation with pGBK.52K and pGADT7-pVII permitted growth on medium-
stringency (figure 4.1, panel A) and high-stringency media (figure 4.1, panel B). Yeast co-
transformed with pGBKT7 and pGADT7-pVII were not able to grow on selective media (data
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A. 
pGBK.52K + pGADT7-V 
pGBK.52K + pGADT7-IVa2 
pGBK.52K + pGADT7-pVI 
pGBK.52K + pGADT7-pVII 
pGBK.52K + pGADT7-VII 
pGBK.52K + pGADT7-V 
pGBKT7 + pGADT7-pVI 
Figure 4.1 Yeast two-hybrid analysis of BAdV-3 proteins interacting with 52K.  Yeast 
were co-transformed with indicated plasmids and plated on selective media. A. Growth on 
medium-stringency selective media (Leu–/Trp–/His–).  Interactions between 52K and IVa2, 
pV, pVI, and pVII were detected. B. Growth on high-stringency selective media (Leu–/Trp–
/His–/Ade–/X-α-gal). Interactions between 52K and pV and pVII were detected. C. Co-
transformation of pGBKT7 with pGADT7-IVa2 or pGADT7-pVI permits growth on 
medium-stringency media. 
B. 
C. pGBKT7 + pGADT7-IVa2 
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not shown), indicating that there is a specific interaction between 52K and pVII. An interaction 
between 52K and pVII has previously been demonstrated in HAdV-5 (Zhang and Arcos, 2005). 
 
4.3.2 52K interacts with pVII 
To confirm the interactions between 52K and IVa2, pV, and pVII detected by the yeast two-
hybrid system, a GST pulldown assay was performed. A GST-52K fusion protein was expressed 
in bacteria and purified, then allowed to bind to in vitro translated, [35S]-labeled IVa2, pV, or 
pVII. As shown in figure 4.2 (panel A), pVII is pulled down by the GST-52K fusion protein (lane 
2) but not by GST alone (lane 3). However, GST-52K did not interact with pV or IVa2 (data not 
shown). This shows that pVII interacts specifically with 52K. Since this interaction occurs in an 
in vitro binding assay, it is a direct interaction that does not require other viral or cellular factors.  
Next, we confirmed the interaction of 52K with pVII during BAdV-3 infection. Initially, we 
examined pVII expression during BAdV-3 infection. As shown in figure 4.2 (panel B), anti-pVII 
serum recognizes two proteins of 22 kDa and 20 kDa, slightly larger than the predicted molecular 
weights of uncleaved pVII (19 kDa) and cleaved VII (16.6 kDa). No such proteins are detected in 
lysate from uninfected cells (figure 4.2 panel B). The proteins could be detected after 24-48 hrs 
post-infection but were not detected at 12 hrs post infection. Next, we determined if 52K and 
pVII interact in BAdV-3 infected cells. Proteins from lysates of BAdV-3 infected cells were 
immunoprecipitated with anti-pVII serum. The co-immunoprecipitated proteins were separated 
by 10% SDS-PAGE, transferred to PVDF membranes, and probed in Western blot using anti-
52K serum. As seen in figure 4.2 (panel C), the 52K protein could be detected in BAdV-3 
infected cell lysates immunoprecipitated with anti-pVII serum and probed in Western blot with 
anti-52K serum (lane 2). As expected, 52K protein could be detected in BAdV-3 infected cell 
lysates that were left untreated (lane 4) or immunoprecipitated with anti-52K serum (lane 3) and 
probed in Western blot with anti-52K serum. No such protein could be detected in BAdV-3 
infected cell lysates immunoprecipitated with pre-immune serum and probed in Western blot 
with anti-52K serum (lane 1). However, as shown in figure 4.2 (panel D), pVII protein could not 
be detected in BAdV-3 infected cell lysates immunoprecipitated with anti-52K serum and probed 
in Western blot with anti-pVII serum (lane 2). As expected, pVII (cleaved and uncleaved) could 
be detected in BAdV-3 infected cell lysates that were unimmunoprecipitated and probed in 
Western blot with anti-pVII serum (lane 4), while uncleaved pVII protein could be detected in
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Figure 4.2 Interaction of 52K with pVII.  A. GST pulldown assay.  In vitro translated 
pVII (lane 1) is pulled down by GST-52K (lane 2) but not GST (lane 3). B. Expression of 
pVII during BAdV-3 infection. Cell lysates were separated by SDS-PAGE and probed in 
Western blot with anti-pVII serum. Molecular weight standards are indicated in kDa. C. Co-
immunoprecipitation of 52K and pVII from BAdV-3 infected MDBK cells.  Lysate from 
BAdV-3 infected cells was immunoprecipitated with pre-immune serum (Pre, lane 1), anti-
pVII serum (lane 2), or anti-52K serum (lane 3). Untreated lysate was run as a positive 
control (lane 4). Proteins were separated by SDS-PAGE and probed with anti-52K serum by 
Western blot. Molecular weight standards are indicated in kDa. D. Infected cell lysates 
immunoprecipitated with pre-immune serum (Pre, lane 1), anti-52K serum (lane 2) or anti-
pVII serum were separated by SDS-PAGE along with unimmunoprecipitated lysate (lane 4) 
and probed with anti-pVII serum by Western blot. Molecular weight standards are indicated 
in kDa. 
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BAdV-3 infected cell lysates that were immunoprecipitated with anti-pVII serum and probed in 
Western blot with anti-pVII serum (lane 3). No such protein could be detected in BAdV-3 
infected cell lysates immunoprecipitated with prebleed serum and probed in Western blot with 
anti-pVII serum (lane 1). 
 
4.3.3 Mass spectrometry identification of cellular proteins interacting with BAdV-3 52K 
To identify cellular proteins that may interact with 52K during BAdV-3 infection, proteins 
from lysates of BAdV-3 infected MDBK cells were immunoprecipitated with anti-52K serum. 
Immunoprecipitated samples were separated by SDS-PAGE, and fragments of the gel were sent 
for mass spectrometry analysis. Three peaks were identified by a Mascot database search. A 
rabbit transferrin precursor and a rabbit serum albumin precursor were identified, but neither of 
these hits were statistically significant according to the Mascot search. Peptides corresponding to 
an S1 RNA-binding domain-containing protein from Arabidopsis thaliana (GenBank accession 
number 15229915) and the pre-rRNA processing protein Rrp5p of Arabidopsis thaliana 
(GenBank accession number 10998136) were identified and found to be statistically significant 
by the Mascot search (p=0.00079 and p=0.04, respectively).  
The identified proteins from Arabidopsis have known homologs in yeast and humans. The 
yeast homolog, Rrp5p, is known to be involved in ribosomal RNA processing (Venema and 
Tollervey, 1996). A mammalian protein with significant homology to Rrp5p has been identified 
(Venema and Tollervey, 1996), and given a number of different names by different groups, 
including apoptosis-linked gene 4 (ALG-4), programmed cell death protein 11 (PDCD11), and 
NFκB-binding protein (NFBP) (Lacana and D'Adamio, 1999; Sweet et al., 2003). Like yeast 
Rrp5p, human NFBP contains S1 RNA-binding domains and the C-terminus also contains a 
histone acetyl transferase repeat (Sweet et al., 2003). A bovine homolog of NFBP also exists 
(NCBI reference sequence NP_001095573.1). The bovine NFBP has high sequence identity with 
the human NFBP (NCBI reference sequence NP_005791.1), with 84% sequence identity and 
only 3 amino acids difference in length (1871 and 1874 for human and bovine NFBP, 
respectively). 
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4.3.4 In vitro interaction of 52K and NFκB-binding protein (NFBP) 
To confirm the mass spectrometry results, we determined if 52K and NFBP could interact 
directly in an in vitro binding assay. Plasmid pcDNA-NFBP-HA (expressing human NFBP fused 
to an HA epitope tag) or plasmid pcDNA.52K were transcribed and translated in vitro in the 
absence or presence of [35S]-methionine, respectively. After incubating the in vitro translated 
labeled (52K) and unlabeled (NFBP-HA) proteins for 4 hrs at 4˚C, the unlabeled NFBP-HA 
protein was immunoprecipitated using an anti-HA antibody. The immunoprecipitated proteins 
were separated by SDS-PAGE and radiolabeled protein was visualized by exposure to a phosphor 
screen using a phosphorimager. The anti-HA serum immunoprecipitated a faint band 
corresponding to the 52K protein (figure 4.3), indicating that 52K is bound to NFBP-HA. An 
anti-c-myc serum did not immunoprecipitate the 52K protein, showing that the 52K band was 
specific to NFBP-HA. These results confirm the mass spectrometry identification of NFBP as a 
cellular protein that interacts with 52K, and the in vitro binding shows that this interaction is 
direct and not mediated by another cellular or viral protein or other co-factors such as RNA. 
 
4.3.5 Identification of NFBP-binding region of 52K 
To identify the region of 52K involved in binding to NFBP, a series of mutant 52K proteins 
were expressed. Initially, individual deletions in the 52K ORF were cloned into plasmid pcDNA 
and the expression of mutant proteins was examined by SDS-PAGE analysis of mutant proteins 
in vitro transcribed and translated in the presence of [35S]-methionine. As seen in figure 4.4 
(panel A), in vitro translation produced mutant 52K proteins of expected sizes. Finally, NFBP-
HA was translated in vitro and incubated with in vitro translated, [35S]-labeled individual mutant 
52K proteins. The ability of NFBP-HA to interact with each mutant 52K protein was determined 
by separating the HA-immunoprecipitated samples by SDS-PAGE and exposing the gel to a 
phosphor screen to detect the radiolabeled 52K proteins. As seen in figure 4.4 (panel B), all 
mutants except deletions ∆1, ∆2, and ∆3 (amino acids 2 to 134) showed significant binding of 
NFBP-HA with 52K. However, deletions ∆1, ∆2, and ∆3 showed significantly reduced binding 
of 52K to NFBP-HA (figure 4.4, panel B). This could not be due to differences in the expression 
level of in vitro translated mutant 52K proteins, as all in vitro translated mutant proteins showed 
similar levels of expression (figure 4.4, panel A). These results suggest that the N-terminal 134 
amino acids of 52K contain domain(s) involved in the interaction of 52K with NFBP. 
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Figure 4.3 In vitro interaction of NFBP with 52K.  In vitro translated NFBP-
HA was mixed with in vitro translated, [35S]-methionine-labeled 52K, and 
immunoprecipitated with an anti-HA antibody.  Immunoprecipitation with an 
anti-c-myc antibody was used as a negative control. Molecular weight standards 
are indicated in kDa. 
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Figure 4.4 The N-terminus of 52K is involved in binding NFBP.  A. 52K mutants were 
translated in vitro in the presence of [35S]-methionine.  Equal volumes of the translation 
mixture were separated by SDS-PAGE and visualized to determine the level of protein 
expression. B. Immunoprecipitation of 52K mutants by NFBP-HA. In vitro translated 
radiolabeled 52K mutants were mixed with in vitro translated unlabeled NFBP-HA, then 
immunoprecipitated with an anti-HA antibody. Samples were separated by SDS-PAGE and 
exposed to a phosphor screen to visualize the immunoprecipitated radiolabeled 52K 
constructs. Molecular weight standards (M) are indicated in kDa. 
– 52K  
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4.3.6 Co-localization of 52K and NFBP 
Since 52K and NFBP were shown to interact in vitro, we determined if they co-localize in 
transfected cells. NFBP has been shown to localize in distinct regions of the nucleus presumed to  
be the nucleolus (Sweet et al., 2005), while 52K localizes in the nucleus but appears to be 
excluded from the nucleolus (section 3.3.3). 
First, to determine if NFBP does localize to nucleoli, COS7 cells were transfected with the 
plasmid pEY.NFBP that expresses NFBP fused to enhanced yellow-green fluorescent protein 
(EYFP). Cells were fixed in paraformaldehyde, permeabilized, and stained with a mouse 
antibody against nucleolin, a cellular protein known to localize in the nucleolus. As previously 
reported (Sweet et al., 2005), NFBP localized in distinct centers of the nucleus, and co-localizes 
with nucleolin (figure 4.5). This confirms that NFBP does localize to the nucleolus. 
To examine if 52K and NFBP co-localize, cells were co-transfected with pcDNA.52K and 
pEY.NFBP, then fixed in paraformaldehyde, permeabilized, and stained with anti-52K serum. In 
the cells expressing both 52K and NFBP, NFBP appeared diffused throughout the nucleus (figure 
4.6, filled arrow). In cells expressing only NFBP, it accumulated in the nucleoli (figure 4.6, 
empty arrows). This re-distribution of NFBP in the presence of 52K was seen in the majority of 
co-transfected cells and suggests that 52K relocalizes some of the NFBP to other parts of the 
nucleus. 
 
4.4 Discussion 
Protein-DNA and protein-protein interactions are important for capsid assembly and DNA 
packaging, leading to the production of progeny adenovirus. A number of proteins, including 
IVa2 (Zhang and Imperiale, 2000; Zhang et al., 2001; Zhang and Imperiale, 2003; Perez-Romero 
et al., 2005; Tyler et al., 2007), IIIa (D'Halluin et al., 1978b), pVII (Zhang and Arcos, 2005), 22K 
(Ostapchuk et al., 2006), and 52K (Hasson et al., 1989; Gustin and Imperiale, 1998), are 
potentially involved in the packaging of adenovirus DNA. Of these, 52K has been suggested to 
be involved in serotype specific adenoviral DNA packaging (Wohl and Hearing, 2008). Although 
interaction of 52K with other DNA packaging proteins including IVa2 (Gustin et al., 1996) and 
pVII (Zhang and Arcos, 2005) has been reported, the importance of these interactions in DNA 
packaging is not clear yet. Since 52K is detected in empty capsids, assembly intermediates, and
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Figure 4.5 NFBP localizes in the nucleolus of transfected cells.  A plasmid 
expressing an EYFP-NFBP fusion protein was transfected into COS7 cells, 
which were then fixed and stained with a mouse anti-nucleolin antibody 
followed by a Cy3 conjugated goat anti-mouse IgG antibody to visualize the 
nucleoli. A. Intracellular localization of EYFP-NFBP. B. Nucleolin stain to 
identify nucleoli. C. Merge of EYFP and nucleolin staining.  
A B C 
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Figure 4.6 Co-localization of 52K and NFBP in transfected cells. COS7 cells were 
transfected with pcDNA.52K and pEY.NFBP, fixed, and stained with anti-52K serum 
and Cy3-conjugated goat anti-rabbit IgG (panel A). The NFBP-EYFP fusion protein was 
visualized directly (panel B).  A merge of the Cy3 and EYFP images is shown (panel C). 
In cells expressing both 52K and NFBP (filled arrow), NFBP is diffused throughout the 
nucleus with some NFBP still present in the nucleolus. However, cells expressing NFBP 
alone (empty arrows) show nucleolar accumulation of NFBP. 
A 
B 
C 
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young virions but not in mature virions (Hasson et al., 1992), it may interact with other proteins 
(viral/cellular) and perform additional functions. In the present report, we confirm the interaction 
of 52K with pVII previously reported in HAdV-5. In addition, we report for the first time that 
52K interacts with the cellular protein NFBP. 
A yeast two-hybrid system was used to screen for interactions between BAdV-3 52K and 
other viral proteins. On medium- or high-stringency selective media, specific interactions were 
detected between 52K and IVa2, pV, and pVII. In HAdV-5, 52K has been shown to interact with 
IVa2 and pVII (Gustin et al., 1996; Zhang and Arcos, 2005). However, in BAdV-3, only the 
interaction between 52K and pVII could be confirmed by an in vitro GST pulldown assay. If 52K 
and IVa2 interact in BAdV-3, the interaction could be transient or too weak to be detectable by 
the in vitro GST pulldown assay. 
Anti-pVII serum was able to specifically co-precipitate 52K from infected cells, suggesting 
that 52K and pVII interact in BAdV-3 infected cells. However, anti-pVII serum appears to only 
immunoprecipitate the uncleaved form of pVII. Interestingly, GST-52K also interacted with the 
uncleaved form of pVII. These results suggest that 52K interacts with the uncleaved form of 
pVII, although our results do not exclude the possibility that 52K also interacts with the cleaved 
form of protein VII. It is possible that adenovirus protease cleavage of pVII to produce mature 
VII protein during processing of young virions to mature virions removes 52K from the nucleus. 
Support for this comes from the fact that 52K is detected in empty capsids, assembly 
intermediates, and young virions but not in mature virions, and that in the absence of active viral 
protease 52K remains associated with young virions (Hasson et al., 1992). Surprisingly, anti-52K 
serum was not able to co-precipitate pVII from BAdV-3 infected cells. This could be due to 
epitope masking. Binding of pVII to 52K could block access to epitopes recognized by the anti-
52K serum and prevent the pVII/52K complex from being precipitated by anti-52K serum. It is 
also possible that the high affinity binding of antibodies to 52K disrupts the interaction between 
52K and pVII or that only a small percentage of 52K may bind to pVII, making it difficult to 
detect pVII co-precipitated with 52K. 
Mass spectrometry analysis of proteins co-immunoprecipitating with 52K identified a cellular 
protein, NFκB binding protein (NFBP). This interaction appears to be direct and does not require 
other cellular or viral proteins or other factors such as RNA. However, since the detected in vitro 
interaction is very weak, it is possible that other cellular or viral proteins could enhance the 
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interaction between 52K and NFBP in vivo. It is also possible that 52K would bind with higher 
affinity to the bovine NFBP homolog than to the human NFBP protein used for the in vitro 
assays. Although human and bovine NFBP proteins show 84% amino acid sequence identity, 
small differences in the protein sequence could affect the binding affinity of 52K for human 
NFBP compared to bovine NFBP. Deletions within the N-terminal 134 amino acids of 52K 
significantly reduce the in vitro interaction of 52K with NFBP, suggesting that these interactions 
involve residues spanning different regions of the 52K protein. The NFBP binding site of 52K 
could be highly conformation dependent, and thus the deletions may affect proper folding of 
52K. Alternatively, interaction of 52K with NFBP may involve extensive protein-protein 
contacts. 
NFBP localizes to the nucleolus of transfected cells. However, a significant amount of NFBP 
appears to be localized in the nucleus of transfected cells co-expressing 52K and NFBP. Since 
NFBP is involved in normal rRNA processing in the nucleolus (Sweet et al., 2008), it is possible 
that significant redistribution of NFBP to other parts of the nucleus in cells expressing 52K may 
decrease rRNA processing. Thus, the 52K protein may be involved in the disruption of rRNA 
processing observed in HAdV-5 infected cells (Castiglia and Flint, 1983). Alternatively, 
interaction of 52K and NFBP could alter NFκB activity (Sweet et al., 2003) or modulate the 
apoptosis response through NFκB-mediated transcription of the Fas ligand (Lacana and 
D'Adamio, 1999). 
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5.0 52K AND RIBOSOMAL RNA PROCESSING 
 
5.1 Introduction 
Adenovirus infection inhibits a number of normal cellular processes, including host ribosomal 
RNA (rRNA) processing (Raskas et al., 1970; Ledinko, 1972; Castiglia and Flint, 1983; Lawler 
et al., 1989). Normally, a single rRNA precursor is synthesized and processed in the nucleolus by 
cleavage and covalent modification into three smaller rRNA molecules (5.8S, 18S, and 28S) that 
are associated with ribosomes (Gerbi and Borovjagin, 2004; Nazar, 2004; Henras et al., 2008). In 
adenovirus infected cells, the production of new 28S, 18S, and 5.8S rRNA species from the pre-
rRNA precursor is inhibited, indicating a block in rRNA processing (Raskas et al., 1970; 
Ledinko, 1972; Castiglia and Flint, 1983; Lawler et al., 1989). Export of the rRNA to the 
cytoplasm may also be inhibited (Castiglia and Flint, 1983). Whether rRNA transcription is also 
decreased is unclear. While several viral proteins such as IVa2, pV, IVa2, and µ have been shown 
to localize to the nucleolus (Lutz et al., 1996; Matthews, 2001; Lee et al., 2003; Lee et al., 
2004b), where rRNA transcription and processing occurs, the viral protein responsible for 
inhibiting rRNA processing during virus infection has not been identified. 
The processing of rRNA requires the association of many ribosomal and non-ribosomal 
proteins and ribonucleoprotein molecules with the pre-RNA, and occurs in a step-wise manner.  
The NFκB-binding protein (NFBP) has been shown to be essential for rRNA processing (Sweet 
et al., 2008). Knocking down the expression of NFBP by small interfering RNA inhibits the 
appearance of 18S rRNA but not of pre-rRNA precursors, suggesting that NFBP has an essential 
role in the processing of the pre-rRNA. Similarly, Rrp5p, a yeast homolog of NFBP, is required 
for the recruitment of several other factors required for rRNA processing (Venema and Tollervey, 
1996; Vos et al., 2004; de Boer et al., 2006; Pérez-Fernández et al., 2007). 
The L1 region of human adenovirus (HAdV) -5 encodes a nonstructural 52/55K protein which 
is present as two differentially phosphorylated forms of a 48 kDa precursor (Lucher et al., 1986; 
Hasson et al., 1992). The 52K protein is involved in the packaging of adenovirus DNA (Hasson 
et al., 1989; Gustin and Imperiale, 1998). The N-terminal half of the 52K protein mediates 
serotype specificity for packaging of the viral genome into the capsid (Wohl and Hearing, 2008). 
Recently, we demonstrated that the 52K protein of bovine adenovirus (BAdV)-3 interacts with 
NFBP (section 4.3), which is involved in rRNA processing (Sweet et al., 2008). Co-expression of 
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52K and NFBP in transfected cells results in significant redistribution of NFBP from the 
nucleolus to other parts of the nucleus. This suggested that relocalization of NFBP away from the 
nucleolus may affect rRNA processing occurring in the nucleolus (Henras et al., 2008). Here, we 
determined if the 52K protein is involved in the inhibition of rRNA processing during BAdV-3 
infection of bovine cells. 
 
5.2 Materials and Methods 
 
5.2.1 Cell lines and viruses 
Madin-Darby bovine kidney (MDBK) cells were propagated in minimal essential medium 
(MEM; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; SeraCare Life 
Sciences). 293T cells were propagated in Dulbecco’s modified Eagle’s medium (DMEM; Sigma-
Aldrich) supplemented with 10% FBS.  
Wild-type BAdV-3 (WBR-1 strain) was grown in MDBK cells in MEM supplemented with 
2% FBS and was purified by cesium chloride density-gradient centrifugation (Reddy et al., 
1999a). The virus titer was determined by plaque assay (Mittal et al., 1995) to be 1x108 plaque-
forming units (pfu)/mL.  
HAdV-5 mutant viruses were propagated in 293T cells grown in DMEM supplemented with 
2% FBS. A replication-defective HAdV-5 vector expressing GFP (AdGFP) was provided by M. 
Cotten and has been previously described (Michou et al., 1999). 293T cells infected with AdGFP 
in three 150cm2 flasks were lysed by five freeze-thaw cycles and the titer of the lysate was 
determined by TCID50 assay (Both et al., 2007) to be 1x107 TCID50/mL. 
 
5.2.2 Plasmid construction 
A second generation lentivirus system was a gift from Dr. Robert Brownlie (Vaccine and 
Infectious Disease Organization, University of Saskatchewan) and included plasmids pTRIP-
WRE-pur [a modified lentiviral vector (Brownlie et al., 2009) containing the encapsidation 
signal] pXPAX2 [encoding HIV Gag and Pol proteins; (al Yacoub et al., 2007)] and pMD2.G 
[encoding the VSV G protein; (al Yacoub et al., 2007)]. The plasmid pTRIP.GFP [expressing 
green fluorescent protein [GFP]) was also a gift from Dr. Brownlie (unpublished data). A 1.1-kb 
XhoI-BamHI fragment containing the BAdV-3 52K ORF was isolated from plasmid pcDNA.52K 
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(section 3.2.7) and ligated to XhoI-BamHI digested plasmid pTRIP-WRE-pur creating plasmid 
pTRIP.52K.  
A 599-bp BsrGI-NcoI fragment containing the internal ribosome entry site (IRES) from 
encephalomyocarditis virus (Bochkov and Palmenberg, 2006) was isolated from plasmid pGIPz 
(Open Biosystems) and ligated to BsiWI-NcoI digested plasmid Litmus28i (New England 
Biolabs) to create plasmid pL28i.IRES. Similarly, a 1.1-kb EcoRV-BamHI fragment containing 
the BAdV-3 52K ORF was isolated from plasmid pcDNA.52K and ligated to SnaBI-BglII 
digested plasmid pL28i.IRES creating plasmid pL28i.52K.IRES. Finally, a 745-bp AgeI-XbaI 
fragment containing enhanced yellow fluorescent protein (EYFP) was isolated from plasmid 
pEYFPN1 (Clontech) and ligated to AgeI-XbaI digested plasmid pL28i.52K.IRES creating 
plasmid pL28i.52K.IRES.EY. The entire 2.5-kb EcoRI-StuI fragment containing 52K-IRES-
EYFP was isolated from plasmid pL28i.52K.IRES.EY and ligated to EcoRI-EcoRV digested 
plasmid pH5L (Zakhartchouk et al., 2005) creating plasmid pH5L.52K.EY (figure 5.1). This 
plasmid is predicted to express BAdV-3 52K and EYFP from a single bicistronic mRNA 
transcript. 
 
5.2.3 Rescue of replication-defective lentivirus vectors 
Plasmid pTRIP.52K DNA (1.5 µg) or plasmid pTRIP.GFP DNA (1.5 µg) was co-transfected 
with plasmid pXPAX2 DNA (1 µg) and plasmid pMD2.G DNA (0.5 µg) into 293T cells in 100-
mm dishes using lipofectin (Invitrogen) in Opti-MEM (Invitrogen) as per the manufacturer’s 
instructions. Supernatant was collected at 48 and 72 hrs post-transfection. Cell debris was cleared 
by centrifugation at 3,000 rpm (1,950xg) for 20 min at 4˚C. Virus was harvested by 
centrifugation at 23,000 rpm for 1.5 hrs in a Beckman SW28 rotor and resuspended in DMEM. 
 
5.2.4 MDBK cell lines expressing 52K or GFP 
Purified pseudotyped lentivirus vectors (TRIP.52K or TRIP.GFP) were mixed with 8 µg/mL 
Sequa-brene (Sigma-Aldrich) and incubated at room temperature for at least 30 minutes.  
The virus mixtures were added to MDBK cells in serum-free MEM in 6 wells (TRIP.52K) or 
1 well (TRIP.GFP) of a 24-well plate. After 6 hrs, media was supplemented with FBS to a final 
concentration of 2%. At 24 hrs post-infection, cells were split into 100-mm dishes. At 48 hrs 
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Figure 5.1 Plasmids used to generate a replication-defective HAdV-5 vector 
expressing 52K and EYFP. Plasmid pH5L.52K.EY contains the left-hand portion of the 
HAdV-5 genome including the ITR but is deleted for the E1 region and instead contains 
52K and EYFP under the control of a CMV promoter and separated by an IRES.  Plasmid 
pH5R contains the right-hand portion of the HAdV-5 genome from pIX onward, including 
the right ITR.  Plasmids are linearized by digestion with PacI and homologous 
recombination between the pIX/IVa2 regions generates a linear genome with an ITR and 
both ends that is replication-competent in cells expressing adenovirus E1 proteins. 
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post-infection, media was replaced with MEM containing 10% dialyzed FBS (Invitrogen) and 2 
µg/mL puromycin for selection.  Media was changed every 3 days. After 7-10 days, puromycin 
concentration was increased to 8 µg/mL. When the puromycin-selected cells were confluent, they 
were split into 100-mm plates to reach a confluence of 20% the next day and the puromycin 
concentration was increased to 50µg/mL after 24 hrs. For TRIP.52K-transduced cells, after 7-10 
days puromycin-resistant colonies were harvested and transferred to individual wells of a 96-well 
plate. Out of 30 clones isolated, a single clone which showed adequate growth was selected for 
use in further experiments. Expression of BAdV-3 52K in this cell line (MDBK:52K) was 
confirmed by indirect immunofluorescence using anti-52K serum as described in section 3.2.6 
and by Western blot using anti-52K serum as described in section 3.2.5. 
For TRIP.GFP-transduced cells, the puromycin-selected cells in two 100-mm dishes were 
allowed to reach confluence and were passaged in the presence of 50µg/mL puromycin and used 
for further experiments. Expression of GFP in this cell line (MDBK:GFP) was confirmed by 
visualizing cells directly on an AxioVert UV microscope.  
 
5.2.5 Rescue of a replication-defective HAdV-5 vector expressing BAdV-3 52K 
Plasmids pH5L.52K.EY and pH5R (Zakhartchouk et al., 2005) (figure 5.1) were linearized by 
PacI digestion and DNA was purified by phenol-chloroform extraction followed by ethanol 
precipitation. To rescue recombinant virus by homologous recombination, 293T cells in one well 
of a 6-well plate were co-transfected with 1 µg each of linearized pH5R and pH5L.52K.EY DNA 
using lipofectin (Invitrogen) in serum-free Opti-MEM (Invitrogen) as per the manufacturer’s 
instructions. At 8 hrs post-transfection, Opti-MEM was replaced with DMEM containing 2% 
FBS. Cells were passaged as required post-transfection. After 24 days, fluorescent cells were 
visible but no cytopathic effects (CPE) were observed. Cells in a 75cm2 flask were lysed by five 
freeze-thaw cycles and used to infect new 293T cells in a 25cm2 flask. Visible CPE and 
fluorescence were visible after several days, indicating rescue of the recombinant virus (HAdV5-
52K).  The infected cells in a 75cm2 flask were lysed by five freeze-thaw cycles and the lysate 
was passaged several more times in 293T cells to amplify the virus. At the end of amplification, 
the virus was released from cells in three 150cm2 flasks by five freeze-thaw cycles and titered. 
The titer of the lysate was determined by TCID50 assay (Both et al., 2007) and was determined to 
be 1x109 TCID50/mL. 
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To confirm the expression of BAdV-3 52K, 293T cells in one well of a 6-well plate were 
infected with HAdV5-52K lysate (50 TCID50/cell) in MEM. Two hrs post infection, media was 
supplemented with 2% FBS. After 24 hrs post infection, the cells were harvested, lysed, and 
analyzed by Western blot using anti-52K serum as described in section 3.2.5. In addition, 293T 
cells infected with HAdV5-52K were fixed 24 hrs post infection in methanol for 20 min at -20˚C 
and the intracellular localization of 52K was examined by indirect immunofluorescence using 
anti-52K serum and Cy3-conjugated goat anti-rabbit IgG (diluted 1:800) as described in section 
3.2.6. 
 
5.2.6 Ribosomal RNA processing assay 
Analysis of cellular rRNA processing was carried out based on a previously described method 
(Sweet et al., 2008). MDBK cells were grown to approximately 80% confluency and rinsed in 
MEM before incubating with wild-type BAdV-3 (MOI of 5 pfu/cell), AdGFP (MOI of 50 
TCID50/cell), or HAdV5-52K (MOI of 50 TCID50/cell) in MEM for 2 hrs. Media was then 
replaced with MEM supplemented with 2% FBS.  
At the indicated time post infection, the cells were starved in phosphate-free DMEM 
(Invitrogen) in 10% FBS for 30 min before pulsing with MEM containing 15µCi/mL [32P]-
orthophosphate (Perkin Elmer) and 10% FBS for 45 minutes. The [32P] pulsed cells were chased 
with MEM supplemented with 10% FBS for 2 hrs. Finally, the cells were harvested, lysed, and 
total RNA was extracted using either an RNeasy purification system (Qiagen) or TRIzol reagent 
(Invitrogen). The cpm/mL of each RNA sample was calculated by measuring radioactivity of a 
mixture of an aliquot of the purified RNA and scintillation fluid in a Beckman scintillation 
counter.  
Equal cpms of purified RNAs in 8 µL of RNase-free water were mixed with 2 µL of 5X RNA 
loading buffer [0.16% bromophenol blue, 4 mM EDTA (pH 8.0), 7.2% formaldehyde, 20% 
glycerol, 30% formamide, 10X formaldehyde agarose gel buffer (200 mM MOPS, 50 mM 
sodium acetate, 10 mM EDTA, pH adjusted to 7.0) at a final concentration of 4X] and separated 
on a 1.2% formaldehyde-agarose gel by electrophoresis. Finally, the gel was dried onto filter 
paper and exposed to a phosphor screen overnight. The phosphor screen was visualized on a Bio-
Rad Molecular Imager FX using Quantity One software (Bio-Rad). Densitometric analysis of the 
gels was also performed using the Quantity One program. 
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5.3 Results 
 
5.3.1 Inhibition of ribosomal RNA processing during BAdV-3 infection 
To determine if BAdV-3 infection of bovine cells affects rRNA processing, MDBK cells were 
infected with BAdV-3 at an MOI of 5 pfu/cell and ribosomal RNA processing was examined at 
various times post-infection in a pulse-chase experiment. At 0 hrs post infection, 47S and 32S 
precursor rRNA is efficiently processed into 28S and 18S rRNA (figure 5.2, panel A). By 24 hrs 
post infection, there is a significant reduction in the amounts of 28S and 18S rRNA with a 
significant increase in the amount of 32S and 47S precursors. This reduction in processing is also 
apparent at 36 and 48 hrs post infection. There also appears to be less total labeled rRNA at 36 
and 48 hrs post infection, suggesting a reduction in rRNA synthesis in proportion to total RNA 
synthesis. 
 
5.3.2 Construction of an MDBK cell line expressing BAdV-3 52K 
Due to the low transfection efficiency of MDBK cells, our initial attempts to study the effects 
of BAdV-3 52K in the absence of other BAdV-3 viral proteins using a transient expression 
system proved futile. As such, we chose to construct a stable MDBK cell line expressing BAdV-
3 52K using a replication-defective lentivirus system (Brownlie et al., 2009). 
BAdV-3 52K was cloned into a plasmid from a second generation lentivirus expression 
system (pTRIP-WRE-pur) and pseudotyped lentivirus TRIP.52K was produced by co-
transfection of 293T cells with plasmids pTRIP.52K, pXPAX2, and pMD2.G. Similarly, 
pseudotyped lentivirus TRIP.GFP was produced by co-transfection of 293T cells with plasmids 
pTRIP.GFP, pXPAX2, and pMD2.G. The TRIP.52K or TRIP.GFP lentiviruses were used to 
transduce MDBK cells and puromycin resistant clones were selected by culturing the lentivirus-
transduced cells in the presence of puromycin (50 µg/mL). A single puromycin-resistant clone 
was selected and checked for the expression of 52K by Western blot analysis and indirect 
immunofluorescence or expression of GFP by fluorescent microscopy. Cell lines expressing GFP 
(MDBK:GFP) or BAdV-3 52K (MDBK:52K) were selected for further analysis. As shown in 
figure 5.3, the level of expression of BAdV-3 52K in the MDBK:52K cell line is significantly 
lower than that seen in BAdV-3 infected MDBK cells (panel A) and does not appear to be 
expressed in 100% of cells (panel B). 
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Figure 5.2 Inhibition of ribosomal RNA processing during BAdV-3 infection.  
MDBK cells infected with BAdV-3 were labeled at 12, 24, 36, or 48 hours post-
infection with media containing [32P] and chased in MEM for 2 hours. Uninfected 
cells (0 hrs post-infection) were similarly labeled and chased. Total RNA was 
harvested and 2.5x103 cpm were loaded in each lane and separated by formaldahyde-
agarose electrophoresis, then visualized by exposure to a phosphor screen. A. 
Ribosomal RNA species in uninfected (0 hrs) and infected cells (12-48 hrs) are 
marked. B. Total RNA visualized by ethidium bromide staining. Molecular weight 
standards (M) are indicated in kilobases.  
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Figure 5.3 Expression of 52K in MDBK:52K cells. A. The expression of 52K 
in MDBK:52K cells and BAdV-3 infected MDBK cells was examined by 
Western blot using anti-52K serum. Molecular weight standards are indicated in 
kDa. B. Expression of 52K in MDBK:52K cell line visualized by indirect 
immunofluorescence of fixed cells using anti-52K serum and Cy2 conjugated 
goat anti-rabbit IgG. 
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5.3.3 Construction of a replication-defective HAdV-5 vector expressing BAdV-3 52K 
To attempt to express BAdV-3 52K in close to 100% of cells, we chose to construct a 
replication-defective HAdV-5 expressing BAdV-3 52K and EYFP on a single bicistronic 
transcript under the control of the CMV promoter, with EYFP translation under the control of an 
IRES (figure 5.1).  
To rescue recombinant virus, we used two plasmids. The plasmid pH5L.52K.EY contains the 
left-hand portion of the HAdV-5 genome including pIX and IVa2, while the plasmid pH5R 
contains the rest of the genome containing overlap of the pIX and IVa2 regions. Briefly, 293T 
cells were transfected with PacI-linearized plasmids pH5R and pH5L.52K.EY. The homologous 
recombination in the co-transfected cells between the two linearized plasmids generates a linear 
viral genome containing an inverted terminal repeat at both ends that permits virus replication 
and allows the recombinant virus to be rescued. Cells showing cytopathic effects and green 
fluorescence were collected, freeze-thawed, and cell lysate was used to infect MDBK cells. 
The expression of BAdV-3 52K was analyzed by Western blot using anti-52K serum. As seen 
in figure 5.4, anti-52K serum detected two proteins of 35 kDa and 36 kDa in HAdV5-52K 
infected (figure 5.4, panel A) or pH5L.52K.EY transfected (data not shown) 293T cells. 
However, a protein of 40 kDa was detected in BAdV-3 infected MDBK cells (figure 5.4, panel 
A). The difference in the molecular weight of BAdV-3 52K expressed in BAdV-3 infected 
MDBK cells and HAdV5-52K infected or pH5L.52K.EY transfected 293T cells suggested that an 
error in the 52K ORF had been introduced during cloning. DNA sequencing revealed a four 
nucleotide deletion (nucleotides 10,984 to 10,897 in Genbank AF030154) in the 52K ORF in 
plasmid pH5L.52K.EY which caused a frame shift and introduced a stop codon, truncating the 
52K ORF at amino acid 302. While it is possible that this could affect BAdV-3 52K function for 
the ribosomal RNA assay, considering that the NFBP-binding domain of 52K appears to be 
located in the N-terminus of the protein and that the truncated BAdV-3 52K protein still localizes 
to the nucleus (figure 5.4, panel B), the HAdV5-52K virus was used for the following ribosomal 
RNA experiments. 
 
5.3.4 Effect of 52K expression on ribosomal RNA processing 
To determine if expression of BAdV-3 52K in MDBK:52K cells inhibits rRNA processing, 
cellular rRNA was labeled with [32P] and analyzed by formaldehyde-agarose gel electrophoresis.
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Figure 5.4 Expression of 52K by the recombinant virus HAdV5-52K. A. Lysates 
from 293T cells infected with HAdV5-52K (lane 1) or MDBK cells infected with 5 
pfu/cell BAdV-3 (lane 2) were separated by SDS-PAGE and analyzed by Western blot 
using anti-52K serum. Molecular weight standards (M) are indicated in kDa. B. The 
intracellular localization of 52K in MDBK cells infected with HAdV5-52K was 
determined by indirect immunofluorescence using anti-52K serum and Cy3-conjugated 
goat anti-rabbit IgG.   
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As seen in figure 5.5, at 24 hrs post infection there is no detectable amount of 28S and 18S rRNA 
produced in MDBK cells infected with 5 pfu/cell of BAdV-3 (panel A, lane 4). However, 
detectable amounts of 28S and 18S rRNAs are produced in normal MDBK cells (panel A, lane 
1). Interestingly, similar detectable amounts of 28S and 18S rRNA are also produced in 
MDBK:GFP (panel A, lane 2) or MDBK:52K (panel A, lane 3) cells. 
To determine if expression of the truncated BAdV-3 52K in HAdV5-52K infected cells 
inhibits cellular rRNA processing, cellular rRNAs in uninfected, HAdV5-52K infected, AdGFP 
infected, or BAdV-3 infected MDBK cells were labeled with [32P] and analyzed by 
formaldehyde-agarose gel electrophoresis. As seen in figure 5.6, at 24 hrs post infection there 
was significant increase in the amount of 47S rRNA precursor and a slight decrease in the 
amount of 28S and 18S rRNA in BAdV-3 infected cells (panel A, lane 4). However, there was no 
detectable 47S rRNA precursor in normal MDBK (panel A, lane 1) or AdGFP infected MDBK 
(panel A, lane 2) cells. Similarly, there was no detectable 47S rRNA precursor in HAdV5-52K 
infected MDBK cells expressing BAdV-3 52K (panel A, lane 3). Taken together, our data 
suggests that the expression of the full-length or truncated 52K in the absence of other viral 
proteins does not inhibit rRNA processing. 
 
5.4 Discussion 
Although inhibition of ribosomal RNA processing during adenovirus infection was first 
discovered in the 1970s, the mechanism of this inhibition remains poorly understood (Ledinko, 
1972; Castiglia and Flint, 1983). Earlier, we demonstrated that the 52K protein of BAdV-3 
interacts with the cellular protein NFBP (section 4.3), which is known to be essential for rRNA 
processing (Sweet et al., 2008). Since co-expression of 52K and NFBP in transfected cells 
disrupts the nucleolar localization of NFBP (section 4.3.6), we hypothesized that the interaction 
between 52K and NFBP may inhibit rRNA processing during BAdV-3 infection. 
Like HAdV-5 (Ledinko, 1972; Castiglia and Flint, 1983; Lawler et al., 1989), processing of 
cellular precursor rRNA into 28S and 18S rRNAs is inhibited in BAdV-3 infected cells. This 
suggests that inhibition of precursor rRNA processing may be a common phenomenon conserved 
across adenoviruses, including members of the Mastadenovirus genus.  
Expression of a truncated BAdV-3 52K (amino acids 1-302) in MDBK cells using replication-
defective HAdV5-52K did not affect the efficiency of processing of precursor rRNA to 28S and 
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Figure 5.5 Ribosomal RNA processing in a 52K-expressing cell line. A. MDBK 
(lane 1), MDBK:GFP (lane 2), or MDBK:52K cells (lane 3), along with BAdV-3 
infected MDBK cells 24 hrs post-infection (lane 4) were phosphate starved, labeled 
with 32P, and chased for 2 hrs in complete media. Total RNA was harvested and  
4.7x103 cpms were loaded into each lane of a formaldehyde-agarose gel and separated 
by electrophoresis. The gel was dried and exposed to a phosphor screen to visualize 
rRNA species. B. Ethidium bromide stain of the formaldehyde-agarose gel to 
visualize total RNA loaded. Molecular weight standards are indicated in kilobases. 
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Figure 5.6 Ribosomal RNA processing in HAdV5-52K infected cells.  
MDBK cells were mock-infected (lane 1) or infected with AdGFP (lane 2), 
HAdV5-52K (lane 3), or BAdV-3 (lane 4). After 24 hours, cells were starved 
in phosphate-free media, labeled with 32P, and chased for 2 hrs in complete 
media before total RNA was harvested. A. 1.2 x 104 cpms were and separated 
on a formaldehyde-agarose gel to visualize rRNA. B. Total RNA was 
visualized by ethidium bromide staining. Molecular weight standards are 
shown in kilobases. 
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18S rRNAs. It is possible that amino acids 303-370 may be required for inhibiting the processing 
of precursor rRNA. However, we have demonstrated that the N-terminal 134 amino acids of 
BAdV-3 52K may be involved in binding to NFBP. Alternatively, it is possible that the amount 
of 52K required to inhibit rRNA processing is not sufficient in HAdV5-52K infected cells as seen 
in figure 5.4. 
Surprisingly, expression of the complete BAdV-3 52K ORF in MDBK cells also did not affect 
the efficiency of processing of precursor rRNA to 28S and 18S rRNAs. Since immunofluorescent 
staining showed that not all cells were expressing 52K, it was possible that the lack of inhibition 
of rRNA processing was due to not enough cells expressing 52K, or cells not expressing 52K at a 
high enough level. Alternatively, it is possible that 52K co-operates with other viral proteins to 
inhibit rRNA processing but is unable to exert this effect when expressed alone. Viral proteins 
IVa2, pV, pVII, and µ have been shown to localize to the nucleolus in HAdV (Lutz et al., 1996; 
Matthews, 2001; Lee et al., 2003; Lee et al., 2004b) and could potentially be involved in 
inhibition of rRNA processing. 
It is also possible that the interaction between 52K and NFBP may have other effects during 
BAdV-3 infection, such as altering NFκB transcriptional activity (Sweet et al., 2003) or 
modulating the apoptosis response through transcription of the Fas ligand (Lacana and 
D'Adamio, 1999). 
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6.0 GENERAL DISCUSSION AND CONCLUSIONS 
 
Bovine adenovirus (BAdV)-3 has potential as a vector for gene delivery and vaccination 
(Reddy et al., 1999b). Because of the observed differences between human and non-human 
adenoviruses, including differences in cell entry (Bangari et al., 2005), transcriptional 
organization of the genome (Reddy et al., 1998), location of DNA packaging signals (Xing et al., 
2003; Xing and Tikoo, 2007), proteins encoded by the E3 and E4 regions (Reddy et al., 1998; 
Idamakanti et al., 1999), and the absence of the virus-associated RNAs in BAdV-3 (Reddy et al., 
1998), it is important to characterize the structure and function of individual BAdV-3 proteins in 
order to develop improved and efficient BAdV-3 vectors. 
Adenoviruses encode a non-structural late protein named 52K, which is conserved in members 
of the family Adenoviridae (Davison et al., 2003). Earlier reports have suggested a role for 52K 
in serotype specific packaging of adenovirus DNA (Hasson et al., 1989; Gustin and Imperiale, 
1998; Wohl and Hearing, 2008). Moreover, 52K has been shown to interact with the viral IVa2 
and pVII proteins (Gustin et al., 1996; Zhang and Arcos, 2005). Despite significant sequence 
identity among 52K proteins encoded by adenoviruses including BAdV-3 52K, the 52K protein 
has been suggested to determine the serotype specificity of adenovirus DNA packaging (Wohl 
and Hearing, 2008). 
Thus, the main aim of the present investigation was to characterize the BAdV-3 52K protein 
and determine its interaction with other viral and cellular proteins. 
DNA sequence analysis revealed that the BAdV-3 52K ORF encoded a protein of 370 amino 
acids rather than 331 amino acids as previously reported (Reddy et al., 1998). A high degree of 
sequence identity (50-60%) among 52K proteins encoded by members of the Mastadenovirus 
genus including BAdV-3 suggests that some functions of 52K may be conserved among 
members of the Mastadenovirus genus. 
Anti-52K serum detected a protein of 40 kDa at 24 to 72 hrs post-infection. This is similar to 
the expression pattern of other late genes of BAdV-3 (Reddy et al., 1998; Kulshreshtha et al., 
2004; Patel and Tikoo, 2006). BAdV-3 52K localizes predominantly to the nucleus of infected 
cells. Moreover, localization of 52K to the nucleus in transfected cells suggests that the transport 
of 52K to the nucleus is independent of other viral proteins. Due to its small size (40kDa), 52K 
could be capable of diffusing across the nuclear pores. However, free diffusion of the protein 
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across the nuclear pores would distrubute 52K equally in the cytoplasm and nucleus of the cell. 
Localization of 52K predominantly in the nucleus of infected or transfected cells suggests that the 
protein uses active import pathways, or is retained preferentially in the nucleus. To create a large 
protein incapable of entering the nucleus without using active transport pathways, we constructed 
a plasmid expressing 52K fused to enhanced yellow fluorescent protein (EYFP) to analyze the 
nuclear localization of 52K. The EYFP-52K fusion protein localized to the nucleus, indicating 
that 52K contains a nuclear localization signal (NLS) that can direct its nuclear import. Deletions 
and point mutagenesis of 52K demonstrated that a cluster of basic residues (105RKR107) was 
essential for nuclear localization, but that residues 102GMPRKRVLT110 were not sufficient to 
direct nuclear import of an unrelated protein. This suggests that either upstream or downstream 
residues of the 52K NLS are required, or the NLS is dependent on its conformation within 52K. 
The nuclear import of 52K could be reconstituted in an in vitro nuclear import assay. Nuclear 
accumulation of 52K was significantly but not completely dependent on soluble factors, ATP, 
and temperature. In contrast, a protein with the nuclear localization signal of the simian virus 40 
T antigen, which uses a classical importin α/importin β pathway, was completely dependent on 
soluble factors, ATP, and temperature. The nuclear import of 52K could be significantly inhibited 
by a peptide that competes for binding to importin β and slightly inhibited by a peptide 
containing the NLS from Ycbp80, but could not be blocked by a dominant negative mutant of 
Ran. This suggests that 52K uses the classical importin α/importin β pathway for nuclear import. 
A specific interaction of 52K with importin α3 supports this conclusion. 
52K could also localize to the nucleus in the absence of soluble factors and ATP when the 
nuclear membrane was permeabilized with detergent, suggesting that it can bind to nuclear 
components. This suggests that 52K is imported into the nucleus not only by the importin 
α3/importin β pathway, but is also retained there by binding to nuclear components. Since 52K 
interacts with the nucleolar protein NFBP, it is tempting to speculate that NFBP could be one of 
the nuclear components which may help in the localization of 52K to the nucleus. The matrix 
protein of respiratory syncytial virus and the integrase protein of human immunodeficiency virus 
have similar mechanisms of nuclear import, using the importin α/importin β pathway in addition 
to accumulating in the nucleus independently of soluble factors by binding to nuclear 
components (Ghildyal et al., 2005; Hearps and Jans, 2006). 
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A yeast two-hybrid system was used to identify viral proteins interacting with BAdV-3 52K, 
and interactions of 52K with pV, pVI, pVII, and IVa2 proteins of BAdV-3 were detected. 
However, only the interaction of 52K with pVII could be confirmed by GST pulldown. 
Moreover, 52K and pVII also interact in BAdV-3 infected cells. Although similar results have 
been reported in HAdV-5 infected cells (Zhang and Arcos, 2005), the importance of these protein 
interactions are not known. Thus, future work should focus on isolating and analyzing mutant 
BAdV-3s containing deletions or point mutations to identify protein domains/motifs involved in 
these interactions. 
Interactions of adenovirus proteins with cellular proteins during different stages of viral 
replication have been shown to be required for efficient production of progeny adenovirus. These 
interactions may alter the cell cycle (Berk, 2005), inhibit apoptosis (Berk, 2005) or host cell 
protein synthesis (Cuesta et al., 2000), and may help to defend against antiviral cellular responses 
(Horwitz, 2004). Mass spectrometry analysis of proteins co-immunoprecipitating with 52K from 
BAdV-3 infected cells identified a cellular protein, NFBP, which interacts with 52K. This 
interaction was confirmed in vitro and in vivo.  
NFBP has been shown to be essential for ribosomal RNA (rRNA) processing (Sweet et al., 
2008) and is normally localized in the nucleolus (Sweet et al., 2005). Co-expression of 52K and 
NFBP results in redistribution of NFBP from the nucleolus to other parts of the nucleus. Since 
NFBP is essential for rRNA processing in the nucleolus, it is possible that 52K inhibits rRNA 
processing by redistributing NFBP away from the nucleolus. However, we could not detect any 
difference in rRNA processing in cells expressing truncated or full length 52K. Further 
experiments are required to determine if other viral proteins are required along with 52K to 
inhibit rRNA processing in BAdV-3 infected cells. 
NFBP appears to be a multifunctional protein. The interaction between 52K and NFBP could 
therefore have other functions during BAdV-3 infection. NFBP binds to the p50 and p65 subunits 
of NFκB (Sweet et al., 2003). The interaction between 52K and NFBP could potentially modulate 
NFκB activity in BAdV-3 infected cells. NFBP has also been shown to bind the human 
immunodeficiency virus Tat protein and is able to modulate Tat- and NFκB-mediated 
transcriptional activation from the viral long terminal repeat (Sweet et al., 2005). The mouse 
homolog of NFBP, apoptosis-linked gene 4, induces apoptosis through increased transcription of 
the Fas ligand when overexpressed (Lacana and D'Adamio, 1999). It is therefore possible that the 
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interaction between 52K and NFBP inhibits apoptosis during virus infection. The 33K protein of 
BAdV-3 has been shown to inhibit apoptosis through its interaction with the bovine presenilin-1-
associated protein, a cellular mitochondrial protein that has pro-apoptotic effects (Kulshreshtha, 
2009). Further investigation will be required to determine the biological significance, if any, of 
the interaction between 52K and NFBP. 
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